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Abstract
Approximately 50% of chronic heart failure (CHF) patients have obstructive sleep apnoea 
(OSA);  however  the  mechanisms associated  with  OSA in  CHF patients  are  incompletely 
understood. The overall aim of this thesis was to characterise upper airway phenotypes that 
may contribute to OSA in patients with CHF. Specifically, I sought to test the hypothesis that 
CHF  patients  with  OSA have  overnight  rostral  fluid  shift.  Pharyngeal  phenotypes  were 
measured  non-invasively;  pharyngeal  calibre  was  measured  using  acoustic  reflection, 
pharyngeal  collapsibility  using  the  passive  critical  closing  pressure  (Pcrit)  technique,  and 
changes  in  pharyngeal  compliance  during  sleep  using  oesophageal  pressure  manometry 
combined with direct visualisation of the pharynx using bronchoscopy. Chapter 5 investigated 
differences  in pharyngeal  anatomy  and  morphology  in  healthy  younger  and  older  male 
volunteers  using  acoustic  reflection,  testing  the  hypothesis  that  older  healthy males  have 
similar pharyngeal dimensions to younger healthy males.
The findings of this thesis showed that CHF patients with OSA have similar pharyngeal cross-
sectional areas to CHF patients without OSA and healthy controls (Chapter 3). Pharyngeal 
collapsibility was also similar between groups (Chapter 4). CHF patients may be predisposed 
to  pharyngeal  collapse due to  overnight  attenuation  of  normal  pharyngeal  dilation during 
inspiration  (Chapter  6).  Finally,  it  was  demonstrated  that  there  may  be  differences  in 
pharyngeal dimensions and morphology in older males compared to younger males (Chapter 
5).
The  implications  of  the  studies presented  in  this  thesis  are  that  fluid  shift  may  be  a 
contributing factor to OSA in CHF but the findings in this thesis suggest that its role is not 
likely to be dominant over more established mechanisms of OSA. Moreover, there may be no 
special features of CHF that explain the high prevalence of OSA in CHF.
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1.1. General Introduction
Obstructive sleep apnoea (OSA) is a respiratory disorder characterised by repetitive episodes 
of  pharyngeal  narrowing and collapse during sleep.  These episodes  result  in  cessation  of 
ventilation  and  hypoxia,  despite  ongoing  efforts  to  breathe.  The  airway  reopens  and 
ventilation  is  restored  following  arousal  from sleep.  The  symptoms  of  OSA can  include 
daytime somnolence, although this is not always present, witnessed apnoeas (e.g. by a bed 
partner), and snoring. If these symptoms are not recognised then OSA can remain undetected 
for many years.
The prevalence of OSA syndrome (≥5 apnoeas or hypopnoeas per hour of sleep with daytime 
symptoms of somnolence) in the general population is estimated to be approximately 4% in 
males and 2% in females (Young et al., 1993). However the prevalence of OSA irrespective of 
daytime symptoms is even higher, rising to 24% in males and 9% in females (Young et al., 
1993). As well as being more common in males than females, the prevalence of OSA tends to 
increase with age (Bixler et al., 2001, 1998; Durán et al., 2001; Young et al., 1993), although 
there is some evidence to suggest that it plateaus or decreases over the age of 65  (Ancoli-
Israel et al., 2001). In the general population the strongest predictors of OSA are high body 
mass index (BMI) and large neck circumference (for a review see Young et al., 2002). Some 
individuals may also be predisposed to OSA by their cranio-facial morphology (Dempsey et 
al., 2002).
Sleep  apnoea  is  more  common  in  congestive  heart  failure  (CHF)  than  in  the  general 
population. The prevalence is estimated to be approximately 50%, with approximately half 
having OSA and half having central sleep apnoea (CSA), though estimates vary depending on 
the criteria used to define sleep apnoea and the population studied (Bitter et al., 2009; Ferrier 
et al., 2005; Javaheri, 2006; Javaheri et al., 1998; Lanfranchi et al., 2003; MacDonald et al., 
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2008; Oldenburg et al.,  2007; Schulz et al.,  2007; Vazir et al., 2007). Unlike typical OSA 
patients,  the  prevalence  of  obesity  in  CHF  patients  is  similar  to  the  general  population 
(approximately 25%; Johansson et al., 2001; The NHS Information Centre, 2004), and CHF 
patients with OSA tend not to present with daytime somnolence (Hastings et al., 2006). It is 
not currently known what causes such a high prevalence of OSA in CHF or whether different 
daytime symptoms indicate a different underlying aetiology.
The overall aim of this thesis was to investigate the pathophysiology of OSA in CHF and to 
determine whether the underlying mechanisms of OSA differ in CHF patients compared to the 
general population. In the following sections I will describe the aetiology of OSA and CHF.
1.2. Mechanisms of Obstructive Sleep Apnoea
Obstructive  sleep  apnoea  is  defined  as  repetitive  narrowing  and  collapse  of  the  pharynx 
during  sleep.  The  pharynx  is  a  muscular  region  of  the  upper  airway  composed  of  the 
nasopharynx, oropharynx, and laryngopharynx. It  is unsupported by any bone or cartilage 
attachments except at its inferior border with the larynx and its superior border with the nasal 
and oral cavities. Due to the pharynx lacking any rigid support or bony attachments along 
most of its length, its patency is determined by a balance of factors that act on the pharyngeal  
lumen. These factors are discussed further in the following sections.
1.2.1. Site of Pharyngeal Collapse
A number of studies have attempted to localise the site of airway collapse. Due to the dynamic 
nature of the pharynx there are a number of regions in the pharynx that may be susceptible to 
collapse. The majority of papers report that pharyngeal collapse occurs in most people with 
OSA in the retro-palatal region of the oropharynx (the most narrow region of the pharynx), 
and to a lesser extent, the retro-glossal and hypopharyngeal regions (Rama et al., 2002). It is 
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interesting to  note that  several  studies  identify multiple  sites  of  collapse within the same 
individual,  suggesting  that  in  some  individuals  the  whole  airway  may  be  susceptible  to 
collapse and that it simply collapses at its most susceptible region (see Rama et al., 2002 for a 
meta-analysis and full review of this topic).
1.2.2. Pharyngeal Critical Closing Pressure
Obstructive sleep apnoea is traditionally thought to be a consequence of negative intrathoracic 
pressure  generating  a  sub-atmospheric  upper  airway  intra-luminal  pressure,  coupled  with 
insufficient upper airway muscle tone to maintain patency, resulting in pharyngeal narrowing 
and closure (Remmers et al., 1978). However, this paradigm only takes account of collapsing 
intra-luminal forces and does not account for extra-luminal forces, which may also contribute 
to upper airway resistance and collapsibility. The importance of extra-luminal forces can be 
demonstrated  by observations  of  collapse  occurring  at  pressures  equal  to  or  greater  than 
atmospheric pressure under conditions of pharyngeal hypotonia (Schwartz et al., 1998), and of 
the upper airway closing passively during central apnoea (Badr et al., 1995; see Figure 1.1). 
Neither of these observations can be explained by a paradigm where negative intra-luminal 
pressure is the only collapsing force acting on the upper airway.
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Images show the pharyngeal lumen becoming progressively narrower during a period of  
absent airflow and oesophageal pressure swings (a surrogate for respiratory effort). The  
pharynx is completely occluded in image 4 and 5. Passive pharyngeal collapse cannot be  
explained  by  a  model  of  the  pharynx  that  relies  exclusively  on  negative  intra-luminal  
pressure being the only collapsing force (Badr et al., 1995).
A comprehensive paradigm for understanding upper airway collapse is to model the upper 
airway as a Starling resistor (Knowlton and Starling, 1912). A Starling resistor consists of a 
collapsible  tube  attached  at  each  end  (upstream  and  downstream)  to  rigid  tubes  and 
surrounded by a sealed box (Figure 1.2). 
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Figure 1.1. Pharyngeal occlusion during central apnoea.
The  collapsible  segment  represents  the  pharynx,  the  upstream  segment  represents  the  
airway  opening,  the  downstream  segment  represents  the  trachea,  and  the  sealed  box  
represents extra-luminal tissue. The collapsible segment can be induced to collapse when  
pressure inside the segment (Pin) is equal to or less than the pressure outside the segment  
(Pout). See text for further description (Gold and Schwartz, 1996; Dempsey et al., 2010). 
Flow of fluid through the collapsible  segment  of the tube (above)  is  dependent  upon the 
pressure of the upstream segment (Pus) and downstream segment (Pds), the pressure of the 
rigid  box  outside  the  collapsible  segment  (Pout),  and  the  pressure  inside  the  collapsible 
segment itself (Pin) (Gold and Schwartz, 1996). In the human airway, the collapsible segment 
is  the pharynx,  Pus  is  equal  to  atmospheric  pressure,  Pds  is  equal  to  the  pressure in  the 
trachea,  and  Pout  is  the  sum  of  tissue  pressures  surrounding  the  pharynx.  Therefore 
pharyngeal patency can be subject to negative intra-luminal pressure generated by inhalation, 
and to positive extra-luminal pressures exerted by surrounding tissue (Schwartz et al., 1988). 
Under the Starling resistor model, the patency of the collapsible segment is maintained as 
long as Pin is greater than Pout. The collapsible segment will close if Pin is ever equal to, or 
less than Pout. The Pin at which collapse occurs is defined as the critical closing pressure 
(Pcrit).
The pharyngeal Pcrit is subject to additional physiological factors that are not represented by 
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Figure 1.2. Starling resistor model of the pharynx.
the Starling resistor model. Pharyngeal Pcrit can be modified by increasing or decreasing the 
stiffness  of  the  pharyngeal  wall.  This  can  be  achieved  by  increasing  or  decreasing 
neuromuscular tone of pharyngeal dilator muscles. It can also be achieved by varying the 
caudal traction on the pharynx generated by changes in lung volumes (see Section 1.2.5). The 
Pcrit can also be modified by increasing or decreasing pharyngeal size (see Section 1.2.3). 
The  pharyngeal  Pcrit  has  been  studied  extensively  in  OSA patients  and  healthy  subjects 
during wake and sleep. The Pcrit of OSA patients is consistently found to be greater (more 
positive) than healthy controls, indicating that the pharynx is more collapsible in OSA patients 
(Kirkness et al., 2008). As predicted by the Starling resistor model, the Pcrit of OSA patients 
is often found to be greater than atmospheric pressure (Patil et al., 2007). A Pcrit of -5cmH2O 
has been suggested as an important threshold for Pcrit, as the risk of OSA increases markedly 
when Pcrit is higher than this threshold  (Kirkness et al., 2008). Pcrit also correlates with a 
number of risk factors for OSA including obesity, neck circumference, soft palate length, and 
a narrow retro-palatal pharynx (Kirkness et al., 2008; Sforza et al., 2000).
Pharyngeal Pcrit in Heart Failure 
The Pcrit of CHF patients has never been measured before, therefore it is unclear whether the 
pharynx of CHF patients is more collapsible than healthy controls (see Chapter 4). However, 
there is  some evidence to  suggest that CHF patients may be prone to a more collapsible 
airway due to their age. Eikermann et al. (2007) measured pharyngeal collapsibility in healthy 
subjects  aged  18-75 years  old  using  the  Pclose  technique.  This  technique  is  not  directly 
comparable  with  Pcrit,  however  it  offers  a  useful  indication  of  the  correlation  between 
pharyngeal collapsibility and age.  It was found that Pclose positively correlated with age, 
suggesting that the pharynx became more collapsible with age. Another study that did use the 
Pcrit  technique  found  that  there  was  a  positive  correlation  between  age  and  Pcrit  when 
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regression models were adjusted for BMI and gender. Pcrit was estimated to increased 0.52 
cmH2O per decade (95% CI: 0.1 – 0.93 cmH2O per decade)  (Kirkness et al.,  2008).  This 
notion led me to conclude that it would be necessary for me to control my studies for age.
Neither  of  these studies  were  able  to  explain the possible  mechanism for  the  age-related 
increase in pharyngeal collapsibility. The possible mechanisms may be predicted using the 
Starling resistor model as a framework. It is possible that there is an age-related increase in 
the  pressure  surrounding  the  pharynx,  perhaps  due  to  increasing  body fat  with  age  (see 
Section 1.2.6). Alternatively, the pharynx may undergo changes to its dimensions due to age 
that result in a narrower or more collapsible airway (see Section 1.2.3).
1.2.3. Anatomical Determinants of Pharyngeal Calibre
According to Poiselle's law of fluid dynamics, flow of a fluid (such as air) through a conduit 
is proportional to radius raised to the 4th power (radius4), assuming flow is laminar. Therefore 
the radius of a conduit has a very large influence on the flow of fluid through it. Under the 
Starling resistor model of the pharynx, maximum airflow through the collapsible segment (the 
pharynx) can be described by the equation:
Vmax =  (Gold and Schwartz, 1996)
Where Vmax = maximal flow; Pus = pressure upstream of collapsible segment; Pcrit =  
critical closing pressure of collapsible segment; Rus = resistance upstream of collapsible  
segment.
According to this equation, maximum airflow through the collapsible segment is inversely 
proportional  to  upstream  resistance,  which  itself  is  largely  determined  by  radius.  This 
demonstrates  the  important  role  that  pharyngeal  calibre  has  on  pharyngeal  resistance, 
pharyngeal collapse, and the pathogenesis of OSA.
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Pus – Pcrit
Rus
Pharyngeal calibre in OSA patients is consistently found to be narrower than healthy controls 
(Bradley et al., 1986; Ciscar et al., 2001) and in particular, the minimum cross-sectional area 
of the pharynx is smaller (Ciscar et al., 2001). It has also been demonstrated that the shape of 
the pharyngeal lumen may be different in OSA patients compared to healthy controls (Ciscar 
et  al.,  2001).  In healthy people the shape of the pharynx in the retro-glossal region is  an 
ellipse in the lateral plane. In OSA patients the shape of the pharynx in the same region is  
more circular or elliptical in the transverse plane. It has been suggested that this may result in 
the pharynx being less resistant to collapsing forces exerted on its lateral walls by surrounding 
tissue.
Influence of Bone Structures and Cranio-Facial Morphology
The reasons for OSA patients having a narrower pharynx are multi-factorial. Cephalometric 
studies examining the bone structures that surround the pharynx have identified a number of 
key anatomical features that appear to be more common in OSA patients than in the general 
population. OSA patients have been found to have a relatively short distance between the 
spine and the anterior portion of the mandible and the maxilla which may be associated with a 
narrower retro-palatal  pharyngeal  lumen  (Dempsey  et  al.,  2002).  These  findings  are  not 
universal however, as some studies have failed to find a correlation between cranio-facial 
morphology  and  OSA  (Battagel  and  L’Estrange,  1996).  There  may  be  some  impact  of 
ethnicity on the prevalence of cranio-facial abnormalities in OSA, as some authors have noted 
a  higher  proportion  of  cranio-facial  bony restriction  in  east  Asian  OSA patients  than  in 
Caucasian or African OSA patients (Sutherland et al., 2012). Taken together, the literature to 
date suggests that cranio-facial features may be a key factor in some individuals and in certain 
populations, but that they cannot be assumed to be a universal mechanism for an anatomically 
narrow pharynx.
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Influence of Soft Tissue Structures
In addition  to  skeletal  restrictions  on the  pharynx,  there  may be  a  number  of  soft  tissue 
structures that restrict pharyngeal patency. The soft palate and tongue are among the muscles 
that  comprise  the  oropharynx,  therefore  any  variation  in  their  size  and  shape  could  be 
expected to have a direct impact on pharyngeal patency. This has been found to be the case in 
several respects for each muscle. The soft palate length is greater in OSA patients compared to 
healthy controls (Sforza et al., 2000). The soft palate volume is also increased in OSA patients 
(Schwab et al., 2003). These effects combined seem to result in significant encroachment of 
the soft palate on the retro-palatal pharyngeal lumen in OSA patients (Schwab et al., 2003). 
This could represent a significant compromise to pharyngeal patency, given that the retro-
palatal region of the pharynx is the most common site of pharyngeal collapse in OSA (Rama 
et al., 2002; see Section 1.2.1).
The tongue may encroach on the retro-glossal region of the pharynx either due to skeletal  
limitations imposed by the length of the mandible and maxilla (Dempsey et al., 2002) or due 
to enlargement of the tongue volume. In the case of skeletal restriction, the tongue may be a  
normal size but forced into a more posterior position relative to the posterior pharyngeal wall.  
Alternatively, the tongue volume may be enlarged in OSA patients, which may result in retro-
glossal narrowing (Schwab et al., 2003), irrespective of skeletal structures. Given that another 
common site of pharyngeal collapse is the retro-glossal region (Rama et al., 2002; see Section 
1.2.1), tongue encroachment on the pharynx may also represent an important compromise to 
pharyngeal patency in OSA.
Other soft tissue structures may also act directly or indirectly on the pharyngeal wall to cause 
narrowing of the pharynx. In particular, fat deposits lateral of the pharynx appear to be larger 
in  OSA patients  than  healthy controls  (Horner  et  al.,  1989;  Schwab  et  al.,  2003).  These 
enlarged fat deposits may exert lateral forces on the pharynx, causing it to narrow, particularly 
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in  the  retro-palatal  region  (Schwab  et  al.,  2003).  This  may  offer  an  explanation  for  the 
observation that the pharyngeal lumen appears to narrow in the lateral plane, leading to a 
more rounded pharyngeal shape in OSA patients (Ciscar et al., 2001).
Pharyngeal Calibre in Heart Failure 
As with pharyngeal  collapsibility,  the pharyngeal  calibre and cranio-facial  morphology of 
CHF patients has not been specifically studied. There are several large cohort studies that 
have investigated the clinical and physiological risk factors for OSA in CHF. These studies 
suggest  that  the risk factors for OSA in CHF and the general  population may be similar. 
Obesity is associated with OSA in CHF, as is age and male gender  (Yumino et al., 2009). 
Given  that  the  risk  factors  for  OSA are  similar  in  the  CHF  population  and  the  general 
population it could be assumed that pharyngeal patency may be an underlying mechanism for 
OSA in CHF as it  appears  to be in the general  population.  The lack of specific  research 
investigating the pharyngeal calibre of CHF patients with OSA is surprising, given that the 
high prevalence of OSA in CHF has been established for some time (Javaheri et al., 1998; Sin 
et al., 1999). In Chapter 3 I have attempted to address this gap in the literature by measuring 
the pharyngeal calibre of CHF patients with OSA and comparing it to the pharyngeal calibre 
of CHF patients without OSA and healthy age matched controls.
Ageing is associated with decreased facial height, and a more inferiorly located hyoid bone in 
relation to a number of anatomical reference points (Kollias and Krogstad, 1999a). Changes in 
hyoid bone location associated with age may also be mediated by facial morphology; people 
with a relatively acute angle of the mandible relative to the horizontal plane tend to have a 
greater inferior relocation of the hyoid bone associated with age than people with a more 
shallow mandible  angle  (Pae  et  al.,  2008).  The location  of  the hyoid bone may act  as  a 
surrogate of pharyngeal dimensions, particularly pharyngeal length. Pharyngeal length may be 
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an  additional  pharyngeal  dimension  that  increases  the  risk  of  OSA in  older  people,  and 
because CHF patients are older I considered it important to take this mechanism into account.
Changes  in  pharyngeal  calibre  associated  with  ageing  are  complex  and  there  is  no  firm 
consensus in the literature. Five studies found that pharyngeal calibre is decreased in older age 
(Brown et al., 1986; Huang et al., 1998; Kollias and Krogstad, 1999b; Martin et al., 1997; 
Shigeta et al., 2008b), compared to 4 studies that showed pharyngeal calibre was increased in 
older age  (Brooks and Strohl, 1992; Burger et al., 1992; Mayer et al., 1996; Tagaya et al., 
2011),  and  one  study  only  just  failed  to  show  a  significant  increase  with  age  (p=0.08; 
Malhotra et al., 2006). The characteristics of all of these studies are presented in Chapter 5, 
Table 5.3.  It is possible that the reported age-related decrease in pharyngeal calibre in some 
studies  was  due  in  part  to  unknowingly  including  asymptomatic  and  undiagnosed  OSA 
patients in their “healthy” cohorts. Therefore the reported effect was not necessarily due to 
ageing alone.
Overall, the consensus from these studies is that the pharyngeal calibre is probably increased 
in older age,  however,  given the contrasting findings in the literature,  this  consensus is a 
tentative  one.  In  Chapter  5  I  aimed  to investigate the  putative differences  in  pharyngeal 
calibre  between  younger  and  older  males.  The  groups  were  very  well  matched  for  key 
predictors of OSA including BMI and neck circumference. Groups were screened for OSA 
using polysomnography or respiratory polygraphy to ensure both groups were healthy and 
free of OSA.  I tested the hypothesis that  pharyngeal length and calibre would be similar in 
healthy older and younger males.
1.2.4. Rostral Fluid Shift
In addition to the factors influencing pharyngeal calibre described in the sections above, there 
is evidence to suggest that pharyngeal patency may be influenced by rostral fluid shift. This 
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idea was first postulated in 1996 by  Shepard et al., however the theory did not gain wider 
recognition until a later series of studies was conducted by a group in Toronto on healthy 
volunteers  (Chiu et al., 2006; Redolfi et al., 2009; Shiota et al., 2007; Su et al., 2008), and 
later on OSA patients  (Redolfi et al., 2009) and CHF patients  (Yumino et al., 2010). Under 
normal  conditions  inspiration  is  associated  with  an  increase  in  pharyngeal  calibre  and 
expiration is associated with a decrease in pharyngeal calibre. Shepard et al. (1996) found that 
mean  pharyngeal  cross-sectional  area  during  inspiration  was  significantly  smaller  when 
subjects lay in a supine posture with their legs tilted 33º up, compared to when they lay in a 
supine posture with their legs flat. The authors proposed a physiological model whereby an 
increase in central venous pressure (as would be imposed by elevating the legs) results in 
increased jugular vein volume, thus preventing normal inspiratory pharyngeal dilation (Figure
1.3).
Baseline  central venous pressure (CVP) in the supine posture is illustrated by the CVPnl  
condition.  At  low  central  venous  pressure  (CVP-)  venous  volume  is  also  low,  making  
jugular  veins  collapsible  and  able  to  compress  as  the  upper  airway  dilates  during  
inspiration. At high CVP (CVP+) venous volume is also high, making jugular veins more  
resistant  to  collapse  and  resistant  to  compression  as  the  upper  airway  dilates  during  
inspiration. Thus inspiratory pharyngeal dilation is attenuated under conditions of high  
CVP (Shepard et al., 1996).
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Figure 1.3. Model for attenuation of inspiratory pharyngeal dilation due to raised central  
venous pressure.
Subsequent  studies  have  confirmed  that  rostral  fluid  shift  is  associated  with  increased 
pharyngeal resistance (Chiu et al., 2006), decreased pharyngeal calibre (Shiota et al., 2007), 
and increased pharyngeal collapsibility  (Su et al., 2008) in healthy volunteers subjected to 
lower body positive pressure.  Furthermore,  rostral  fluid shift  has been associated with  an 
increased apnoea-hypopnoea index (AHI) in non-obese OSA patients  (Redolfi et al., 2009), 
and the AHI of sedentary OSA patients can be reduced by wearing compression stockings 
during the day; theoretically reducing the fluid available for rostral fluid shift during the night 
(Redolfi et al., 2011a). However, Jafari and Mohsenin (2011) found that only 65 of 135 OSA 
patients (48%) had any detectable rostral fluid shift. Moreover, of those that did have rostral 
fluid shift, there was no correlation between fluid shift and AHI. This finding was replicated 
by  Fischer  et  al.  (2012) who  found  no  correlation  between  overnight  changes  in  neck 
circumference and AHI, but who did find a correlation between postural changes in neck 
circumference and AHI. Overall, these studies suggest that rostral fluid shift may contribute to 
OSA severity but that this contribution may be relatively small.
Influence of Rostral Fluid Shift in Heart Failure
The effects of rostral fluid shift may be more significant in disease states where excess fluid is 
retained, as more fluid would be expected to accumulate in dependent veins and extra-cellular 
compartments during the day, making more fluid available for rostral fluid shift during the 
night. In people with hypertension, overnight decreases in leg fluid volume and increases in 
neck circumference correlate with AHI  (Friedman et  al.,  2010).  Furthermore,  people with 
drug-resistant hypertension had more severe OSA to begin with and experienced a greater 
overnight decrease in leg fluid volume and increase in neck circumference than people with 
controlled hypertension (Friedman et al., 2010). In people with chronic venous insufficiency, 
wearing compression stockings during the day resulted in significant reductions in AHI when 
compared to not wearing compression stockings (Redolfi et al., 2011b). In renal disease there 
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does not seem to be a strong association between OSA severity (according to the AHI) and 
rostral fluid shift (Elias et al., 2012); nevertheless, nocturnal renal dialysis appears to be more 
effective at  reducing AHI than ambulatory daytime dialysis  in patients with chronic renal 
disease, suggesting that fluid clearance during sleep is of added benefit for reducing AHI in 
these patients (Tang et al., 2006).
In CHF patients,  rostral  fluid shift  correlates  with AHI in patients with both obstructive-
dominant and central-dominant sleep apnoea  (Yumino et al., 2010). Also, as in other fluid-
loaded states, treatment of fluid retention may result in improvement of OSA severity. Bucca 
et  al.  (2007) hospitalised  CHF patients  with  OSA for  3  days  of  intensive  diuresis  using 
furosemide and spironolactone. This resulted in significant reduction in AHI and an increase 
in pharyngeal cross-sectional area (measured at the oro-pharyngeal junction). However, there 
are several limitations to consider in interpreting this study. First, the CHF patients in this 
study also had drug-resistant hypertension.  As discussed above, people with drug-resistant 
hypertension are prone to more severe nocturnal rostral fluid shift than people with controlled 
hypertension. Therefore it is not clear whether fluid overload in these patients was due to 
hypertension or  CHF, and whether  removal  of  excess fluid using diuretics  had additional 
ameliorative effects on their hypertension (such as reduced blood pressure and central venous 
pressure)  beyond  simple  fluid  volume reduction.  Second,  patients  in  this  study were  not 
receiving any diuretics as part of their normal CHF treatment prior to entering this study. 
Therefore  it  is  not  clear  whether  CHF patients  with OSA who are  on optimal  treatment, 
including optimally titrated diuretics, would receive the same reduction in AHI and increase 
in pharyngeal calibre as the diuretic-naive patients of this study.
The literature to date strongly suggests that rostral fluid shift is a potential mechanism for 
OSA in CHF. However, there remain uncertainties around how strong the impact of fluid shift 
is on OSA severity in CHF and whether targeting of fluid retention for treatment is of benefit 
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to patients already using diuretics to control extra-cellular fluid overload. Furthermore, the 
mechanisms by which rostral fluid shift may increase the risk of OSA in CHF have not been 
adequately explored, with only one physiological model being proposed but not tested in over 
15 years of research. In Chapters 3 and 4 I present two studies performed in the same groups 
of participants that measure overnight rostral fluid shift (using changes in neck circumference 
as a surrogate) in CHF patients with OSA. In Chapter  3 overnight changes in pharyngeal 
calibre were measured,  and I tested the hypothesis that overnight fluid shift would result in 
overnight narrowing of the pharynx. In Chapter 4 overnight changes in Pcrit were measured to 
test  the hypothesis  that  overnight  fluid shift  would  result  in  an overnight  increase in  the 
collapsibility of the pharynx.
1.2.5. Caudal Traction, Lung Volumes and Pharyngeal Length
Another determinant of pharyngeal collapsibility (Section 1.2.2) and calibre (Section 1.2.3) is 
the longitudinal tension of the pharyngeal walls, created by caudal traction. Caudal traction is 
generated when the  pharynx is  pulled  caudally towards  the  thorax.  This  occurs  either  by 
activation  of  upper  airway  dilator  muscles  located  caudally  of  the  pharynx,  and/or  by 
expansion of the lungs during inspiration, causing the trachea to be tugged further into the 
thorax. It is thought that expansion of the lungs generates caudal traction in two ways: 1) 
contraction of the diaphragm causes it to flatten and descend within the thoracic cavity. This 
caudal movement is transmitted to the pharynx via the lungs, trachea and other mediastinal 
structures; 2) Contraction and flattening of the diaphragm generates negative intra-thoracic 
pressure which inflates the lungs and also sucks the trachea further into the thoracic cavity. 
This  motion  is  transmitted  to  the  pharynx.  Therefore,  by a  combination  of  mechanisms, 
caudal traction is increased during inspiration and decreased during expiration (Van de Graaff, 
1988).  An increase in  end-expiratory lung volume has been shown to result  in decreased 
pharyngeal resistance (Begle et al., 1990; Van de Graaff, 1988), increased pharyngeal calibre 
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(Hoffstein et al., 1984) and decreased pharyngeal collapsibility (Eastwood et al., 2002; Jordan 
et al., 2010; Owens et al., 2010; Squier et al., 2010; Stanchina et al., 2003; Tagaito et al., 
2007). Lung volume-dependent changes in caudal traction appear to be independent of upper 
airway muscle activation, based on studies in an isolated dog trachea model (Van de Graaff, 
1988)  and in  humans  whose  lung volumes  are  passively manipulated  using  an iron  lung 
(Sériès et al., 1990). Therefore, it is likely that these effects are directly related to mechanical 
changes  imposed  on  the  pharynx  due  to  caudal  traction.  These  mechanical  effects  may 
include: pharyngeal unfolding; reduced pharyngeal wall compliance; decreased pharyngeal 
compression from surrounding tissue; and hyoid bone repositioning (Van de Graaff, 1988; see 
Figure 1.4).
Solid lines represent the configuration of the pharynx without caudal traction; dotted lines  
represent the configuration with caudal traction applied (Van de Graaff, 1988). 
It has been suggested that pharyngeal length may act as an additional mechanism for OSA 
(see Section 1.2.3). Pharyngeal length correlates significantly with OSA severity (Segal et al., 
2008) and is increased significantly when moving from an upright to supine posture in OSA 
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Figure  1.4.  Mechanisms  by  which  caudal  traction  may  improve  pharyngeal  patency,  
resistance and collapsibility. 
patients but not in control subjects  (Pae et al.,  1997). Pharyngeal length is also greater in 
males than females, which may be one of the causes of the higher prevalence of OSA in males 
than females  (Malhotra et al.,  2002). It is thought that a longer pharynx is more prone to 
collapse  than  a  shorter  pharynx  due  to  increased  negative  intra-luminal  pressure.  During 
inspiration,  airflow  through  a  longer  pharynx  must  necessarily  travel  faster  than  airflow 
through a shorter pharynx, assuming that lung volumes, pharyngeal calibre and inspiratory 
time are constant. Faster airflow would require a more negative intra-luminal pressure which 
would increase the collapsibility of the pharynx (Pae et al., 1997; see Figure 1.5). 
Assuming that pharyngeal calibre and inspiratory time are constant and that airflow is  
laminar, a longer pharynx (A) would require faster airflow during tidal breathing to inflate  
the same lung volume than a shorter pharynx (B). This would generate a more negative  
intra-luminal pressure and increase the collapsing forces acting on the pharyngeal lumen  
(Pae et al., 1997). 
1.2.6. Body Composition and Neck Circumference
Obesity is a consistent predictor of OSA (Kirkness et al., 2008). A high body fat percentage is 
associated  with  increased  fat  deposits  lateral  of  the  pharynx  (Horner  et  al.,  1989) and 
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Figure 1.5. Mechanism by which a longer pharynx may be more collapsible than a shorter  
pharynx.
increased tongue volume and pharyngeal wall  thickness may be associated with increased 
deposition  of  intra-muscular  fat  (Nashi  et  al.,  2007).  The  increase  in  tissue  volumes 
surrounding the pharynx may increase its collapsibility by increasing extra-luminal pressure 
(see Section 1.2.2). Given that the soft tissues of the upper airway occupy a finite space that is 
bounded by fixed skeletal structures, increased soft tissue volumes may also contribute to the 
observation that the pharyngeal lumen is narrowed in obese subjects  (Martin et  al.,  1997; 
Mayer et al., 1996; Shigeta et al., 2008a). Obesity may also promote pharyngeal collapse by 
causing  reduced  lung volumes  in  a  supine  posture.  Reduced  lung  volumes  may promote 
pharyngeal  collapse  by reducing caudal  traction  on  the  pharynx (as  discussed  in  Section 
1.2.5).
The prevalence of obesity increases with age, therefore the contribution of obesity to the risk 
of developing OSA may increase with age. Obesity is also associated with OSA in the CHF 
population (Yumino et al., 2009), however obesity is no more prevalent in the CHF population 
than in the general population (Johansson et al., 2001; The NHS Information Centre, 2004). 
Therefore obesity is likely to contribute to OSA in the CHF population, but probably cannot 
alone account for the increased prevalence of OSA in CHF patients. 
1.2.7. Control of Breathing
It has been documented previously in our laboratory as well as others, that the type of SDB 
that presents in individuals with CHF can vary; both central and obstructive events can be 
observed in the same patient in a single night, and across several nights (Tkacova et al., 2001; 
Vazir et al., 2008). It has been demonstrated in OSA patients who do not have CHF that AHI 
correlates with greater centrally-mediated breathing instability (loop gain, discussed below). 
This relationship was found in patients with severe OSA and whose Pcrit occurred above 
atmospheric pressure (Wellman et al., 2004). Furthermore, passive pharyngeal collapse can be 
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observed in as many as 90% of central apnoeas (Badr et al., 1995; see Section 1.2.2). These 
studies together demonstrate the notion that OSA and CSA are not independent of each other 
but rather interact and may in fact promote one another. Therefore in order to understand the 
high prevalence of OSA in CHF, it is also necessary to appreciate the mechanisms of central 
respiratory  control  and  how  instability  in  this  system  during  sleep  may  lead  to CSA. 
Ventilation during sleep can be modelled as a negative feedback system using an engineering 
concept called loop gain. Loop gain can be used as a framework to understand the ability of a 
negative feedback system to maintain a given output  with minimal  oscillation. Under the 
typical  model  of  loop  gain  (Figure  1.6),  a  negative  feedback  system  is composed  of  a 
controller, a plant, and a feedback sensor. The controller sets the input to the plant based on 
achieving a pre-set, desired output.  The  plant performs work that produces an output. The 
output of the system is measured by the feedback sensor and this information is fed back to 
the controller. The controller compares the sensed output to the desired output and modulates 
the input to the plant to bring the sensed output closer to the desired output. In the respiratory 
control system, the chemoreceptors represent the controller, the lungs represent the plant, and 
the circulation represents the feedback sensor. The system is modulated by an increase or 
decrease in respiratory drive with reference to maintaining a desired homeostatic upper and 
lower  limit  of  the  partial  pressure  of  arterial  CO2 (PaCO2). For  example,  a  transient 
hyperventilation due to an arousal from sleep would result in a  decrease in the PaCO2;  this 
would  be detected  by central  and peripheral  chemoreceptors,  which  would then  decrease 
sympathetic tone and ventilatory drive.  Decreased ventilation  would subsequently  increase 
PaCO2 back towards resting levels. This system would result in stability if all signals between 
components of the loop were instantaneous. However, in ventilation there are delays at each 
stage of the loop; there is a delay between a change in alveolar gas tensions being translated to 
a change in arterial gas tensions; there is a delay between a change in arterial gas tensions and 
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these  changes being  detected  at  the  chemoreceptors;  and  there  is  a  delay  between  the 
chemoreceptor response and the resultant change in ventilation  (Khoo, 2000).  These delays 
are exacerbated in CHF due to decreased cardiac output and increased circulation time when 
in a supine posture (Gibbs et al., 1989; Tkacova et al., 2001). By the time the feedback loop 
has detected and responded to  the original perturbation (the transient hyperventilation) the 
ventilatory perturbation itself may have ended. Thus the response to the original perturbation 
may result in an overshoot and become a new perturbation in itself. This would result in a 
transient hypopnoea, increase in PaCO2 and increase in chemoreceptor output; these responses 
themselves would be subject to delay and thus an oscillating pattern would be established 
(Khoo,  2000).  Therefore  for  any  given  perturbation,  a  stable  ventilatory  control  system 
requires  a  response  (or  gain)  that  is  large  enough to  maintain  blood  gas  tensions  within 
desirable limits, but not so large that it  results in an oscillating pattern of ventilation that  
prevents reaching a stable equilibrium.  In CHF an oscillating pattern of ventilation is often 
observed (both Cheyne-Stokes respiration and periodic breathing). In addition to circulatory 
delay, this may also be explained by a high hypercapnic ventilatory response (Javaheri et al., 
1998),  resulting  in  increased  controller  gain  and  an  overall  increase  in  loop  gain.  The 
combination of increased loop gain and circulatory delay have been modelled mathematically 
and  shown  to  be  sufficient  to  create  a  self-sustaining  oscillatory  pattern  of  ventilation; 
furthermore, these mathematical models have been tested in a population of CHF patients 
which confirmed the high loop gain and ventilatory instability produced by circulatory delay 
and high controller (i.e. chemoreceptor) gain (Pinna et al., 2000).
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VE (system  input)  is  set  by  the  chemoreceptors  (controller)  based  on  achieving an 
acceptable  range of  PaCO2 (reference).  The  lungs  (plant)  perform ventilation  and gas  
exchange, producing a given PACO2 (system output).This determines the PaCO2 (measured 
output) which is  transmitted  to  the  chemoreceptors,  subject  to  circulatory  delay.  If  the  
PaCO2 exceeds acceptable limits, the chemoreceptors respond by modifying VE in order to  
bring PaCO2 back within desirable limits. This system is subject to ventilatory disturbance  
which may cause the feedback loop to destabilise and assume an oscillatory pattern of  
ventilation. See text for further description (Figure adapted from Khoo, 2000 and Wellman 
et al., 2003).
Compared to OSA, central sleep apnoea (CSA) occurs when PaCO2 falls below a threshold 
(the hypocapnic apnoeic threshold; Skatrud and Dempsey, 1983). As illustrated in Figure 1.7, 
the apnoeic threshold itself is not a fixed PaCO2, but is influenced by neural respiratory drive 
and the hypercapnic ventilatory response (HCVR), which in turn is influenced by conscious 
state (Douglas et al. 1982b). In CHF, ventilatory drive is often chronically elevated due to 
pulmonary  oedema,  which  stimulates  pulmonary  J  receptors  resulting  in  chronic 
hyperventilation and decreased PaCO2 (Hanly et al.,  1993). If the slope of the ventilatory 
response  to  CO2 were  to  remain  constant  (Figure  1.7A),  chronic  hyperventilation could 
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Figure 1.6: Negative feedback model of ventilatory control based on loop gain.
actually protect against apnoea by increasing the required transient hyperventilation necessary 
to drive PaCO2 below the apnoeic threshold. CHF patients have a high prevalence of CSA, 
therefore  it  is  likely  that  other  factors  offset  the  protection  against  apnoea  conferred  by 
chronic hyperventilation. One such factor could be that CHF patients have an elevated HCVR 
during  wake  (Javaheri  1999)  which  could  mean  that  a  relatively  smaller  transient 
hyperventilation would drive PaCO2 below the apnoeic threshold (Figure 1.7B). However, this 
prediction does not take account of the findings that the slope of the HCVR changes from 
wake to sleep (Douglas et al. 1982b) and above and below eupnoea (Casey et al. 1987). A 
more robust explanation for CSA in CHF is based on the observation that in healthy subjects 
transition from wake to sleep is associated with a decrease in ventilation and an increase in 
PaCO2 of 2-4 mmHg (Douglas et al. 1982a), whereas in CHF patients, the increase in PaCO2 
during sleep is attenuated (Tkacova et al. 2001; Xie et al. 2002). This means that transition to 
sleep is associated with a relatively low PaCO2 and a relative shortfall of ventilatory drive in 
CHF (Xie et al.  2002).  Sleep is also associated with a decrease in cardiac output in CHF 
patients due to assuming a supine posture (Gibbs et al., 1989; Tkacova et al., 2001) which in 
turn leads to an increase in circulation time.  This increases the delay between  a change in 
ventilation and the resulting change in alveolar and arterial gas tensions being fed back to the 
chemoreceptors  via  the  circulation.  This  could  make  ventilatory  overshoots  more  likely, 
resulting in  an oscillating pattern of breathing (i.e.  periodic breathing and Cheyne-Stokes 
respiration). Therefore,  it  is  possible  that  in  CHF  patients,  the  protection  against  CSA 
conferred by chronic hyperventilation and hypocapnia during wake is offset by a high waking 
HCVR  (and  thus  a  higher,  less  stable  controller gain),  an  attenuated  rise  in  PaCO2 and 
ventilatory drive when transitioning from wake to sleep (thus causing them to ventilate close 
to  their  apnoeic  threshold), and  circulatory  delay  during  sleep  (thus  destabilising  the 
ventilatory feedback loop). These factors may all contribute to a higher loop gain and unstable 
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ventilatory control. They also offer mechanisms for some of the features that typify SDB in 
some CHF patients; namely a tendency towards an oscillatory breathing pattern during sleep 
(Cheyne-Stokes respiration and/or periodic breathing) and increased risk of developing CSA.
Eupnoea is represented by the hyperbolic line on both graphs. The apnoeic threshold is the 
PACO2 at which ventilation is zero. A: Effect of hyperventilation or hypoventilation when 
the slope of the ventilatory response to CO2 is constant below eupnoea. Under conditions of 
chronic hyperventilation (towards the left on the metabolic hyperbola) a relatively greater 
transient hyperventilation is required to drive PACO2 down to the apnoeic threshold. Under 
conditions of chronic hypoventilation (towards the right on the metabolic hyperbola) a 
relatively small transient hyperventilation is sufficient to drive PACO2 down to the apnoeic 
threshold. B: Effect of changing the CO2 response below eupnoea. If the slope of the CO2 
response changes, the transient hyperventilation required to drive PACO2 to the apnoeic 
threshold is altered (Dempsey et al., 2010). 
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Figure 1.7. Metabolic hyperbola for ventilatory response to CO2 below eupnoea. 
1.3. Obstructive Sleep Apnoea in Heart Failure
1.3.1. Pathophysiology of Heart Failure
CHF is  a  clinical  syndrome that  may result  from a  number  of  cardiovascular  conditions 
affecting the structure and function of the heart. Due to its often heterogeneous and multi-
factorial disease progression it can be defined according to any number of signs or symptoms 
but is most simply and broadly defined as any structural or functional cardiac disorder that 
impairs the ability of the heart to function effectively as a pump (Cowie and Zaphiriou, 2002). 
CHF occurs in approximately 1% of the UK population but increases markedly with age, 
occurring in approximately 13% of people aged ≥75 years  (Scarborough et  al.,  2011). Its 
prevalence is expected to rise as the average age of the UK population increases (Scarborough 
et al., 2011).
Clinical diagnosis of CHF is based on manifestation of symptoms (e.g. breathlessness at rest 
or during exercise), fatigue, signs of fluid retention (e.g. pulmonary or peripheral oedema), 
and objective evidence of structural or functional  abnormality of the heart  (e.g.  abnormal 
echocardiogram; raised brain natriuretic peptide) (Dickstein et al., 2008). Approximately two-
thirds  of  CHF patients  present  with  an  impaired  left  ventricular  ejection  fraction  (LVEF; 
<40% although there is no diagnostic threshold per se) (Aurigemma and Gaasch, 2004). This 
is referred to as systolic heart failure because it suggests a dysfunction in the systolic phase of  
the cardiac cycle. A reduced LVEF results in a high left-ventricular after-load and reduced 
volume of blood passing through the aorta to the systemic circulation which is insufficient to 
meet the oxygen requirements of the body.
When patients present with signs and symptoms of CHF but with a normal ejection fraction 
this  is  called  diastolic  heart  failure  and  is  associated  with  impaired  relaxation  of  the 
myocardium. This results in impaired filling of the chambers of the heart and raised end-
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diastolic pressure that ultimately prevents adequate venous return of blood to the right atrium 
(Aurigemma  and  Gaasch,  2004).  Although  systolic  and  diastolic  heart  failure  can  be 
conceptualised as separate entities, they often occur simultaneously in patients either at rest or 
during exercise and the clinical consequences and symptoms often overlap. Treatment is also 
the same regardless of whether a patient's CHF is systolic or diastolic in origin; therefore the 
distinction between these differing aetiologies could be considered to be more academic than 
clinically relevant.
In normal physiology there are a number of challenges to the maintenance of cardiac output 
that  operate  on  both  acute  and  chronic  time-scales.  For  example,  blood  pressure  can  be 
reduced due to acute challenges such as orthostatic stress, or chronic and gradual challenges 
such as dehydration. Both of these may result in decreased venous return and reduced cardiac 
output, however this is prevented by activation of sympathetic systems to constrain fluid loss. 
These can include transient increase in heart rate and cardiac contractility, vasoconstriction, 
and fluid re-uptake at the kidneys via the renin-angiotensin-aldosterone system. All of these 
responses  serve  to  maintain  blood  pressure,  increase  venous  return  and  maintain  cardiac 
output.
These normal physiological responses to reduced cardiac output are also activated in CHF as 
cardiac output is reduced in this condition. During an acute decompensation of  CHF these 
processes  work to  transiently attenuate cardiac output  reduction.  However,  these  adaptive 
mechanisms become maladaptive in CHF over a longer period of time and contribute to the 
symptoms that  typify the  condition.  Vasoconstriction  increases  the  transmural  pressure in 
capillary beds, resulting in increased diffusion of fluid from the blood plasma into interstitial 
space. This is one of the causes of peripheral and pulmonary oedema often observed in CHF. 
Normally excessive fluid in the interstitial space is drained by the lymphatic circulation and 
filtered by the kidneys to be excreted. However, vasoconstriction also occurs at the kidney, 
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and combined with increased fluid reabsorption due to activation of the renin-angiotensin-
aldesterone system, this contributes to increased extra-cellular oedema (Levick, 2003).
Vaso- and veno-constriction may also impair cardiac function by increasing the stroke volume 
required to eject blood from the left ventricle against constricted arteries, and by excessive 
cardiac  dilation  due  to  atrial  filling.  Combined,  these  mechanisms  can  result  in  cardiac 
remodelling  and  hypertrophy  (Levick,  2003).  Remodelling  and  hypertrophy  of  the 
myocardium may also be caused by chronic elevation of the sympathetic nervous system, 
resulting in chronically elevated heart rate and cardiac contractility. Initially this allows the 
heart to contract with greater force but remodelling in the long term results in impaired filling 
and emptying of the chambers of the heart. Therefore mechanisms that are effective in normal 
physiology for attenuating transient  falls  in  cardiac output  interact  chronically in  CHF to 
produce a fluid-loaded state and a net-detriment to cardiac function.
1.3.2. Treatment and Prognosis
The  aim of  CHF treatment  is  to  prevent,  reverse  or  attenuate  the  maladaptive  processes 
underpinning its pathogenesis (described above). Treatment and management incorporate one 
or more of the following types of intervention (Dickstein et al., 2008):
Non-pharmacological treatment: Consisting of education and behavioural modification that 
allows patients to recognize worsening signs and symptoms and respond appropriately (e.g. 
self-adjustment of diuretics, contacting healthcare professionals).
Pharmacological treatment: Consisting of ACE inhibitors, diuretics and beta blockers, unless 
poorly tolerated. In severe cases aldosterone antagonists and angiotensin receptor blockers 
may also be prescribed.
Surgical treatment: Surgery is recommended when the underlying cause of CHF is correctable 
by surgery (e.g. coronary artery disease). Heart transplantation is also an accepted treatment 
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for CHF when indicated by careful screening of candidates. It is believed to improve survival, 
exercise capacity and quality of life.
Device  treatment:  Devices  are  usually  used  in  patients  whose  symptoms  persist  despite 
optimum treatment.  Cardiac resynchronisation therapy is recommended for severe patients 
(NYHA III-IV;  LVEF  <40%)  who  have  prolonged  QRS  width.  Implantable  cardioverter 
defibrillators are recommended for patients who have previously had ventricular fibrillation.
Prognosis  in  CHF remains  relatively  poor,  despite  continuing  advances  in  treatment  and 
management. In the UK in 2010, 32% of all patients admitted for CHF died within one year 
(The NHS Information Centre, 2009). Prognosis for individuals is complex and determined by 
a number of factors including disease severity and progression, age, co-morbidities and course 
of treatment (Dickstein et al., 2008).
1.3.3. Mechanisms of Obstructive Sleep Apnoea in Heart Failure
Despite  the  high  prevalence  of  OSA in  CHF,  there  have  been  surprisingly  few  studies 
investigating the pathophysiological interactions between these two diseases. It is relatively 
well established that OSA may be a contributing mechanism for CHF. OSA that is undetected 
and untreated for many years may contribute to CHF progression by sympathetic nervous 
system activation, decreased left ventricular pre-load and increased after-load and increased 
hypertension (Bradley and Floras, 2003). Despite this well established causative relationship 
between OSA and CHF, there is surprisingly little data on the reverse relationship whereby 
CHF may cause OSA.
In the preceding sections, the mechanisms of OSA were discussed in light of their specific 
effects in CHF where this data was available, and also in light of their effects in older age. 
Older age was used as a surrogate of CHF where specific data could not be found for CHF 
because CHF is predominantly a disease of older age. Review of the literature reveals that 
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there are several mechanisms by which OSA may be increased in older age and CHF. These 
include changes in  cranio-facial  morphology (Section  1.2.3),  decreased pharyngeal  calibre 
(Section 1.2.3), increased pharyngeal collapsibility (Section 1.2.2), and increased pharyngeal 
length (Section 1.2.5). Given that all of these factors are affected in some way by ageing, all 
of these could be potential mechanisms for OSA in CHF, however, no studies of any of these 
factors have been conducted in CHF patients to date. The one exception to this is in the case 
of rostral fluid shift.
Rostral  fluid  shift  correlates  with AHI in CHF patients  with  OSA and reduction  of  fluid 
overload by diuresis  may increase  pharyngeal  calibre  and decrease  AHI.  The theory that 
rostral  fluid  shift  contributes  to  OSA in  CHF  is  very  attractive,  as  it  proposes  a  direct  
mechanism by which CHF may cause OSA. However, the mechanisms by which rostral fluid 
shift may cause OSA have not themselves been adequately explored and there are still large 
gaps in our understanding of the pathophysiological causes of OSA in CHF. The experiments 
presented in this thesis are designed to address some of these gaps in our present knowledge. 
1.4. Aims of Thesis
The aim of this thesis was to investigate the mechanisms of OSA in CHF. Specifically, I have 
investigated the contribution of fluid shift to the pathogenesis of OSA in CHF. This was done 
by investigating pharyngeal phenotypes of CHF patients relating to pharyngeal collapsibility 
and pharyngeal calibre.
In Chapter 3, changes in pharyngeal calibre were measured in CHF patients with OSA, CHF 
patients without OSA and healthy controls. Measurements  were performed in a seated and 
supine posture and in the evening and morning. The aim of this study was to determine the 
effects  of  rostral  fluid shift  and postural  change on pharyngeal  calibre during wake.  The 
hypotheses were that neck circumference would be greater and pharyngeal calibre would be 
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smaller in CHF patients with OSA than CHF patients without OSA and healthy age-matched 
controls; and that neck circumference would increase and pharyngeal calibre would decrease 
overnight in CHF patients with OSA more than CHF patients without OSA and healthy age-
matched controls.
In  Chapter  4,  the  same  cohort  of  participants  from  Chapter  3  had their  pharyngeal 
collapsibility measured in the early and late part of the night. The aim of this study was to 
investigate  whether  overnight  rostral  fluid  shift  results  in  the  pharynx  becoming  more 
collapsible overnight. The hypotheses were that CHF patients with OSA would have a more 
collapsible pharynx than CHF patients without OSA and healthy age-matched controls; and 
that the pharynx would become more collapsible overnight in CHF patients with and without 
OSA but not healthy age-matched controls.
CHF  patients studied in Chapters 3 and 4 were older,  and so in Chapter 5 I  investigated 
whether  ageing  had any impact  on  pharyngeal  calibre. Two groups  of  healthy older  and 
younger males were recruited for this study and were very carefully matched for BMI, neck 
circumference, AHI and ODI. I tested the hypothesis that pharyngeal calibre and length would 
be similar between older and younger healthy males.
In Chapter 6 a study is presented that was conducted during a 6 month sabbatical in Detroit, 
USA.  CHF patients  with  CSA were  recruited  in  order  to  investigate  passive  pharyngeal 
collapse in CHF patients with CSA. The study also aimed to investigate any effects of rostral 
fluid shift on pharyngeal calibre during sleep. The pharynx was visualised during sleep using 
a  fibre-optic  bronchoscope.  I  tested  the  hypotheses  that  CSA is  associated  with  passive 
pharyngeal collapse in CHF patients with CSA; and that pharyngeal calibre would reduce 
progressively overnight.
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Chapter 2: General Methods
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2.1. Participants
Three of the studies presented in this thesis were conducted at the Royal Brompton Hospital, 
London, UK, and one study was conducted during a 6 month sabbatical in Detroit, USA. The 
studies presented in Chapters 3 and 4 involved the recruitment of CHF patients and healthy 
volunteers.  The  study presented  in  Chapter  5  involved  the  recruitment  of  two groups  of 
healthy  volunteers:  younger  males,  and  older  males.  The  study  presented  in  Chapter  6 
involved the recruitment of CHF patients with CSA.
For Chapters 3 and 4, CHF patients were recruited from heart failure clinics at the Royal  
Brompton Hospital from March 2009 to March 2012. Patients were screened for OSA using 
polysomnography (see Section 2.2). They were assigned to groups of CHF patients with OSA 
(CHF-OSA; AHI ≥10 events/hour  with >50% of  apnoeas defined as obstructive)  or CHF 
patients without OSA (CHF-only; AHI <10 events/hour).
For  Chapter  5,  healthy  volunteers  were  recruited  from  the  general  population  using 
advertising placed in local  newspapers and by contacting local charity groups,  sports  and 
social clubs from January 2010 to March 2012. Healthy volunteers were screened for OSA 
using polysomnography or respiratory polygraphy (see Section 2.2). Volunteers with an AHI 
≥5 events/hr were excluded from further studies. Those with an AHI ≥5 events/hr and with 
daytime symptoms of sleepiness were referred for further clinical assessment and follow-up 
via their GP.
For Chapter 6, CHF patients with CSA (CHF-CSA) were identified by screening of hospital 
records for the 5 years preceding the start of the study (February 2005 – August 2010) and by 
screening sleep apnoea clinic lists at the John D Dingell Veterans Affairs Hospital, Detroit, 
USA. Patients who had CHF and CSA (AHI ≥10 events/hr with >50% of apnoeas defined as 
central) confirmed by polysomnography were invited to participate in the study.
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2.1.1. Inclusion Criteria
Individual  inclusion  criteria  are  listed  in  each  chapter  –  they  are  also  listed  below  for 
completeness.  All  studies  received  ethical  approval  from local  ethics  committees  and  all 
participants gave written informed consent.  The studies presented in Chapters 3 and 4 were 
reviewed by the Brompton Harefield and NHLI Research Ethics Committee and received 
ethical approval (REC number 09/H0708/24). The study presented in Chapter 5 was reviewed 
by the London-Chelsea Research Ethics Committee (previously the Brompton Harefield and 
NHLI  Research  Ethics  Committee)  and  received  ethical  approval  (REC  number 
09/H0708/24). Ethical approval for the study presented in Chapter 6 was granted locally  in 
Detroit, USA by the John D. Dingell Veterans Affairs Medical Center  and the Wayne State 
University Institutional Review Board (IRB number 081596MP4F). 
On their first visit to the research sleep laboratory all participants were screened to assess their 
general  health  by  answering  a  questionnaire  on  their  medical  history  and  undergoing 
spirometry and blood pressure measurements.
Chapters 3 and 4:
Both groups of CHF patients:
• Age 18-85
• CHF severity of class II-III according to New York Heart Association criteria
• Clinically  stable  condition,  having  had  no  hospital  admissions  in  the  3  months 
preceding  testing  and no change  in  medication  4  weeks  preceding testing  (except 
minor dose changes to diuretics).
CHF patients with sleep apnoea (all the above, with the addition of):
• Apnoea-Hypopnoea Index (AHI) ≥10 events/hr.
Healthy volunteers:
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• Age 18-85
• AHI <10 events/hr and no known history of sleep disorders 
Chapter 5:
• Male
• Age 18-40 years (younger) or Age 60-85 years (older)
• No sleep disorders
• No upper airway surgery
• No ferrous metal in body
• AHI <5 events/hr
Chapter 6:
• 18-85 years old
• AHI ≥10 events per hour with >50% of events classified as central
• Left ventricular ejection fraction <40% 
• In a clinically stable condition, having had no heart failure-related hospital admission 
in the 3 months prior to recruitment. 
• No previous upper airway surgery, uncontrolled or treatment-resistant hypertension or 
recent or current problems with opioid abuse.
2.2. Experimental Techniques
In  Chapters  3,  4  and  6  participants  were  monitored  throughout  the  night  using 
polysomnography.  In  Chapter  5  participants  were  screened  for  OSA  using  unattended 
respiratory polygraphy.
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2.2.1. Polysomnography
A commercial polysomnography system was used for OSA screening studies in Chapter 3 and 
4 (SOMNOscreen,  Somnomedics  GmbH, Germany).  Data were recorded onto an  integral 
micro computer and flash card and transmitted in real time to a personal computer for online 
review. In Chapter 4 sleep was monitored using an analogue polysomnography system (Model 
12 Neurodata acquisition system, Grass Instruments,  USA). Signals were collected via an 
analogue to digital converter (Micro 1401, Cambridge Electronic Design, UK) and recorded 
using data acquisition software (Spike2 version 3.21, Cambridge Electronic Design, UK). In 
both systems, sleep/wake state was determined by using Electroencephalography (EEG) to 
monitor  brain  waves,  electro-occulogram  (EOG)  to  monitor  eye  movements  and  chin 
electromyography  (EMG)  to  monitor  muscle  tone.  Heart  rate  was  monitored  using 
electrocardiography (ECG), oxygen saturation (SaO2) was monitored using pulse oximetry, 
snoring was monitored using a vibration sensor placed over the larynx, breathing effort was 
monitored  using  respiratory  inductance  plethysmography,  and  airflow at  the  nostrils  was 
monitored using a thermistor and a pressure transducer referenced to ambient pressure.
EEG, EOG and EMG Electrode Placement
Electrodes for EEG were placed at locations on the scalp according to the international 10-20 
system  of  electrode  placement  and  according  to  the  recommendations  of  the  American 
Academy of Sleep Medicine guidelines (Iber et al., 2007). Anatomical landmarks were used 
as reference points for the placement of electrodes (inion, nasion, left and right pre-auricular 
points). The distance between pairs of anatomical landmarks was measured and subdivided 
into lengths of 10% and 20% of the total distance in order to locate electrode sites. Gold cup 
electrodes (Grass Technologies, USA) were filled with conducting paste (Ten20 EEG Paste, 
D.O. Weaver and Co., USA) and secured to the scalp using a conductive adhesive cream (EC2 
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Electrode Cream, Grass Technologies, USA) and a patch of gauze. Electrodes were placed at 
C3, C4, CZ, O1 and referenced contra-laterally to either A1 or A2. A grounding electrode was 
also  placed  on  the  forehead.  Disposable  skin  surface  electrodes  (Neuroline  720,  Ambu, 
Denmark) were used for EOG and chin EMG. EOG electrodes were placed 1cm below the 
left eye outer canthus and 1cm above the right eye outer canthus. Chin EMG electrodes were 
placed approximately 2cm below the inferior edge of the mandible and approximately 2cm to 
the left and right of the mid-line of the mandible.
ECG, Pulse Oximetry, Breathing Effort and Airflow
A 3-lead  ECG  was  used  to  record  heart  rate  continuously  throughout  all  studies,  with 
electrodes placed below the left and right clavicle notch and below the left rib cage to form an 
Einthoven's triangle. A transcutaneous infra-red pulse oximeter was placed on the finger to 
monitor  blood  oxygen  saturation.  Breathing  effort  was  measured  using  uncalibrated 
respiratory inductance plethysmography bands placed around the chest and abdomen. Airflow 
was measured at the nostrils using a catheter coupled with a pressure transducer referenced to 
ambient pressure. A thermistor was also used to indirectly measure airflow at the nostrils and 
the mouth.
Polysomnography Scoring
Polysomnography data were analysed according to the AASM recommended scoring criteria 
(Iber et al., 2007). Sleep data were scored using standard visual rules to differentiate wake and 
different stages of sleep. Data were divided into 30 second epochs and classified as either 
wake, rapid eye movement (REM) sleep or non-REM sleep (further divided into stages N1, 
N2 and N3). Apnoeas were defined as a decrease in airflow of ≥90% lasting for ≥10 seconds 
accompanied  by  either  ongoing  respiratory  efforts  (obstructive);  cessation  of  respiratory 
efforts  (central);  or  cessation  of  respiratory  effort  in  the  first  half  of  the  apnoea  with 
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resumption of respiratory efforts  before resumption of airflow (mixed).  Hypopnoeas were 
defined  as  a  ≥30% reduction  in  airflow lasting  for  ≥10 seconds  accompanied  by a  ≥4% 
decrease  in  oxygen  saturation.  No  distinction  was  made  between  obstructive  and  central 
hypopnoeas.
2.2.2. Respiratory Polygraphy
A commercial  polysomnography system (SOMNOscreen, Somnomedics GmbH, Germany) 
was adapted for respiratory polygraphy for screening studies in Chapter 5. Chapter 5 only 
included healthy volunteers with no signs or symptoms of OSA and had no comorbidities; 
thus they had low pre-test probability of OSA. In such a population respiratory polygraphy 
has  been  validated  for  screening  for  OSA,  under  the  condition  that  studies  are  scored 
manually  (Chesson  et  al.,  2003).  Respiratory  polygraphy  studies  were  unattended  and 
performed either in the home of participants or in the Royal Brompton Hospital Research 
Sleep Laboratories. Data were recorded overnight onto an integral micro computer and flash 
card and downloaded the following morning onto a personal computer. A reduced number of 
signals were recorded compared to polysomnography; the parameters monitored were heart 
rate using electrocardiography (ECG), oxygen saturation (SaO2) using pulse oximetry, snoring 
using a vibration sensor placed over the larynx, breathing effort using respiratory inductance 
plethysmography, and airflow at the nostrils using a pressure transducer referenced to ambient 
pressure. Sleep/wake state was not monitored using EEG, therefore participants were asked to 
complete a sleep diary recording the time that they turned their lights off to go to sleep, the 
time that they woke up in the morning, and any extended periods of wake during the night.
The time between participants recording lights off and recording that they had woken in the 
morning on their sleep diary was designated as “sleep”. This period was then analysed to 
determine the AHI using standard AASM criteria for apnoeas and hypopnoeas  (Iber et al., 
2007). See section on polysomnography scoring above for a full description.
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2.2.3. Respiratory Measurements
In  Chapter  4  additional  respiratory monitoring  was  required  during  the  night  in  order  to 
perform the Pcrit technique (see Chapter 1, Section  1.2.2 for a review of the literature; see 
Section 2.2.4 for the methods of the technique). Analogue respiratory signals were recorded in 
synchrony with sleep signals (described in Section  2.2.1 above) via an analogue to digital 
converter  (Micro  1401,  Cambridge  Electronic  Design,  UK)  and  recorded  using  data 
acquisition  software  that  allowed  real-time  viewing  of  signals  (Spike2  version  3.21, 
Cambridge Electronic Design, UK).
Measurement of Airflow
In Chapter 4 respiratory airflow was measured using a non-heated pneumotachometer (model 
4700A, Hans Rudolph, USA; linear flow range 0-160 l/min) attached to a nasal mask. The 
pneumotachometer contained 3 resistive mesh screens through which air was passed. It was 
assumed that airflow through the screens was laminar and that the pressure drop across the 
screens was proportional to airflow. The pressure drop across the screens was measured by 
coupling the pneumotachometer with a pressure transducer (DP45-14, Validyne, USA; range 
± 2 cmH2O) that produced a voltage signal proportional to airflow. This signal was amplified 
via  a  carrier  demodulator  (CD19A,  Model  MC1-3,  Validyne,  USA),  passed  through  an 
analogue to digital converter (Micro 1401, Cambridge Electronic Design, UK) and recorded 
in real-time using data acquisition software (Spike2, version 3, Cambridge Electronic Design, 
UK). 
Before each study a 5-point calibration was performed on the pneumotachometer to ensure the 
accuracy of airflow measurements. Five known airflows (0 L/min, ±10 L/min and ±20 L/min) 
were  passed  through  the  pneumotachometer  in  both  directions  to  calibrate  positive  and 
negative airflow. Linear regression analysis of the relationship between known airflows and 
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voltage  output  from  the  pneumotachometer  was  used  to  determine  the  airflow  value 
corresponding to 1 volt output from the pneumotachometer and this equation was entered as a 
correction factor in the data acquisition software. 
Measurement of Mask Pressure
Mask pressure was measured using a differential  pressure transducer (DP45-26, Validyne, 
USA; range ± 35 cmH2O) attached to a nasal mask. The pressure transducer was composed of 
2 air-tight compartments with very low dead-space, each housing a magnetic inductance coil. 
The compartments were separated by a steel diaphragm which in the undeflected position was 
equidistant between the two magnetic coils. A pressure line was routed into each air-tight 
compartment and a change in pressure caused the steel diaphragm to be deflected towards the 
compartment  with  lower  air  pressure.  This  caused  a  change  in  magnetic  inductance  and 
generated  a  voltage  that  was  proportional  to  the  change  in  air  pressure.  This  signal  was 
amplified by a carrier demodulator (CD19A, Model MC1-3, Validyne, USA), passed through 
an  analogue  to  digital  converter  (Micro  1401,  Cambridge  Electronic  Design,  UK)  and 
recorded  in  real-time  using data  acquisition  software  (Spike2,  version  3,  Cambridge 
Electronic Design, UK).
Before each study a 5-point calibration was performed on the pressure transducer to ensure 
the accuracy of mask pressure measurements. Five known positive and negative pressures (0 
cmH2O, ±10 cmH2O and ±20 cmH2O) were applied to the pressure transducer using a water 
manometer.  Linear  regression  analysis  of  the  relationship  between  known  pressures  and 
voltage  outputs  from  the  pressure  transducer  was  used  to  determine  the  pressure  value 
corresponding to 1 volt output from the pressure transducer and this equation was entered as a 
correction factor in the data acquisition software. 
57
Measurement of Intrathoracic Pressure
Oesophageal pressure was measured using a solid tip pressure sensor (CTO-1, Gaeltec Ltd, 
UK) coupled with a pressure transducer (model S7b/2, Gaeltec Ltd, UK). The sensor was 
passed into the oesophagus via the nostril and positioned approximately 40 cm past the nares. 
Small adjustments were made to the positioning of the sensor in order to minimise cardiac 
artefacts.  The sensor was secured externally by taping it  below the nostrils  and was held 
securely below the nasal mask during sleep studies. The pressure sensor contained a metal 
diaphragm in contact with the outside environment and was connected to an internal strain 
gauge. Changes in external pressure caused the diaphragm to deform which in turn deformed 
the strain gauge and caused a small  alteration to  its  electrical  resistance.  This signal  was 
amplified  by  the  pressure  transducer  to  produce  a  voltage  proportional  to  pressure.  The 
voltage signal was passed through an analogue to digital converter (Micro 1401, Cambridge 
Electronic Design, UK) and recorded in real-time  using data acquisition software (Spike2, 
version 3, Cambridge Electronic Design, UK).
Before each study a 5-point calibration was performed on the pressure transducer to ensure 
the  accuracy  of  oesophageal  pressure  measurements.  Five known  positive  and  negative 
pressures (0 cmH2O, ±10 cmH2O and ±20 cmH2O) were applied to the pressure transducer 
using a water manometer. Linear regression analysis of the relationship and equation were 
calculated and entered into the data acquisition software as explained above.
2.2.4. Pharyngeal Critical Closing Pressure
Pharyngeal  critical  closing  pressure  (Pcrit)  can  be  measured  under  conditions  of  active 
neuromuscular  tone  (active  Pcrit)  (Schwartz  et  al.,  1988) or  passive  neuromuscular  tone 
(passive Pcrit)  (Schwartz et al., 1998). Both techniques have been used to demonstrate the 
increased upper airway collapsibility of patients with OSA (Patil et al., 2007). Active Pcrit is 
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thought to reflect the effect of the dynamic neuromuscular response to upper airway resistance 
on collapsibility, whereas passive Pcrit is thought to reflect the effect of mechanical loads on 
collapsibility (Patil et al., 2007). For my research I have chosen to perform measurements of 
passive  Pcrit.  If  fluid  accumulation  in  the  upper  airway  does  influence  upper  airway 
collapsibility it would be expected to be via increased extraluminal pressure acting on the 
pharynx. This is a passive,  mechanical force, and would not be expected to have a direct 
effect on neuromuscular tone.
Passive Pcrit is measured by inducing upper airway muscle hypotonia. This is achieved by 
applying continuous positive airway pressure (CPAP) via a nasal mask to a sleeping subject at 
the  minimal  effective  pressure  (holding  pressure)  sufficient  to  eliminate  flow  limitation 
(Schwartz et al., 1998). Hypotonia is assumed to prevail after approximately 3 minutes of 
stable sleep at holding pressure. After this, pressure at the mask (Pmask; taken as a surrogate 
of upper airway pressure) is rapidly reduced in order to induce upper airway narrowing and 
flow limitation (Figure 2.1). Following a rapid reduction in Pmask, hypotonia persists for up 
to 5 breaths, with the upper airway becoming most collapsible on the third inspiratory effort 
(Schwartz et al. 1998). Therefore measurement of Pcrit is made using the median of 5 breaths 
immediately after rapid reduction of Pmask.
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Patients were supplied with CPAP sufficient to eliminate flow limitation (holding pressure).  
Pressure was then reduced in a square wave fashion for runs of 5 breaths. Runs of reduced  
pressure were repeated at 60 second intervals at  progressively more negative pressures  
until airflow ceased (defined as flow falling below 50 ml/s). This pressure was defined as  
Pcrit. A second and third series of runs were then performed to confirm the pressure at  
which Pcrit occurred. This protocol was performed at the start of the night and at the end  
of the night (Patil et al. 2004).
2.2.5. Protocol for Pcrit
Figure 2.2 is a diagram of the Pcrit breathing circuit. Patients were fitted with a tight-fitting 
nasal  mask  connected  to  a  positive  pressure  source  (Companion  318,  Puritan  Bennett, 
Colorado, USA) and a negative pressure source (Pegaso Cough, Dima Italia, Italy) via a 3-
way tap. Airflow was measured using a pneumotachometer and Pmask was measured using a 
differential  pressure  transducer  referenced  to  ambient  pressure.  A solid  tipped  pressure 
transducer was used to measure oesophageal pressure in participants that were able to tolerate 
the pressure transducer during sleep (see Section  2.2.3 for a full description of respiratory 
monitoring  techniques).  Sleep  stage  of  the  participants was  monitored  continuously 
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Figure 2.1: Protocol for Pcrit.
throughout Pcrit measurements using the techniques described in Section 2.2.1.
Delivery  of  positive  and  negative  pressure  was  controlled  via  a  3-way  tap.  This  also  
allowed pressure to be rapidly reduced during measurements of Pcrit.
Patients were allowed to fall  asleep with a low pressure set  on the CPAP machine.  Once 
patients had entered stage I-III NREM sleep, CPAP was titrated to eliminate flow limitation 
(holding pressure). After at least 3 minutes at holding pressure, Pmask was rapidly reduced by 
2 cmH2O from holding pressure for a run of 5 breaths in order to induce flow limitation; 
holding pressure was then re-established. After 60 seconds, Pmask was rapidly reduced by 4 
cmH2O  from  holding  pressure  for  another  run  of  5  flow-limited  breaths.  Pmask  was 
progressively reduced for runs of 5 breaths in this manner in 1 or 2 cmH2O increments over at 
least 3 different mask pressures until criteria for Pcrit were met. 
The criteria used to define Pcrit were dependent  on whether participants were able to sleep 
with the oesophageal  pressure transducer.  In participants that  were able  to  sleep with the 
oesophageal pressure transducer, Pcrit was defined as the pressure at which airflow at the 
nasal  mask  was  absent  accompanied  by ongoing oesophageal  pressure  swings,  indicating 
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closure of the pharynx (Schwartz et al., 1998, 1988). In participants who were studied without 
the oesophageal pressure cannula, Pcrit was defined as the pressure at which airflow at the 
nasal mask was absent accompanied by ongoing thoracic and abdominal movements. In some 
participants, it was not possible to reach a mask pressure low enough to cause airflow to cease 
without  causing  an  arousal  from  sleep.  In  these  participants,  linear  regression  of  the 
relationship between airflow and mask pressure was performed in order to predict the mask 
pressure at which airflow would have ceased (Patil et al., 2004). Both of these methods have 
been validated and have been shown to produce similar results for Pcrit when used to analyse 
the same sets of data (Patil et al., 2004).
Once Pcrit was established, a second set of at least 3 runs encompassing holding pressure, 
flow limitation, and Pcrit were performed to confirm the Pmask at which Pcrit occurred. If the 
patient aroused during runs of reduced Pmask they were immediately returned to holding 
pressure and allowed at least 3 minutes of stable stage II-III NREM sleep before another run 
was attempted.
2.3. Validation of Pcrit Technique
Before recruiting any patients to my studies it was necessary to validate the Pcrit circuit. I  
constructed  the  Pcrit  circuit  using  a  CPAP machine  (Companion  318,  Puritan  Bennett, 
Colorado, USA) to generate positive pressure and a cough assist machine (Pegaso Cough, 
Dima Italia, Italy) to generate negative pressure. It was necessary to test that the capabilities  
of the circuit were comparable to the system used in the seminal papers on the technique 
(Schwartz et al. 1988; Smith et al. 1988).
2.3.1. Pharyngeal Pcrit Circuit
Key capabilities  of  the  circuit  were  that  it  could  rapidly  alternate  between  positive  and 
negative pressures of ±15 cmH2O, and that it could deliver controlled increments in pressure 
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of ≤2 cmH2O. According to its  built-in micro computer, the negative pressure source was 
capable of delivering negative pressures in increments of 1 cmH2O. In order to achieve a 
mask pressure of -2 cmH2O a controlled leak was introduced into the negative pressure limb 
of the Pcrit circuit. The micro computer of the positive pressure source was also capable of 
delivering increments of 1 cmH2O and could deliver a minimum mask pressure of 1.5 cmH2O. 
The aim of the validation was to quantify the sensitivity with which pressure at the mask 
could  be  controlled  using  the  positive  and  negative  pressure  sources.  Reproducibility  of 
pressure delivery was not tested as part of the validation because the positive and negative 
pressure sources were both commercial products in routine clinical use and were assumed to 
deliver positive or negative air pressure reliably.
2.3.2. Methods
The Pcrit circuit was tested on an awake, healthy volunteer, who was set up as described in 
Section 2.2.5 The volunteer lay supine and was exposed to increments of mask pressure for up 
to 5 breaths, separated by 30 seconds of normal breathing on CPAP of 2.5 cmH 2O. Mask 
pressure was increased in increments of 2 cmH2O up to 15 cmH2O to test the positive pressure 
source. Mask pressure was then decreased in 2 cmH2O increments down to -15 cmH2O to test 
the  negative  pressure  source.  The  Pearson  correlation  coefficient  was  calculated  for  the 
pressures measured at the mask and the pressures indicated by the micro computers of the 
positive and negative pressure sources.
2.3.3. Results
The measured pressures at the mask correlated strongly with the indicated pressures of the 
positive and negative pressure sources (positive source: r2 = 0.99; negative source: r2 = 0.99; 
Figure 2.3). There was also a strong correlation between the change in indicated pressures and 
the measured pressures for both the positive and negative pressure source (positive source: r2 
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= 0.99; negative source: r2 = 0.99;  Figure 2.4). A 1 cmH2O increase in indicated pressure 
using the positive pressure source equated to an increase of 1 cmH2O at the mask. A 1 cmH2O 
decrease in indicated pressure using the negative pressure source equated to a decrease of 0.5 
cmH2O at the mask.
Squares represent positive pressures and diamonds represent negative pressures.
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Figure  2.3: Correlation between indicated pressure from positive and negative pressure  
sources and nasal pressure measured at the mask. 
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Squares represent positive pressures and diamonds represent negative pressures.
2.3.4. Summary of Pcrit Validation
The  performance  of  the  positive  and  negative  pressure  sources  were  comparable  to  the 
systems used in the seminal papers on the technique (Schwartz et al., 1998, 1988; Smith et al., 
1988). Therefore the circuit as described in this Chapter was used for measurements of Pcrit 
in Chapter 4.
2.4. Acoustic Reflection
Acoustic reflection (AR) is the second technique that I developed for the measurements of 
upper airway  calibre reported in this  thesis. It is a non-invasive method for measuring the 
dimensions of any tube using sound waves. It was first used to measure airway geometry 
when Jackson et al. (1977) used the technique to make measurements of dog lungs in vitro. It 
was later used to make non-invasive measurements of human airways (Fredberg et al., 1980) 
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Figure  2.4: Correlation between change in display pressure at  machine and change in  
measured pressure at mask. 
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and  has  been  developed  in  recent  years  for  routine  assessment  of  oral  and nasal  airway 
geometry (Brooks et al., 1989, 1984; Hilberg and Pedersen, 2000; Kamal, 2004, 2001). The 
advantages  of  AR over  imaging  techniques  such  as  computerized  tomography  (CT)  and 
magnetic  resonance imaging (MRI) are  that  it  can be performed quickly and easily,  with 
practically no discomfort to the subject. However, some skill is required of the subject in 
keeping relaxed but still during measurements and arranging their soft palate to occlude the 
nasal pharynx. Also, AR does not produce images, so although a 3-dimensional measurement 
of the upper airway can be obtained, only a limited number of specific anatomical landmarks 
can be reliably identified.
AR measurements can be made by subjects breathing a helium-oxygen gas mixture or by 
breathing  air.  Breathing  a  helium-oxygen  mixture  allows  accurate  and  reproducible 
measurements to be made to the level of the trachea. Measurements made while breathing air 
are technically less challenging to perform, but are only accurate and reproducible to the level 
of the glottis (Brooks et al., 1984; Fredberg et al., 1980; Huang et al., 1998). I chose to make 
measurements  during  air  breathing  because  the  collapsible  region  of  the  upper  airway 
encompasses the oropharynx and glottis,  but does not extend to the trachea  (Rama et al., 
2002).
AR exploits the physical principle that sound waves travelling in tubes are reflected by a 
change in tube dimensions. A microphone is used to record the amplitude and wavelength of 
reflected waves, which can be analysed to construct serial measurements of cross-sectional 
area  as  a  function  of  distance.  The assumptions  are  that  sound waves  reflected  from the 
airway  have  an  amplitude  proportional  to  the  cross-sectional  area  of  the  airway,  and  a 
wavelength  proportional  to  the  airway length  (Jackson  et  al.,  1977).  Figure  2.5 shows  a 
typical trace, recorded during my experiments. Cross-sectional area on the y-axis is plotted 
against distance from the microphone on the x-axis. The region from 0-8 cm corresponds to 
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the  wave  tube  and  mouthpiece.  The  region  from 8-18  cm encompasses  the  oral  cavity, 
oropharynx, part of the laryngo-pharynx, and terminates at the glottis. In AR measurements 
this region (from the end of the mouthpiece to the glottis) is conventionally defined as the 
pharynx (Brown et al., 1986). Pharyngeal length can be measured between these two points. 
The peak pharyngeal  area  is  assumed to  inhabit  the  oral  cavity but  does  not  represent  a 
specific anatomical feature. The glottis is identified as the minimum area distal to the peak 
pharyngeal area, and glottis area (AG) is measured at this point on the trace. Mean pharyngeal 
area  (APmean)  is  obtained  by  calculating  the  mean  cross-sectional  area  of  serial 
measurements made between the end of the mouthpiece and the glottis. Pharyngeal volume 
(VP) can be obtained by integrating the area under the curve between the mouthpiece opening 
and the glottis.
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The pharynx is designated as the region between the end of the mouthpiece and the glottis.  
Pharyngeal  length  is  measured  between  the  end  of  the  mouthpiece  and  glottis.  Mean  
pharyngeal area is obtained by calculating the mean cross-sectional area over the length of  
the pharynx. Pharyngeal volume is obtained by multiplying pharyngeal length by mean  
pharyngeal area. Glottis area is measured as the cross-sectional area at the glottis.
Figure 2.6 shows a diagram of the AR device used in my research (A1 Executive Acoustic 
Rhinometer, GM Instruments Ltd, Kilwinning, UK). It consists of a wave-tube sealed at the 
end  distal  to  the  mouth  and  open  at  the  end  proximal  to  the  mouth.  An  acoustic  pulse 
generator is positioned at the distal end of the wave-tube and a microphone for detection of 
acoustic pulse waves is positioned approximately 9cm from the proximal end.
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Figure 2.5: Original record of a single acoustic reflection trace of the upper airway.
In order to model the human airway as a continuous tube with no branching, it is necessary to 
make measurements with the soft palate elevated to occlude the nasopharynx (Fredberg et al., 
1980). This can be achieved by asking subjects to breathe through their mouth only (Brooks et 
al., 1984, 1984). Allowing volunteers in my studies to breathe through their mouths during 
measurements presented a logistical problem because the wave-tube was sealed airtight at the 
end distal to the mouth. In other AR systems this problem is overcome by extending the wave-
tube distal from the microphone by a distance that exceeds the length of the airway region to 
be measured (normally to the glottis; see Figure 2.7). In these systems, sound waves travel in 
both directions down the wave-tube, but because the distance to the open end of the wave-
tube is greater than the distance to the glottis, reflected waves from the open end of the wave-
tube arrive at the microphone later than reflected waves from the airway and so do not affect 
airway measurements. This is crucial because waves reflected from the open end of the wave-
tube have amplitude that is proportional to the cross-sectional area of the surrounding room. If 
these waves arrived at the microphone at the same time or before reflected waves from the 
airway, they would saturate the signal recorded at the microphone and completely mask the 
smaller amplitude waves reflected from the upper airway.
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The length of the wave-tube distal to the microphone must exceed the sum of the length of  
the wave-tube between the microphone and mouth (length A) and the length of the region of  
the airway to be measured (length B). This ensures that reflected waves from the open end  
of the wave-tube arrive at the microphone later than reflected waves from the upper airway  
and do not mask airway measurements.
In order to overcome this problem for the AR device used in these studies, a different solution 
was  required  because  it  could  not  be  simply  extended  at  the  distal  end.  Therefore  a 
mouthpiece arrangement  was designed with advice and guidance from Eric  Grieg of GM 
Instruments that positioned a breathing tube parallel to the wave-tube. The breathing tube was 
longer  than  the  distance  from  the  microphone  to  the  glottis,  therefore,  as  with  a 
conventionally extended wave-tube (as in  Figure 2.7), sound waves reflected from the open 
end of the breathing tube could not interfere with sound waves reflected from the airway.
However, with the breathing tube aligned parallel to the wave-tube a systematic offset was 
introduced to the signal recorded at the microphone equal to the cross-sectional area of the 
breathing tube (1.8 cm2). Therefore it was necessary to apply a post-hoc correction during 
analysis to remove the effect of the breathing tube from the upper airway measurements (see 
Section 2.5 for validation study of AR device).
70
2.4.1. Protocol
AR measurements were made in both a seated and supine posture. For seated measurements, 
the same standard chair was used for all experiments. Participants sat in a comfortable upright 
posture with their arms either resting on the arms of the chair or on their lap. The height of the 
AR device was adjusted using a tripod to allow the head to rest in a neutral position, with the 
line  of  the  chin  parallel  to  the  floor.  This  height  was  noted  and used  for  all  subsequent 
measurements of a given participant. For supine measurements, participants rested their head 
on a single pillow in a neutral position and the AR device was aligned perpendicular to the 
floor. Patients were instructed to breathe only through the mouth and were asked to remain 
still throughout the test and avoid moving the head, neck, jaw or tongue. Patients had at least 
50 traces recorded at end tidal expiration, close to functional residual capacity. End expiration 
was estimated by careful observation of the patients abdominal and chest movements. This 
point in the respiratory cycle was chosen because it is relatively easy to identify by careful 
observation, and because acoustic reflection measurements of pharyngeal calibre are known 
to be relatively stable at end-tidal expiration (Brown et al., 1986; Huang et al., 1998).
Each end-expiratory trace was individually analysed to obtain the glottis cross-sectional area 
(AG), mean pharyngeal area (APmean), and pharyngeal volume (VP). These measurements 
from individual traces were then averaged in order to obtain mean values for each participant. 
Traces where the soft palate had not fully occluded the nasal cavity were identified by the 
cross-sectional area exceeding 15 cm2 at any point on the airway trace. These traces were 
excluded from analysis. Traces where the participant had swallowed during data acquisition 
(resulting in a flat trace close to 0 cm2) were also excluded from analysis.
2.5. Validation of Acoustic Reflection Technique
The AR device was a commercial system that was designed for measuring the nasal cavity 
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and  nasopharynx.  It  had  not  previously  been  validated  for  oral  measurements.  However 
acoustic  reflection  technology  can  be  readily  adapted  to  measure  any  tube,  therefore  a 
mouthpiece was fashioned to couple with the AR device to allow measurements to be made 
orally.  The  acoustic  reflectometer  was  tested  using  this  novel  interface  for  accuracy and 
reproducibility. 
The  mouthpiece  featured  a  breathing  tube  that  allowed  patients  to  breathe  orally  during 
measurements. This is an important requirement for making accurate measurements of the 
oropharynx as it allows patients to breathe while elevating their soft palate to occlude the 
nasopharynx. Occluding the nasopharynx. allows the oropharynx to be modelled as a single 
tube, with no branching, which is a prerequisite for accurate AR measurements. 
The aims of the validation tests were:
1. Establish the accuracy and repeatability of the AR device and compare its performance 
to established international standards.
2. Establish the effect  of installing the novel  mouthpiece onto the AR device on the 
accuracy and repeatability of measurements.
3. Establish  the  within-test  repeatability  and  between-test  reproducibility  of  the  AR 
device when used in conjunction with the novel mouthpiece to measure human airway 
dimensions via the oral cavity.
2.5.1. Methods
Accuracy and Repeatability of Acoustic Reflection Device
The AR device  was  tested  for  accuracy and within-test  repeatability  using  a  tube  with  a 
known constant internal cross-sectional area (straight tube) and a tube designed to replicate 
the human nose that had a variable internal cross-sectional area (model nose). The straight 
tube was 18.5 cm long and had a constant internal cross-sectional area of 1.3 cm2 (see Figure
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2.8, bottom left panel for area-distance trace). The model nose was 15 cm long and had an 
internal cross-sectional area that varied along its length across a physiological range from 0.5 
cm2 to 7.6 cm2 (see Figure 2.8, bottom right panel for area-distance trace). The model nose is 
a standard model that is used widely for standardisation of AR devices (Hilberg and Pedersen, 
2000). It is constructed to replicate the internal cross-sectional area of a normal human nose 
based on known geometric dimensions.
The protocol used to test the accuracy and repeatability of the AR device was adapted from 
standard  validation  procedures  designed  for  nasal  measurements,  described  by  the 
International  Standardization Committee for Rhinomanometry (Hilberg & Pedersen 2000). 
The straight tube was measured geometrically to obtain is internal cross-sectional area. The 
geometric dimensions of the model nose had been measured previously, therefore a copy of 
these dimensions was obtained from the supplier of the model nose (GM Instruments, UK). 
The geometric dimensions of the two tubes were designated as the “known” dimensions. The 
known dimensions were used for comparison to the measured dimensions.
The straight tube and model nose were then measured under two sets of conditions. In the first 
condition  the  tubes  were  attached directly  to  the  AR device.  This  condition  was  used to 
establish  the  accuracy  and  repeatability  of  the  device  itself  and  to  act  as  a  control  for 
comparison against  the installation of  the  mouthpiece  onto the AR device.  In  the second 
condition the mouthpiece was connected to the AR device and the straight tube and model 
nose were attached in line to the mouthpiece. A total of 90 acoustic traces were recorded for 
each tube under each condition. This allowed the mean cross-sectional area to be calculated 
for the entire length of each tube.
The accuracy and repeatability of the AR measurements under each condition were tested by 
comparing  the  measured  dimensions  to  the  known  dimensions  of  each  tube.  In  acoustic 
measurements,  accuracy  tends  to  decrease  as  distance  from  the  microphone  increases 
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(Fredberg et al., 1980; Hilberg and Pedersen, 2000). Therefore the accuracy and repeatability 
of the AR device were calculated as a mean over the entire distance of each tube.
Measurement error was calculated as the measured dimensions minus the known dimensions. 
The  percentage  error  was  calculated  as  the  measurement  error  divided  by  the  known 
dimensions,  multiplied  by  100.  Accuracy  was  calculated  as  100  minus  percentage  error. 
Repeatability of the device was expressed as the standard deviation of the mean measured 
dimensions. Coefficient of variation was calculated as the standard deviation divided by the 
mean measurement, multiplied by 100.
Repeatability and Reproducibility of Acoustic Reflection Measurements in Humans
Within-test repeatability and between-test reproducibility in human subjects was assessed by 
measuring the upper airway of 17 healthy volunteers. Each volunteer attended the laboratory 
on two separate occasions at least 24 hours apart and at the same time of day (±2 hours). On 
each  occasion  volunteers  underwent  AR  measurements  in  a  seated  and  supine  posture 
according to the standard protocol described in Section 2.4.1.
Each individual trace was analysed to locate the junction where the mouthpiece ended and the 
oral cavity began, and to locate the glottis.  The region between these two landmarks was 
designated as the pharynx. Further analysis of each trace was then performed to obtain the 
mean  pharyngeal  area.  The  mean  pharyngeal  area  was  then  tested  for  its  within-test 
repeatability and between-test reproducibility.
Within-test  repeatability  was  assessed  in  each  volunteer  by  calculating  the  coefficient  of 
variation (CV). A CV of 10% or less has been suggested as an acceptable level of variance for 
AR measurements  (Brooks et  al.,  1989, 1984; Hilberg and Pedersen,  2000).  Between-test 
reproducibility was tested using the Bland-Altman method for assessing limits of agreement 
(Bland and Altman, 1999).
74
2.5.2. Results
Accuracy and Repeatability of Acoustic Reflection Device
Plots  comparing  measured  dimensions  to  the  known dimensions  of  the  straight  tube  and 
model  nose  when directly  connected  to  the  acoustic  device,  and when connected  via  the 
mouthpiece,  are  presented in  Figure 2.8.  The accuracy and repeatability of  measurements 
made of the straight tube and model nose when connected directly to the acoustic device are 
presented in Table 2.1. Measurements of the straight tube and the model nose had a very low 
measurement error and CV, meaning that they had high accuracy and repeatability.
Table  2.1: Accuracy and repeatability of measurements made while the straight tube and  
model nose were connected directly to the acoustic reflection device.
Mean over length of tube Straight Tube
(mean ± SD of 90 traces)
Model Nose
(mean ± SD of 90 traces)
Known Dimensions (cm2) 1.30 1.84 ± 1.6
Measured Dimensions (cm2) 1.27 ± 0.03 1.84 ± 1.4
Measurement Error (cm2) -0.03 ± 0.03 0.003 ± 0.2
Repeatability 0.01 ± 0.01 0.1 ± 0.1
Coefficient of Variation (%) 1.2 ± 0.4 4.3 ± 3.7
The accuracy and repeatability of measurements made of the straight tube and model nose 
when  connected  to  the  AR  device  via  the  mouthpiece  are  presented  in  Table  2.2. 
Measurements of both tubes again had a low measurement error, meaning that they had high 
accuracy.  The CV was slightly increased  for  each tube,  meaning that  the  repeatability of 
measurements made with the mouthpiece installed were reduced.
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Table  2.2: Accuracy and repeatability of measurements made while the straight tube and  
model nose were connected to the acoustic reflection device via the mouthpiece.
Mean over length of tube Mouthpiece+Straight Tube
(mean ± SD of 90 traces)
Mouthpiece+Model Nose
(mean ± SD of 90 traces)
Known Dimensions (cm2) 1.30 1.84 ± 1.6
Measured Dimensions (cm2) 1.29 ± 0.2 1.85 ± 1.4
Measurement Error (cm2) -0.01 ± 0.2 0.01 ± 0.6
Repeatability 0.06 ± 0.02 0.1 ± 0.03
Coefficient of Variation (%) 4.9 ± 1.0 8.7 ± 7.2
Bottom  left,  straight  tube  connected  directly  to  AR  device;  bottom  right,  model  nose  
connected  directly  to  AR  device;  top  left,  straight  tube  connected  to  AR  device  via  
mouthpiece; top right, model nose connected to AR device via mouthpiece.
Figure Key: Known dimensions: ; Measured dimensions: .
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Figure 2.8: Measured and known dimensions of straight tube and model nose. 
Repeatability and Reproducibility of Acoustic Reflection Measurements in Humans
Each individual subject's AR measurements of APmean made in a seated and supine posture 
on Day 1 and Day 2 are presented in Table 2.3. The mean CV for each posture on each day 
were calculated for the whole group of subjects. The mean CV was consistently below 10%. 
The mean difference between measurements made on Day 1 and 2 in a seated posture was 
0.08 ± 0.52cm2, suggesting there was minimal day to day variation. This was also the case in 
supine measurements, where the mean difference between Day 1 and 2 was 0.15 ± 0.55cm2.
There were no significant differences between measurements made on Day 1 and 2 in the 
seated posture (p=0.5) or the supine posture (p=0.3). This was confirmed by measuring limits 
of agreement of measurements made in the same posture on Day 1 and 2 using Bland-Altman 
plots.
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Table  2.3:  Mean  of  90  APmean  measurements  in  17  individual  healthy  volunteers  (3  
female).
Seated Day 1 Seated Day 2 Supine Day 1 Supine Day 2
Subject
Mean ± SD 
(cm2)
CV 
(%)
Mean ± SD 
(cm2)
CV 
(%)
Mean ± SD 
(cm2)
CV 
(%)
Mean ± SD 
(cm2)
CV 
(%)
1 7.7 ± 0.3 4 8.1 ± 0.3 4 7.0 ± 0.4 6 8.0 ± 0.4 6
2 5.7 ± 0.3 5 5.1 ± 0.3 5 3.9 ± 0.4 10 3.2 ± 0.4 12
3 5.6 ± 0.5 9 6.3 ± 0.5 9 6.3 ± 0.5 8 5.8 ± 0.6 10
4 5.9 ± 0.7 12 6.2 ± 0.7 10 6.6 ± 0.5 8 6.0 ± 0.3 5
5 5.8 ± 0.2 3 5.9 ± 0.3 5 4.6 ± 0.3 6 4.1 ± 0.7 17
6 6.0 ± 0.3 5 5.6 ± 0.3 6 4.7 ± 0.4 9 4.3 ± 0.4 9
7 5.3 ± 0.2 4 5.5 ± 0.3 6 5.5 ± 0.3 6 5.6 ± 0.3 6
8 5.1 ± 0.2 4 5.6 ± 0.4 7 4.3 ± 0.4 8 5.0 ± 0.3 6
9 6.1 ± 0.6 3 5.9 ± 0.8 13 3.8 ± 0.4 10 4.2 ± 0.4 10
10 5.1 ± 0.8 13 5.1 ± 0.9 18 4.4 ± 0.5 11 4.2 ± 0.4 10
11 7.1 ± 0.3 4 6.5 ± 0.3 5 5.9 ± 0.4 6 5.1 ± 0.5 9
12 5.6 ± 0.4 7 6.1 ± 0.2 3 5.0 ± 0.3 6 5.1 ± 0.2 4
13 8.7 ± 0.3 3 8.0 ± 0.4 5 7.0 ± 0.4 6 7.2 ± 0.4 6
14 6.9 ± 0.5 7 6.4 ± 0.5 8 6.4 ± 0.8 13 5.5 ± 0.6 11
15 5.1 ± 0.3 6 4.5 ± 0.2 5 4.8 ± 0.2 5 4.5 ± 0.3 7
16 6.6 ± 0.4 6 5.6 ± 0.3 5 4.7 ± 0.4 8 4.1 ± 0.3 6
17 4.6 ± 0.3 7 5.1 ± 0.4 8 3.5 ± 0.2 6 4.0 ± 0.2 6
Mean ± 
SD
6.1 ± 1.1 7 ± 3 6.0 (1.0) 7 ± 4 5.2 ± 1.1 8 ± 2 5.1 ± 1.2 8 ± 3
Data are presented as mean ± SD. See Bland-Altman plots for limits of agreement between  
Day 1 and Day 2.
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The plot shows the mean of APmean measurements made on Day 1 and Day 2 (x-axis)  
plotted against the difference between APmean measurements made on Day 1 and Day 2  
(y-axis). Each data point represents an individual subject. The mean difference between  
days (indicated by horizontal line) was close to zero, and all individuals had a difference  
between Day 1 and Day 2 of less than 2 SD from the mean (dashed lines). Therefore the  
agreement was high between Day 1 and Day 2. 
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Figure  2.9: Bland-Altman plot showing agreement between Day 1 and Day 2 for seated  
measurements. 
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The plot shows the mean of APmean measurements made on Day 1 and Day 2 (x-axis)  
plotted against the difference between APmean measurements made on Day 1 and Day 2  
(y-axis). Each data point represents an individual subject. The mean difference between  
days (indicated by horizontal line) was close to zero, and all but one individual had a  
difference between Day 1 and Day 2 of  less than 2 SD from the mean (dashed lines).  
Therefore the agreement was high between Day 1 and Day 2. 
2.5.3. Summary of Acoustic Reflection Validation
Accuracy and Repeatability of Acoustic Reflection Device
A threshold CV of approximately 10% has been suggested by other researchers as a standard 
for reasonable within-test variability for AR measurements of the upper airway via the oral 
cavity  (Brooks et al.,  1989, 1984; Hilberg and Pedersen, 2000). By this  standard,  the AR 
equipment  and  methods  used  in  this  study were  within  acceptable  operating  limits  and 
comparable to other validated commercial and bespoke systems used by other laboratories.
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Figure 2.10: Bland-Altman plot showing agreement between Day 1 and Day 2 for supine  
measurements. 
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It has been demonstrated that the use of the novel mouthpiece in the AR circuit introduced 
greater variability in measurements, as CV was approximately doubled. However, CV was 
still below 10%, which is within acceptable limits for device repeatability. The accuracy of the 
device did not seem to be significantly affected by introduction of the mouthpiece into the AR 
circuit.
Repeatability and Reproducibility of Acoustic Reflection Measurements in Humans
The within-test CV was also within acceptable limits in measurements of the human airway. 
Although there was individual variation, the mean CV across the group was below 10% in 
both the seated and supine posture on Day 1 and Day 2.
There  were  no  significant  differences  in  APmean  between  Day  1  and  Day  2.  The 
reproducibility of AR measurements in humans was confirmed using Bland-Altman limits of 
agreement  plots.  The  agreement  between  two  measurements  can  be  said  to  have  good 
agreement if ≥95% of measurements fall between 2 standard deviations of the mean (Bland 
and Altman, 1999). By this standard, the measurements between Day 1 and Day 2 fell within 
the limits of agreement in the seated and supine posture.
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Chapter 3: Pharyngeal Calibre in Heart Failure Patients 
with Obstructive Sleep Apnoea
82
3.1. Introduction
The prevalence of SDB in CHF is estimated to be up to 50% with approximately 25% OSA 
(Bitter et al., 2009; Ferrier et al., 2005; Javaheri, 2006; Javaheri et al., 1998; Lanfranchi et al., 
2003; MacDonald et al., 2008; Oldenburg et al., 2007; Schulz et al., 2007; Vazir et al., 2007). 
This contrasts with the general population where the prevalence of OSA in older subjects (50-
60 yrs) is up to 15% (Young et al., 1993). The higher prevalence of OSA in CHF cannot be 
readily explained by mechanisms that most often contribute to OSA in the general population. 
For example, OSA is strongly associated with obesity, however the prevalence of obesity in 
the  CHF  population  is  similar  to  that  in  the  general  population  when  matched  for  age 
(Johansson et al., 2001; The NHS Information Centre, 2004).  This finding would appear to 
support the theory that external extraluminal pharyngeal pressure,  associated with obesity, 
may have different relative contributions to OSA in CHF, compared to OSA only.  It is also 
possible that there may be mechanisms that contribute to OSA in CHF that are not present in 
the general population.
One such feature of CHF that may predispose patients to OSA is fluid retention during the day 
and subsequent rostral fluid shift during the night (see Chapter 1, Section 1.2.4). A series of 
studies have shown that application of 40 mmHg positive pressure to the legs using anti-shock 
trousers resulted in decreased leg fluid volume and increased neck circumference.  After 5 
minutes of positive pressure being applied to the legs it was found that pharyngeal resistance 
increased  (Chiu  et  al.,  2006),  pharyngeal  calibre  decreased  (Shiota  et  al.,  2007) and 
pharyngeal critical closing pressure increased (Su et al., 2008). These studies were performed 
on a small number of healthy volunteers but support the notion that rostral fluid shift (albeit  
actively-induced fluid shift) may contribute to OSA by promoting pharyngeal narrowing and 
collapse.  Passive  overnight  rostral  fluid  shift  has  subsequently been  shown to  negatively 
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correlate  with  AHI in OSA patients  (Redolfi  et  al.,  2009),  although this  finding was  not 
replicated in  a similar more recent  study  (Jafari  and Mohsenin,  2011).  Both studies were 
uncontrolled observational  investigations  and so it  is  not  clear  whether  passive  overnight 
rostral fluid shift is a normal physiological phenomenon or whether it is a feature of patients 
with OSA and/or CHF.
Rostral fluid shift could be more common and more severe in fluid-overloaded states such as 
CHF. The only study to date to investigate fluid shift in CHF studied 35 CHF patients with 
OSA and 22 CHF patients with CSA (Yumino et al., 2010). It was found that both groups 
experienced  an  overnight  decrease  in  leg  fluid  volume  (measured  using  bioelectrical 
impedance) and an increase in neck circumference (measured using a tape measure); both of 
these factors  correlated with  the AHI.  However,  as  with previous  studies,  this  study also 
lacked a healthy control group, therefore it remains unclear whether passive overnight rostral 
fluid shift is a special mechanism of OSA in CHF or whether passive nocturnal rostral fluid 
shift is a normal physiological phenomenon.
Changing from an upright posture to a supine posture is a normal event that frees fluid that 
has  accumulated  in  dependent  veins  due  to  gravity  and  allows  it  to  rejoin  the  vascular 
circulation.  There  has  been only one  study,  published very recently,  comparing overnight 
rostral fluid shift with posture-related fluid shift. Fischer et al. (2012) studied 9 males without 
OSA and 36 males with OSA (using an AHI cut-off of 5 events/hr); half of the whole group 
were  obese.  It  was  found  that  there  was  a  significant  immediate  increase  in  neck 
circumference when changing posture from upright to supine and an additional significant 
increase in neck circumference overnight. Furthermore, the magnitude of the change in neck 
circumference from upright to supine was correlated with the AHI, whereas there was no such 
correlation  with  overnight  change  in  neck  circumference.  The  postural  changes  in  neck 
circumference happened immediately, leading the authors to suggest that they were due to 
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rostral displacement of soft tissue in and around the neck. 
The aims of this study were: 1) to determine any relative effects of postural change on neck 
circumference  and  pharyngeal  calibre  in  CHF patients;  and  2)  to  determine  whether  any 
passive overnight changes in neck circumference and pharyngeal calibre are greater in CHF 
patients  with  OSA (CHF-OSA) compared to  CHF patients  without  OSA (CHF-only)  and 
healthy age-matched controls.  I tested the hypotheses  that CHF-OSA patients have a larger 
neck circumference and smaller pharyngeal calibre during resting wakefulness than CHF-only 
patients and age-matched healthy controls. I also tested the hypothesis that CHF-OSA patients 
experience  a  greater  posture-related  increase  in  neck  circumference  and  decrease  in 
pharyngeal calibre when moving from a seated to supine posture and that CHF-OSA patients 
experience  a  greater  increase  in  neck  circumference  and  decrease  in  pharyngeal  calibre 
overnight  than  CHF-only  and  healthy  controls.  The  primary  outcomes  were  the  neck 
circumference  and APmean  measured  overnight  and in  a  seated  and supine  posture.  The 
secondary outcomes were VP and AG. Pharyngeal dimensions were measured non-invasively 
using acoustic reflection.
3.2. Methods
3.2.1. Ethical Review
This study was reviewed by the local Research Ethics Committee (Brompton Harefield and 
NHLI  Research  Ethics  Committee)  and  given  a  favourable  opinion  (REC  number: 
09/H0708/24).  All  volunteers  gave  written  informed consent  prior  to  participating  in  this 
study.
3.2.2. Subjects
CHF-OSA patients, CHF-only patients, and age-matched healthy controls were recruited to 
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participate in two studies investigating pharyngeal calibre (the present study) and pharyngeal 
collapsibility (see Chapter 4) in CHF patients with OSA. CHF-OSA patients and CHF-only 
patients  were  recruited  from heart  failure  clinics  at  the  Royal  Brompton  Hospital.  Age-
matched healthy controls were recruited from the general population. Possible CHF patients 
were  identified  by  screening  clinics  in  collaboration  with  the  Royal  Brompton  Hospital 
Cardiology Department and CHF specialist team. Patients with systolic and diastolic CHF 
were eligible for this study, and were identified by clinical assessment and functional signs 
and symptoms of CHF by their clinical team. Patients who met the inclusion/exclusion criteria 
(Table 3.1) were approached by a member of their clinical care team and invited to participate 
in this study.
Healthy volunteers were recruited by advertising in local newspapers and by contacting local 
sports clubs, social clubs and charitable groups. Potential participants were matched to the 
CHF groups for age. This was done by targeting recruitment at healthy volunteers over 60 
years old. Potential participants were contacted by telephone and asked for a brief medical 
history in order to determine their eligibility prior to being invited to join the study.
All CHF patients and healthy volunteers that agreed to participate in the study underwent 
nocturnal polysomnography to determine the presence or absence of OSA (see below for full 
description of techniques). CHF patients with an AHI ≥10 events/hr with  >50% of apnoeas 
classified as obstructive were allocated to the CHF-OSA group. CHF patients with an AHI 
<10 events/hr were allocated to the CHF-only group. Healthy controls were admitted to the 
study if they had an AHI <10 events/hr and had no clinical history of CHF. Participants who 
did  not  meet  inclusion/exclusion  criteria  after  the  polysomnography  were  excluded  from 
analysis.  Participants  that  were excluded on the  basis  of  a  previously undiagnosed sleep-
disorder were informed immediately and a letter was sent to their GP explaining the findings. 
Inclusion/exclusion criteria for the 3 groups are presented in Table 3.1.
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Table 3.1. Inclusion/Exclusion Criteria.
Inclusion Criteria Exclusion Criteria
CHF-OSA and CHF-only - 18-85 years old
- NYHA class II-III
- Systolic or diastolic heart 
failure, in a stable condition 
(no hospital admissions or 
medication changes in the 3 
months prior to recruitment)
- Any sleep-disorder other 
than OSA
- Previous upper airway 
surgery or any current 
treatment for sleep apnoea 
(including CPAP)
- Unstable angina or 
arrhythmia
- Myocardial infarction in the 
3 months prior to recruitment
- Primary pulmonary 
hypertension
- Any significant neurological 
condition or respiratory 
disease
- Unable to give written 
informed consent
Healthy Controls - 18-85 years old
- AHI <10 events/hr
- Any previous diagnosis of 
OSA
- Upper airway surgery
- Any other sleep-disorder
- Any history of significant 
cardiac disease
- Any significant neurological 
condition or respiratory 
disease
- Unable to give written 
informed consent
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3.2.3. Protocol
CHF patients and healthy volunteers  were invited to attend the Royal  Brompton research 
sleep laboratory on two occasions, no longer than 1 month apart, as part of a pair of studies  
measuring  pharyngeal  calibre  (visit  1;  the  current  study)  and  pharyngeal  critical  closing 
pressure (visit 2; see Chapter 4). On their first visit,  participants had their height, weight, 
blood pressure and lung function recorded and a detailed medical history was taken including 
current  medications,  sleep  habits  and  subjective  sleepiness  according  to  the  Epworth 
Sleepiness Score.
Participants were set up for nocturnal polysomnography using a multi-channel commercial 
polysomnography system. For full details of the polysomnography equipment and methods, 
see Chapter 2, Section 2.2.1. Before going to sleep participants underwent measurements of 
their weight and neck circumference. Weight was measured immediately before going to bed, 
however participants were allowed to drink during the night if desired and urine excretion was 
not measured.
Measurements of neck circumference and pharyngeal calibre were performed first in a seated 
posture, then in a supine posture. Neck circumference was measured below the level of the 
crico-thyroid  cartilage.  Marks  were  made  on  the  skin  around  the  neck  after  the  first 
measurement in the evening to ensure that subsequent measurements were made at the same 
level. A spring-tensioned tape measure was used for all measurements in order to limit the 
variability in measurements due to human error. 
Pharyngeal calibre was measured before and after sleep using the acoustic reflection  (AR) 
technique. The general protocol for all  AR measurements is given in the General Methods 
(Chapter  2,  Section  2.4.1).  In  brief,  evening  measurements  of  neck  circumference  and 
pharyngeal calibre were first made in the seated posture, after 5 minutes of sitting quietly. 
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Measurements were then made in the supine posture, after 5 minutes of laying quietly. All 
seated measurements were performed in a standardised chair  with participants sitting in a 
comfortable upright posture. All supine measurements were performed with participants lying 
on a  bed with  their  heads  supported  by a  single  pillow.  AR traces  of  the  pharynx  were 
recorded at  a  rate  of  1  per  breath  for  50 breaths  at  end-tidal  expiration.  In  the  morning 
measurements were repeated. Neck circumference and pharyngeal calibre were measured in 
the supine posture before participants had sat up from bed, and then in the seated posture after 
sitting upright in a chair for 5 minutes. Weight was measured within 10 minutes of completing 
pharyngeal  measurements  and  before  participants  had  urinated  or  consumed  any food or 
drink.
3.2.4. Data Analysis
Polysomnography data were analysed according to the AASM recommended scoring criteria 
(Iber et al., 2007). See Chapter 2, Section  2.2.1 for full details of sleep stage and apnoea-
hypopnoea classifications. All participant's sleep studies were analysed to determine their total 
sleep time, posture during the night, sleep architecture and AHI.
Neck circumference measurements  were compared between groups and within groups for 
each  experimental  condition  (evening-seated,  evening-supine,  morning-supine,  morning-
seated). The magnitude of change from seated to supine in the evening, overnight, and from 
supine to seated in the morning were also compared between groups.
Acoustic reflection traces were analysed as described in the General Methods (Chapter 2, 
Section  2.4.1). Each individual  AR trace (approximately 50 per experimental condition per 
participant) was analysed to find 3 measures of pharyngeal calibre: 1) mean pharyngeal area 
(APmean); 2) pharyngeal volume (VP); 3) glottis cross-sectional area (AG). Data for each 
measure of pharyngeal calibre was then averaged according to the experimental condition and 
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compared within and between groups. The magnitude of change from seated to supine in the 
evening, overnight, and from supine to seated in the morning were also compared between 
groups. Percentage changes within groups were also analysed for NC, APmean, VP and AG. 
The  evening-seated  measurement  was  taken  as  the  baseline  measurement  and  all 
measurements were expressed as a percentage of baseline.
3.2.5. Statistical Analysis
The required sample size was calculated based on detecting a within-group change in APmean 
overnight.  Rostral  fluid  shift  in  healthy  volunteers  has  been  demonstrated  to  result  in  a 
significant within-group decrease in APmean from 2.68 ± 0.13 cm2 to 2.40 ± 0.12 cm2 (Shiota 
et al., 2007). The APmean data of Shiota et al. (2007) had a coefficient of variation (CV) of 
5%. The acoustic reflection device used in the present study produced measurements with a 
CV  of  10%  (see  validation  study,  Chapter  2,  Section  2.5).  Therefore  my  sample  size 
calculation was performed assuming similar within-group differences in APmean overnight 
(0.28 cm2) but with twice the variance. The sample size was calculated assuming within-group 
comparisons  of  APmean  would  be  made  using  paired-sample  t-tests  with  a  two-tailed 
hypothesis. Based on these assumptions it was calculated that a sample size of 11 participants 
per group (33 in total) would be required to achieve statistical power of 0.9 with a p-value of  
0.05. This power calculation was verified by our statistician (Mr Winston Banya, Clinical 
Trials and Evaluation Unit, Royal Brompton Hospital and Imperial College London). 
Data  from  most  of  the  measurements  violated  one  or  more  assumptions  of  normality, 
therefore all data were analysed using non-parametric methods and are presented as median 
and interquartile range (IQR). Within-group differences in pharyngeal dimensions and neck 
circumference associated with posture and overnight change were analysed using Friedman 
Rank  Sum  tests.  When  a  difference  was  detected,  pair-wise  analysis  of  conditions  was 
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performed  using  paired-sample  Wilcoxon  tests  with  a  Bonferroni  correction  for  multiple 
comparisons. Between-group differences in pharyngeal dimensions and neck circumference 
were analysed using Kruskal-Wallis tests. When a difference was detected, pair-wise analysis 
of groups was performed using two-sample Wilcoxon tests with a Bonferroni correction for 
multiple  comparisons.  All  data  were  analysed  using  R-Project  statistical  packages  (R 
Foundation for Statistical Computing, Austria) and R Commander (version 1.8-3).
3.3. Results
3.3.1. Subjects
35 CHF patients agreed to participate in this study. Seven were excluded due to previously 
undiagnosed sleep disorders (CSA, 4; periodic limb movements (PLMs), 3) being discovered 
on their polysomnography. Two CHF patients were excluded from final analyses because they 
did not yield complete or usable AR data due to being unable to voluntarily elevate their soft 
palate to occlude the nasal cavity. A total of 14 CHF patients were found to have OSA and met 
all  other inclusion/exclusion criteria,  and 14 CHF patients had no OSA and met all  other 
inclusion/exclusion criteria (see Figure 3.1 for consort diagram). Twenty-one healthy controls 
agreed to participate. Six were excluded from the study due to previously undiagnosed sleep 
disorders (OSA/CSA, 3; PLMs, 3) being discovered on their polysomnography. Two healthy 
controls were excluded from final analyses because they did not yield complete or usable AR 
data due to being unable to voluntarily elevate their soft palate to occlude the nasal cavity. A 
total of 15 healthy controls had no OSA and met all other inclusion/exclusion criteria (see 
Figure 3.1 for consort diagram).
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All three groups were matched for age and neck circumference, however healthy controls had 
a significantly lower BMI than CHF-OSA. Participant characteristics are given in Table 3.2.
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Figure 3.1: Consort diagram for recruitment of CHF patients and healthy controls.
CHF patients invited for sleep study 
= 35
CHF patients with OSA = 14
CHF patients without OSA = 14
Excluded  due to 
sleep disorder = 7
CSA = 4
PLMs = 3
Healthy controls invited for sleep 
study = 21
Healthy controls without OSA = 15
Excluded  due to 
sleep disorder = 6
OSA = 3
PLMs = 3
Polysomnography
Table 3.2: Participant Demographics.
CHF-OSA (n=14) CHF-only (n=14) Controls (n=15)
Age (yrs) 70 (65, 71) 70 (62, 77) 65 (59, 70)
BMI (kg/m2) 29 (29, 31)* 27 (25, 30) 26 (25, 28)
Neck Circumference (cm) 41 (40, 43) 39 (38, 42) 39 (38, 40)
Epworth (/24) 8 (4, 11)* 9 (7, 13)† 5 (2, 6)
NYHA (class I-IV) 2 (2, 2) 2 (2, 3) N/A
LVEF (%) 46 (30, 55) 35 (30, 45) N/A
BNP (pmol/L) 39 (35, 48) 47 (37, 61) N/A
Medications:
Diuretics (%) 100 57 N/A
B-blockers (%) 73 86 N/A
Ace-inhibitors (%) 55 86 N/A
Data  are  expressed  as  median  (interquartile  range)  unless  otherwise  stated.  Although  
females were not excluded from this study, groups were all males. * CHF-OSA significantly  
different to healthy controls (p<0.05). † CHF-only significantly different to healthy controls  
(p<0.05).
3.3.2. Sleep Studies
The CHF-OSA group included patients with  moderate severity of OSA, defined using AHI 
(see  Table  3.3).  By  design,  the  CHF-only  patients  and  healthy  controls  had  AHIs  <10 
events/hr. 
Sleep architecture was similar in all 3 groups with no significant differences in total sleep 
time (TST) or sleep efficiency. Sleep stages were distributed similarly in all 3 groups with the 
exception of Stage N1, which was a significantly higher fraction of TST in CHF-OSA patients 
than healthy controls (p=0.04). Healthy controls also had a significantly higher arousal index 
than CHF-only patients (p=0.001) (Table 3.3).
All three groups spent the majority of the night (60-70% TST) in a lateral posture. CHF-OSA 
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patients appeared to spend a greater fraction of TST in the supine posture than CHF-only and 
healthy controls, however this difference was not significant due to the wide variability of 
sleeping posture in all three groups (Table 3.3).
Table 3.3. Sleep parameters. 
CHF-OSA (n=14) CHF-only (n=14) Controls (n=15)
Respiratory Parameters:
AHI (/hr) 13 (12, 32) 5 (3, 5) 1 (1, 4)
Obstructive apnoea Index (/hr) 2 (0.5, 9) 0 (0, 1) 0 (0, 0.5)
Central apnoea Index (/hr) 1 (0.2, 3) 0.2 (0, 0.3) 0.3 (0, 1)
Mixed apnoea Index (/hr) 0 (0, 0.3) 0 (0, 0) 0 (0, 0)
Hypopnoea Index (/hr) 12 (9, 14) 3 (2, 4) 1 (0, 2)
ODI, 4% desaturations (/hr) 16 (13, 28) 6 (3, 7) 2 (1, 2)
Sleep Architecture:
Total Sleep Time (mins) 367 (330, 415) 351 (289, 380) 379 (277, 417)
Sleep Efficiency (%) 73 (66, 81) 73 (66, 80) 77 (53, 82)
Arousal Index (/hr) 22 (11, 28) 8 (4, 19)† 32 (27, 37)
Stage REM (%TST) 16 (11, 21) 23 (21, 27) 21 (17, 26)
Stage N1 (%TST) 36 (27, 51)* 26 (17, 32) 22 (16, 27)
Stage N2 (%TST) 32 (20, 42) 42 (26, 46) 40 (34, 51)
Stage N3 (%TST) 10 (6, 20) 9 (6, 17) 7 (5, 23)
PLM Index (/hr) 22 (4, 47) 7 (0, 35) 7 (2, 19)
Sleep Posture:
Supine (%TST) 39 (27, 61) 28 (13, 47) 28 (13, 48)
Left (%TST) 22 (0, 37) 19 (15, 31) 20 (15, 42)
Right (%TST) 31 (12, 51) 41 (20, 62) 29 (15, 43)
Total Lateral (%TST) 56 (38, 71) 77 (49, 94) 64 (38. 87)
All data are expressed as median (interquartile range). Due to rounding of figures and data  
not being normally distributed, not all percentages add up to 100. *CHF-OSA significantly  
different to healthy controls (p<0.05). † CHF-only significantly different to healthy controls  
(p<0.05)
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3.3.3. Posture-Related Changes in Neck Circumference
There were no significant  differences between groups in NC. This was the case in every 
experimental  condition  (evening-seated,  evening-supine,  morning-supine,  morning-seated). 
Within groups, NC increased significantly when changing from a seated to a supine posture in 
the evening in CHF-OSA patients (seated: 41.4; IQR 39.9, 42.6 cm; supine: 42.0; IQR 40.5, 
43.9 cm), CHF-only patients (seated: 38.6; IQR 38.0, 43.0 cm; supine: 41.2; IQR 38.9, 43.0 
cm) and healthy controls (seated: 38.6; IQR 38.2, 40.3 cm; supine: 39.6; IQR 39.1, 41.4 cm). 
In the morning the reverse occurred; NC decreased significantly when changing from a supine 
to seated posture in CHF-OSA patients (supine: 43.3; IQR 40.8, 45.2 cm; seated: 41.4; IQR 
40.2, 42.9 cm), CHF-only patients (supine: 41.3; IQR 39.3, 42.3 cm; seated: 39.4; 38.4, 41.3 
cm) and healthy controls (supine: 39.8; IQR 39.4, 41.4 cm; seated: 39.0; IQR 38.7, 40.9 cm) 
(see  Figure 3.2, upper panel). There were no significant differences between groups in the 
magnitude of change in  NC between the seated and supine posture, in the evening before 
sleep  (p=0.3)  or  in  the  morning  after  sleep  (p=0.7).  Similar  results  were  found  when 
comparing  percentage  changes  from baseline within  groups  (see  Table  3.5).  There  were 
significant increases in NC from evening-seated to evening-supine in all 3 groups (CHF-OSA 
p=0.01;  CHF-only  p=0.04;  healthy  controls  p=0.02).  NC  decreased  significantly  in  the 
morning  when  moving  from a  supine  to  seated  posture  in  CHF-OSA patients  (p=0.03), 
healthy volunteers (p=0.002) but not CHF-only (p=0.06). NC did not change significantly 
overnight in any of the groups in the supine posture (CHF-OSA p=0.9; CHF-only p=1.0; 
healthy controls p=0.2) or the seated posture (CHF-OSA p=1.0; CHF-only p=0.9; healthy 
controls p=1.0). 
3.3.4. Posture-Related Changes in Pharyngeal Calibre
There were no significant differences between groups in APmean, VP or AG. This was the 
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case  in  every  experimental  condition  (evening-seated,  evening-supine,  morning-supine, 
morning-seated).  Within  groups,  APmean  decreased  significantly  when  changing  from  a 
seated to a supine posture in the evening in all groups: CHF-OSA patients (seated: 6.0; IQR 
3.6, 6.2 cm2; supine: 4.0; IQR 2.6, 5.7 cm2), CHF-only patients (seated: 6.6; IQR 5.3, 7.3 cm2; 
supine: 4.2; IQR 3.5, 5.5 cm2) and healthy controls (seated: 6.6; IQR 5.4, 7.3 cm2; supine: 4.8; 
IQR 3.9, 6.0 cm2). In the morning the reverse occurred; APmean increased significantly when 
changing from a supine to seated posture in all 3 groups: CHF-OSA patients (supine: 4.0; IQR 
2.1, 4.4 cm2; seated: 4.7; IQR 3.4, 6.2 cm2), CHF-only patients (supine: 4.5; IQR 3.6, 5.0 cm2; 
seated: 5.3; IQR 3.8, 6.4 cm2) and healthy controls (supine: 4.1; IQR 3.4, 4.9 cm2; seated: 6.0; 
IQR 4.8, 6.8 cm2) (see Figure 3.2, lower panel). There were no significant differences between 
groups in the magnitude of change in APmean between the seated and supine posture, in the 
evening before sleep (p=0.2) or in the morning after sleep (p=0.5).
Similar results were found when comparing percentage changes from baseline within groups 
(see Table 3.5). APmean decreased significantly in the evening when moving from a seated to 
supine posture in  all  3 groups (CHF-OSA p=0.005;  CHF-only p=0.0005;  healthy controls 
p=0.0002). In the morning APmean increased significantly when moving from a supine to 
seated posture in CHF-OSA patients (p=0.001) and healthy controls (p=0.0005) but not CHF-
only patients (p=0.05).
VP underwent similar changes to APmean; in the evening it decreased significantly in the 
supine compared to seated posture in all 3 groups: CHF-OSA (seated: 51.8; IQR 27.2, 60.1 
cm3; supine: 37.1; IQR 18.6, 44.8 cm3), CHF-only (seated: 57.6; IQR 48.9, 66.3 cm3; supine: 
39.1; IQR 28.5, 49.9 cm3), and healthy controls (seated: 53.0; IQR 48.9, 61.6 cm3; supine: 
35.1; IQR 31.0, 55.1 cm3). In the morning the reverse occurred; VP increased significantly in 
the seated compared to supine posture in all 3 groups: CHF-OSA (supine: 33.7; IQR 15.5, 
39.6 cm3; seated: 39.7; IQR 29.3, 56.0 cm3), CHF-only (supine: 42.5; IQR 29.3, 46.7 cm3; 
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seated: 50.9; IQR 31.6, 58.7 cm3), and healthy controls (supine: 35.0; IQR 25.8, 46.2 cm3; 
seated: 51.0; IQR 42.6, 58.9 cm3) (see  Figure 3.3, upper panel). There were no significant 
differences between groups in the magnitude of change in VP between the seated and supine 
posture, in the evening before sleep (p=0.3) or in the morning after sleep (p=0.2).
Similar results were found when comparing percentage changes from baseline within groups 
(see  Table 3.5).  VP decreased significantly in the evening when moving from a seated to 
supine posture in  all  3 groups (CHF-OSA p=0.005;  CHF-only p=0.0005;  healthy controls 
p=0.0005). In the morning VP increased significantly when moving from a supine to seated 
posture in CHF-OSA patients (p=0.002)  and healthy controls (p=0.0005) but not CHF-only 
patients (p=0.3).
AG also underwent similar changes to APmean as it was decreased significantly in the supine 
compared to seated posture in all 3 groups: CHF-OSA (seated: 3.1; IQR 1.8, 4.0 cm2; supine: 
2.2; IQR 1.2, 2.7 cm2), CHF-only (seated: 4.0; IQR 3.1, 4.9 cm2; supine: 1.7; IQR 1.2, 2.4 
cm2), and healthy controls (seated: 4.1; IQR 3.3, 5.3 cm2; supine: 2.8; IQR 2.2, 3.6 cm2). In 
the morning the reverse occurred; AG increased significantly in the seated compared to supine 
posture in all 3 groups: CHF-OSA (supine: 1.8; IQR 0.8, 2.3 cm2; seated: 3.1; IQR 1.8, 3.7 
cm2), CHF-only (supine: 1.7; IQR 1.1, 2.6 cm2; seated: 2.5; IQR 1.5, 3.7 cm2), and healthy 
controls (supine: 2.3; IQR 1.3, 2.9 cm2; seated: 3.4; IQR 2.8, 4.2 cm2) (see Figure 3.3, lower 
panel). There were no significant differences between groups in the magnitude of change in 
AG between the seated and supine posture,  in the evening before sleep (p=0.2) or in the 
morning after sleep (p=0.5).
Similar results were found when comparing percentage changes from baseline within groups 
(see  Table 3.5).  AG decreased significantly in the evening when moving from a seated to 
supine posture in  CHF-only (p=0.003) and healthy controls (p=0.008) but not in CHF-OSA 
patients (p=0.05). In the morning AG increased significantly when moving from a supine to 
97
seated  posture  in  all  3  groups (CHF-OSA p=0.001;  CHF-only  p=0.003; healthy  controls 
p=0.002). 
3.3.5. Overnight Changes in Neck Circumference and Pharyngeal Calibre
There were no significant differences in weight at baseline between the 3 groups. Weight 
decreased significantly overnight within CHF-OSA patients (p=0.004), and CHF-only patients 
(p=0.006). Weight also appeared to decrease overnight in healthy controls, however this just 
failed to reach statistical significance (p=0.06) (Table 3.4).
Table 3.4: Differences in weight between evening and morning.
CHF-OSA (n=14) CHF-only (n=14) Controls (n=15)
Evening Weight (kg) 88.7 (82.5, 98.5) 84.6 (78.5, 95.5) 78.8 (76.5, 82.8)
Morning Weight (kg) 86.9 (81.3, 98.4) 81.8 (77.5, 94.5) 77.8 (76.2, 88.1)
p-value (evening vs. morning) 0.004 0.006 0.06
Data expressed and median (interquartile range). All 3 groups appeared to have a decrease  
in weight overnight. This difference was statistically significant in CHF-OSA and CHF-
only but not in healthy controls. 
There were no significant changes in NC overnight in the supine or seated posture in CHF-
OSA,  CHF-only,  or  healthy  controls  (Figure  3.2,  upper  panel).  APmean  decreased 
significantly overnight in the supine posture in the healthy controls (4.8; IQR 3.9, 6.0 cm2 to 
4.1; IQR 3.4, 4.9 cm2) but was unchanged in the CHF-OSA patients (4.0; IQR 2.6, 5.7 cm2 to 
4.0; IQR 2.1, 4.4 cm2) and CHF-only patients (4.2; IQR 3.5, 5.5 cm2 to 4.5; IQR 3.6, 5.0 cm2) 
(Figure 3.2, lower panel). In the seated posture, there was no overnight change in APmean in 
CHF-OSA patients (6.0; IQR 3.6, 6.2 cm2 to 4.7; IQR 3.4, 6.2 cm2), however there was a 
significant decrease in CHF-only patients (6.5; IQR 5.3, 7.2 cm2 to 5.3; IQR 3.8, 6.4 cm2) and 
healthy controls (6.6; IQR 5.4, 7.3 cm2 to 6.0; IQR 4.8, 6.8 cm2).
98
Similar results were found when comparing percentage changes from baseline within groups 
(see  Table 3.5).  APmean decreased significantly overnight in the supine posture in healthy 
controls (p=0.008) but not CHF-OSA patients (p=0.08) or CHF-only patients (p=1.0). It also 
decreased  significantly in  the  seated posture  in  healthy controls  (p=0.002)  and CHF-only 
patients (p=0.002) but not CHF-OSA patients (p=1.0).
VP underwent similar changes to APmean.  In the supine posture VP decreased significantly 
overnight in the healthy controls (35.1; IQR 31.0, 55.1 cm3 to 35.0; IQR 25.8, 46.2 cm3) but 
was unchanged in the CHF-OSA patients (37.1; IQR 18.6, 44.8 cm3 to 33.7; IQR 15.5, 39.6 
cm3) and CHF-only patients (39.1; IQR 28.5, 49.9 cm3 to 42.5; IQR 29.3, 46.7 cm3) (Figure
3.3,  upper  panel).  In  the seated  posture  VP  also decreased  significantly in  the  CHF-only 
patients (57.6; IQR 48.9, 66.3 cm3 to 50.9; IQR 31.6, 58.7 cm3) but not in the CHF-OSA 
patients (51.8; IQR 27.1, 60.1 cm3 to 39.7; IQR 29.3, 56.0 cm3) or healthy controls (53.0; IQR 
48.9, 61.6 cm3 to 51.0; IQR 42.6, 58.9 cm3).
Similar results were found when comparing percentage changes from baseline within groups 
(see Table 3.5). VP decreased significantly overnight in the supine posture in healthy controls 
(p=0.003) but not CHF-OSA patients (p=0.2) or CHF-only patients (p=1.0). VP decreased 
significantly  in  the  seated  posture  in  CHF-only  patients  (p=0.005)  but  not  in  CHF-OSA 
patients (p=1.0) or healthy controls (p=0.2).
AG also underwent similar changes overnight to APmean. In the supine posture AG decreased 
significantly overnight in the healthy controls (2.8; IQR 2.2, 3.6 cm2 to 2.3; IQR 1.3, 2.9 cm2) 
but was unchanged in the CHF-OSA patients (2.2; IQR 1.2, 2.7 cm2 to 1.8; IQR 0.8, 2.3 cm2) 
and CHF-only patients (1.7; IQR 1.2, 2.4 cm2 to 1.7; IQR 1.1, 2.6 cm2) (Figure 3.3, lower 
panel). In the seated posture AG did not change significantly in CHF-OSA (3.1; IQR 1.8, 4.0 
cm2 to 3.1; IQR 1.8, 3.7 cm2), CHF-only (4.0; IQR 3.1, 4.9 cm2 to 2.5; IQR 1.5, 3.7 cm2), or 
healthy controls (4.1; IQR 3.3, 5.3 cm2 to 3.4; IQR 2.8, 4.2 cm2).
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Similar results were found when comparing percentage changes from baseline within groups 
(see Table 3.5). AG decreased significantly overnight in the supine posture in healthy controls 
(p=0.008) but not CHF-OSA patients (p=0.2) or CHF-only patients (p=1.0). AG decreased 
significantly in the seated posture in CHF-only patients (p=0.03) but not in CHF-OSA patients 
(p=1.0) or healthy controls (p=0.08).
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All 3 groups had significant posture-related changes in neck circumference and mean pharyngeal area in the evening and morning. Healthy controls  
also had significant overnight decreases in mean pharyngeal area.
Figure 3.2: Overnight and posture-related changes in neck circumference (upper panel) and mean pharyngeal area (lower panel). 
101
All 3 groups had significant posture-related changes in pharyngeal volume and glottis area in the evening and morning. Healthy controls also had a  
significant overnight decreases in pharyngeal volume and glottis area.
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Figure 3.3: Overnight and posture-related changes in pharyngeal volume (upper panel) glottis area (lower panel). 
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Table 3.5: Percentage changes overnight and in relation to posture.
Evening-Seated Evening-Supine Morning-Supine Morning-Seated
Neck Circumference
CHF-OSA 01 3.5 (2.3, 4.8) 4.0 (2.3, 5.6)3 0.5 (-0.8, 1.5)
CHF-only 01 2.5 (0.8, 3.6) 2.4 (1.0, 5.0) 0.9 (-0.2, 1.2)
Healthy Controls 01 1.7 (0.5, 3.8) 2.4 (1.2, 4.0)3 0.3 (-1.0, 1.7)
M  ean  Pharyngeal Area  
CHF-OSA 01 -20.9 (-31.8, -7.3) -29.3 (-40.6, -20.8)3 -7.7 (-18.7, -1.5)
CHF-only 01 -26.7 (-37.0, -22.3) -30.0 (-37.4, -22.6) -11.3 (-32.0, -5.5)4
Healthy Controls 01 -18.1 (-32.8, -13.8)2 -33.2 (-40.8, -24.0)3 -6.9 (-19.0, -3.2)4
Pharyngeal  Volume  
CHF-OSA 01 -21.7 (-38.1, -13.0) -32.8 (-43.2, -21.6)3 -5.0 (-13.3, 4.0)
CHF-only 01 -31.0 (-37.7, -18.9) -26.9 (-40.6, -16.8) -14.6 (-32.8, -5.9)4
Healthy Controls 01 -23.3 (-34.7, -13.2)2 -34.2 (-46.1, -21.6)3 -12.3 (-17.1, 1.2)
Glottis Area
CHF-OSA 0 -34.5 (-48.6, -18.1) -52.8 (-65.1, -27.7)3 2.2 (-20.9, 13.0)
CHF-only 01 -47.4 (-61.3, -37.9) -47.8 (-64.0, -32.4)3 -17.3 (-51.1, -11.3)4
Healthy Controls 01 -34.7 (-51.7, -12.2)2 -51.1 (-69.8, -30.1)3 -15.4 (-26.2, -5.6)
Data are expressed as percentage change from Evening-Seated. All data are presented as  
median (interquartile range). 1: Evening-seated significantly different to Evening-supine 
(p<0.05);  2:  Evening-supine  significantly  different  to  Morning-supine (p<0.05);  3:  
Morning-supine  significantly  different  to  Morning-seated (p<0.05);  4:  Morning-seated 
significantly different to Evening-seated (p<0.05).
3.3.6. Predictors of Neck Circumference and Pharyngeal Calibre
In  order  to  determine  the  factors  that  predicted  NC  and  pharyngeal  calibre,  a  series  of 
univariate linear regression models were constructed using evening-supine NC and evening-
supine APmean as the respective outcome variables. The factors that were tested as predictors 
of evening-supine NC are shown in Table 3.6. The significant predictors were evening-supine 
APmean,  BMI,  evening  weight  and  AHI.  In  a  multivariate  linear  regression  model  the 
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associations with evening-supine NC remained independently significant for AHI (p=0.01) 
and evening weight (p=0.03) but not for evening-supine APmean (p=0.8) or BMI (p=0.5) 
(Table 3.6).
Table 3.6: Univariate linear regression models with evening-supine neck circumference as  
the response variable.
Variable R2 Univariate p-value Multivariate p-value
Evening-supine APmean 0.1 0.04 0.8
BMI 0.2 0.003 0.5
Evening Weight 0.3 0.0003 0.03
AHI 0.1 0.01 0.01
The factors that were tested as predictors of evening-supine APmean are shown in Table 3.7. 
The only significant predictors were evening supine NC and evening weight. In a multivariate 
linear regression model the associations with evening-supine APmean were not independently 
significant for evening-supine NC (p=0.5) or evening weight (p=0.2) (Table 3.7).
Table 3.7: Univariate linear regression model 2: evening-supine mean pharyngeal area.
Variable R2 Univariate p-value Multivariate p-value
Evening-supine NC 0.1 0.04 0.5
BMI 0.06 0.1 -
Evening Weight 0.1 0.03 0.2
AHI 0.03 0.3 -
3.4. Discussion
The  main  findings  of  this  study were  that  there  were  no  significant  differences  in  NC, 
APmean, VP, and AG in any posture in the evening or morning between groups. All 3 groups 
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experienced significant increases in NC and significant decreases in APmean, VP and AG 
when changing from a  seated  to  supine  posture  in  the  evening;  this  was reversed  in  the 
morning when sitting up from supine to seated. Weight significantly decreased overnight in 
CHF-OSA and CHF-only; this was associated with neither group experiencing any overnight 
change in NC, APmean, VP or AG. Conversely, there was no significant overnight change in 
weight  in  healthy  controls;  this  was  associated  with  a  significant  overnight  decrease  in 
APmean, VP and AG but no significant overnight change in NC.
3.4.1. Limitations
The  main  limitation  of  this  study  was  that  AR  was  used  for  indirect  measurement  of 
pharyngeal dimensions. This technique requires subjects to be awake during measurements. 
Neuromuscular activation of pharyngeal muscles is reduced in sleep compared to wake (Fogel 
et al., 2005) and this may have an impact on the observed differences in pharyngeal calibre 
overnight.  Neuromuscular tone can compensate for an anatomically narrow airway during 
wake, but during sleep this compensation may be lost in OSA patients  (Mezzanotte et al., 
1992). It is possible that overnight rostral fluid shift results in accumulation of fluid that is 
sufficient to cause narrowing of the pharynx during sleep, but that is insufficient to cause 
narrowing of the pharynx during wake, when the neuromuscular tone of the pharynx is higher. 
I  believe  that  this  was  unlikely  in  the  present  study  because  measurements of  neck 
circumference suggest  that  there was not  a significant  overnight  rostral  fluid shift  in  any 
group.
Despite its limitations, the acoustic reflection technique offered a number of advantages over 
other imaging techniques. The system is portable and could be used in the bedroom of the 
sleep laboratory immediately before going to sleep and immediately after waking up. It was 
also easy to make measurements in different postures in quick succession which would not 
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have been possible  with some other  techniques  such as  magnetic  resonance  imaging and 
computed tomography.
3.4.2. Posture-Related  Changes  in  Neck  Circumference  and  Pharyngeal 
Calibre
A number of studies have demonstrated that pharyngeal calibre is decreased in the supine 
compared to seated posture  (Fouke and Strohl, 1987; Huang et al., 1998; Jan et al., 1994; 
Martin et al., 1997). The mechanism for the posture-related decrease in pharyngeal calibre is 
not certain, but it is likely to involve narrowing at the level of the retro-palatal and retro-
glossal pharynx (Neill et al., 1997; Pevernagie et al., 1995; Schwab et al., 1995; Yildirim et 
al.,  1991).  Decreased  lung  volumes  in  a  supine  posture  may  also  contribute  to  reduced 
pharyngeal calibre by decreasing caudal traction on the pharynx, although this effect seems to 
be small (Fouke and Strohl, 1987; Jan et al., 1994). It has been speculated that the volume of 
blood in pharyngeal dilator muscles and other soft tissues surrounding the pharynx is affected 
by gravity and that this may also influence pharyngeal calibre (Beaumont et al., 1998).
The concept that fluid could affect pharyngeal calibre has been developed in recent years. 
Application of lower body positive pressure in healthy volunteers results in decreased leg 
fluid volume and increased neck circumference, suggesting that some fluid may shift rostrally 
under  certain  conditions.  Decreased  leg  fluid  volume  and  increased  neck  circumference 
correlate  with  increased  pharyngeal  resistance  (Chiu  et  al.,  2006),  decreased  pharyngeal 
calibre  (Shiota et  al.,  2007), and increased pharyngeal collapsibility  (Su et al.,  2008) (see 
Chapter 4 for a study on pharyngeal collapsibility in CHF patients). These studies provide 
evidence that rostral fluid shift may be an important mechanism for OSA in CHF, because 
CHF patients retain more fluid in dependent veins during the day, meaning there is potentially 
more fluid able to shift rostrally during the night when a supine posture is adopted by these 
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patients (Yumino et al., 2010). However, the effects of passive rostral fluid shift, that occurs 
overnight as a result of adopting a supine posture, are more modest.  Redolfi et al. (2009) 
found a significant correlation between overnight decreased leg fluid volume, increased neck 
circumference and AHI in OSA patients; however Jafari and Mohsenin (2011) did not. Redolfi 
et al. (2011b) also found that treating patients with venous insufficiency with compression 
stockings reduced daytime leg fluid volume and decreased AHI, however Elias et al. (2012) 
found no correlation  between leg  fluid  volume and AHI in  patients  with  end-stage  renal 
disease. The only study to investigate overnight changes of fluid load in CHF patients found a 
correlation between leg fluid volume, neck circumference and AHI in CHF patients with OSA 
(Yumino et al., 2010). The reason for the variable results between different studies is not clear, 
however there may be a number of factors that could modify the effects of fluid shift on the  
upper airway.
First, the time-course of the fluid shift has not been measured directly.  Berg et al.  (1993) 
report that it takes approximately 40 minutes for a decrease in leg fluid volume to plateau 
after a change in posture from upright to supine. No comparable data exists for neck tissue 
fluid volumes,  however  (Shiota  et  al.,  2007) report  that  a  decrease in  pharyngeal  calibre 
plateaued after 5 minutes of lower body positive pressure. These differing times may be due 
to Berg et al. (1993) measuring passive fluid shift due to posture change, whereas Shiota et al.  
(2007) actively induced fluid shift by lower body positive pressure. This suggests that the 
effects of actively-induced fluid shift via lower body positive pressure are not comparable to 
the effects of passive fluid shift via postural change. It is possible that passive fluid shift takes 
longer  than  actively-induced  fluid  shift,  allowing  more  time  for  normal  fluid  volume 
regulation to occur, thus mitigating any effects on pharyngeal calibre.
Second, in conditions where normal fluid regulation is impaired, such as CHF, the effects of 
fluid shift on pharyngeal calibre may be influenced by diuretics. Bucca et al. (2007) showed 
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that  intravenous  diuresis  of  obese  CHF  patients  with  OSA resulted  in  an  increase  in 
pharyngeal  calibre  and  a  decrease  in  AHI.  This  suggests  that  adequate  diuresis  has  the 
potential to mitigate the effects of fluid-overload and rostral fluid shift on pharyngeal calibre. 
My data confirm previous research showing that pharyngeal calibre is influenced by posture 
as this was evident in all 3 groups. It is not evident from my data that rostral fluid shift was 
the mechanism for this effect. My measurements of pharyngeal calibre were performed after 5 
minutes of quiet breathing in either the seated or supine posture. Given that the time elapsed 
between a change in posture and measurements of pharyngeal calibre was substantially less 
than 40 minutes,  I  believe that the observed decrease in pharyngeal  calibre in the supine 
compared to  seated  posture  in  this  study was  due  to  gravity acting  on  the  pharynx.  The 
observed increase in neck circumference in the supine compared to seated posture was likely 
due to redistribution of the muscles, fat and soft tissues of the neck, not due to passive rostral  
fluid shift.  This view is supported by a recent study comparing neck circumference in the 
upright and supine posture, and overnight in obese and non-obese males, with and without 
OSA (Fischer et al., 2012). This study also found a significant posture-related change in neck 
circumference. The authors also concluded that changes in neck circumference were due to 
soft tissue redistribution, rather than rostral fluid shift.
3.4.3. Overnight Changes in Neck Circumference and Pharyngeal Calibre
The finding that pharyngeal calibre decreased overnight in healthy volunteers suggests that 
there may be a normal physiological nocturnal rostral fluid shift that occurs in the healthy 
population that is not sufficient to independently cause OSA. The fact that pharyngeal calibre 
did not decrease overnight in CHF-OSA or CHF-only may have been due to diuresis, as both 
groups lost  more weight overnight than the healthy controls. Future studies would benefit 
from overnight monitoring of fluid intake and fluid loss.
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3.4.4. Conclusions
In summary, this study shows that CHF-OSA and CHF-only patients experience an increase in 
NC and decrease in pharyngeal calibre in the supine compared to seated posture but that NC 
and  pharyngeal  calibre  do  not  change  overnight.  Furthermore,  the  absolute  NC  and 
pharyngeal calibre of CHF-OSA patients is similar to CHF-only patients and healthy controls. 
Healthy  controls  experienced  a  significant  overnight  decrease  in  pharyngeal  calibre, 
suggesting that nocturnal rostral fluid shift may be a normal physiological feature that is not  
unique to fluid-loaded states such as CHF. Optimal diuresis may be sufficient to attenuate 
fluid shift in CHF patients. Taken together, these data suggest that rostral fluid shift does not 
substantially  contribute  to  pharyngeal  calibre  in  a  cohort  of  optimally  treated  CHF-OSA 
patients.
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Chapter 4: Pharyngeal Critical Closing Pressure in 
Heart Failure Patients with Obstructive Sleep Apnoea
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4.1. Introduction
In chapter 3 it was demonstrated that the pharyngeal calibre of CHF patients with OSA is  
similar to that in CHF patients who do not have OSA and healthy age matched controls. This 
suggests that factors other than pharyngeal calibre are related to the increased prevalence of 
OSA in  the  CHF  population;  an  alternative  mechanism  could  be  increased  pharyngeal 
collapsibility.
Su et al. (2008) observed that fluid shift from the legs to the neck can be induced in healthy 
volunteers, and that this could result in increased pharyngeal collapsibility during wake. It has 
also been observed that passive rostral fluid shift occurs during the night in non-obese OSA 
patients and that the volume of fluid leaving the legs during the night is correlated with OSA 
severity  (Redolfi et al.,  2009). However, a similar study investigating rostral fluid shift in 
OSA patients failed to replicate these findings (Jafari and Mohsenin, 2011).
CHF patients can retain increased fluid volume in the legs during the day, which may make 
them even more susceptible to nocturnal rostral fluid shift than OSA patients. This has led to 
rostral  fluid shift  being proposed as  a  mechanism for  OSA in CHF. This  hypothesis  was 
supported by  Yumino et al.  (2010), who found that leg fluid volume correlated with OSA 
severity in CHF patients with OSA. 
No studies to date have measured the pharyngeal collapsibility of CHF patients with OSA. If 
nocturnal rostral fluid shift has an effect on pharyngeal collapsibility it may also be predicted 
to have a greater effect at the end of the night compared to the start of the night, as greater 
quantities of fluid are displaced from the legs and into tissues of the upper airway overnight.  
Therefore the aim of this study was to measure the pharyngeal collapsibility of CHF patients 
with OSA (CHF-OSA), compared to CHF patients without OSA (CHF-only), and healthy age 
matched  controls.  The  secondary  aim  was  to  measure  overnight  changes  in  pharyngeal 
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collapsibility to determine the effects of nocturnal rostral fluid shift on the pharynx in CHF 
patients.
The primary hypothesis was that the pharynx of CHF-OSA patients would be more collapsible 
than CHF-only patients, who in turn would have a more collapsible pharynx than healthy age 
matched controls. The secondary hypothesis was that the pharynx would be more collapsible 
at the end of the night compared to the start of the night in CHF patients with and without 
OSA but would remain unchanged in healthy age matched controls. Pharyngeal collapsibility 
was measured by the passive Pcrit technique (Schwartz et al., 1998).
4.2. Methods
4.2.1. Ethical Review
This study was reviewed by the local Research Ethics Committee (Brompton Harefield and 
NHLI  Research  Ethics  Committee)  and  given  a  favourable  opinion  (REC  number: 
09/H0708/24).  All  volunteers  gave  written  informed consent  prior  to  participating  in  this 
study.
4.2.2. Subjects
CHF-OSA patients, CHF-only patients, and healthy age-matched controls were recruited to 
participate in a pair of studies investigating pharyngeal calibre (see Chapter 3) and pharyngeal 
collapsibility  (the  present  study)  in  CHF  patients  with  OSA.  Full  details  of  subject 
identification and recruitment  are  described in  Chapter  3,  Section  3.2.2 In brief,  all  CHF 
patients were recruited from heart failure clinics at the Royal Brompton Hospital and healthy 
age-matched controls were recruited from the general population using public advertising. 
Inclusion criteria for CHF patients included a diagnosis of systolic or diastolic heart failure, 
NYHA class  II-III,  and  being  in  a  stable  condition,  having  had  no  unscheduled  hospital 
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admissions in the 3 months preceding recruitment.  Exclusion criteria included having any 
sleep-disorder other than OSA, any current treatment for OSA, and previous upper airway 
surgery.  Inclusion  criteria  for  healthy  controls  included  having  an  AHI  <10  events/hour. 
Exclusion criteria included a history of any sleep-disorder, and a history of any significant 
cardiac disease. A full description of inclusion and exclusion criteria can be found in Chapter 
3, Table 3.1.
All CHF patients and healthy volunteers that agreed to participate in the study underwent 
nocturnal  polysomnography  to  determine  the  presence  or  absence  of  OSA (sleep  study 
described in Chapter 3). CHF patients with an AHI ≥10 events/hr with  >50% of apnoeas 
classified as obstructive were allocated to the CHF-OSA group. CHF patients with an AHI 
<10 events/hr were allocated to the CHF-only group. Healthy controls were admitted to the 
study if they had an AHI <10 events/hr and had no history of CHF. Participants who did not 
meet  inclusion/exclusion criteria  after  the polysomnography were excluded from analysis. 
Participants that were excluded on the basis of a previously undiagnosed sleep-disorder were 
informed immediately and a letter was sent to their GP explaining the findings.
4.2.3. Protocol
All CHF patients and healthy volunteers that agreed to participate in the study were invited to 
attend the  Royal  Brompton research  sleep  laboratory on two occasions  no longer  than  1 
month apart as part of a pair of studies measuring pharyngeal calibre (visit 1; see Chapter 3)  
and pharyngeal critical closing pressure (visit 2; the current study).
On their first visit,  participants had their height, weight, blood pressure and lung function 
recorded and a detailed medical history was taken including current medications, sleep habits 
and  subjective  sleepiness  according  to  the  Epworth  Sleepiness  Score.  Participants  then 
underwent  a  polysomnography  to  determine  their  AHI  and  had  their  pharyngeal  calibre 
measured in the evening and morning using acoustic reflection. For full details of the first 
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visit, see Chapter 3.
On their second visit, participants underwent measurement of their pharyngeal collapsibility 
using the pharyngeal passive Pcrit technique (Schwartz et al., 1998, 1988). For full details of 
the technique, see Chapter 2, Section 2.2.4 In brief, the Pcrit technique was performed during 
sleep  by applying a  negative  pressure  to  the  pharynx  via  a  nasal  mask at  increments  of 
progressively greater negative pressure. The point at which airflow ceased was assumed to be 
the Pcrit, at which the pharynx had collapsed. 
Prior to sleep, participants were instrumented for nocturnal polysomnography using a multi-
channel data collection and signal amplifier system (Model 12 Neurodata acquisition system, 
Grass Instruments, USA). Signals were acquired via an analogue to digital converter (Micro 
1401, Cambridge Electronic Design, UK) and recorded using data acquisition software that 
allowed real-time viewing of  signals  (Spike2 version 3.21,  Cambridge Electronic Design, 
UK).  Brain  waves  were  monitored  using  electroencephalography (EEG),  eye  movements 
were monitored using electro-occulargrams (EOG), chin muscle tone was monitored using 
electro-myogram (EMG). Airflow was measured using a pneumotachometer attached in-line 
to  a  nasal  mask  and  respiratory  effort  was  monitored  using  respiratory  inductance 
plethysmography.  Respiratory  effort  was  also  monitored  using  an  oesophageal  pressure 
cannula (CTO-1, Gaeltec Ltd, UK) coupled with a pressure transducer (model S7b/2, Gaeltec 
Ltd, UK), positioned approximately 40cm past the nares and adjusted to minimise cardiac 
artefact. In participants that were unable to tolerate the oesophageal pressure cannula or in 
whom it could not be passed successfully the study was conducted without it. For full details 
of the Pcrit instrumentation and technique, see General Methods (Chapter 2, Section 2.2).
Participants slept with a tight-fitting nasal mask attached to a CPAP machine that acted as 
positive pressure source and a cough assist machine that acted as a negative pressure source. 
Participants were asked to sleep on their back, however those who could not sleep in this 
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posture were permitted to sleep in a lateral posture. Participants were allowed to fall asleep 
with a low pressure of CPAP being supplied to the mask, sufficient only to allow clearance of 
expired  CO2 from the  nasal  mask  dead-space.  After  participants  had  fallen  asleep  CPAP 
pressure was titrated to the minimum pressure that was sufficient to eliminate flow limitation. 
This  pressure  was  defined  as  the  holding  pressure  and  varied  among  individuals.  Pcrit 
measurements were performed twice,  early and late in the night.  The early measurements 
were made during the first sleep cycle, after participants had entered stage N2 or N3 sleep. 
The late measurements were made approximately 4 hours later in stage N2 or N3 sleep. All 
Pcrit measurements were initiated after participants had maintained stable sleep for at least 3 
minutes. After 3 minutes of stable sleep mask pressure was rapidly reduced from holding 
pressure  for  3-5 breaths,  then  returned to  holding pressure.  After  at  least  one  minute  the 
pressure was reduced further for 3-5 breaths. This was repeated, reducing the mask pressure 
in 1 or 2 cmH2O increments until airflow ceased. This point was defined as the Pcrit. The 
entire  sequence  was  then  repeated  twice  more  to  confirm the  Pcrit  measurement.  Where 
repeated cycles of pressure reductions resulted in different Pcrit values, the median value was 
calculated and taken as the Pcrit.
4.2.4. Data Analysis
Apnoeas were defined as previously described in Chapter 2, Section 2.2.1 Pcrit measurements 
were analysed as described in the General Methods (Section 2.2.5). In participants that were 
able  to sleep with the oesophageal  pressure cannula,  Pcrit  was defined as the pressure at 
which airflow at the nasal mask was absent accompanied by ongoing oesophageal pressure 
swings, indicating closure of the pharynx  (Schwartz et al., 1998). In participants who were 
studied without the oesophageal pressure cannula, Pcrit was defined as the pressure at which 
airflow  at  the  nasal  mask  was  absent  accompanied  by  ongoing  thoracic  and  abdominal 
movements. In some participants, it was not possible to reach a mask pressure low enough to 
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cause airflow to cease without causing an arousal from sleep. In these participants, linear 
regression of the relationship between airflow and mask pressure was performed in order to 
predict the mask pressure at which airflow would have ceased (Patil et al., 2004).
Pcrit measurements at the start of the night were used for comparisons between groups. Pcrit 
measurements made at the start of the night and at the end of the night were compared within 
groups in order to determine whether there was any overnight change in Pcrit due to fluid 
shift.  Percentage changes within groups were also analysed for  Pcrit. The  measurement of 
Pcrit  taken in  the early part  of  the night was taken as  the baseline measurement  and all 
measurements were expressed as a percentage of baseline.
4.2.5. Statistical Analysis
The sample size was calculated based on a recent study comparing pharyngeal Pcrit in healthy 
participants and OSA patients (Patil et al., 2007). It showed that the mean difference between 
groups was -4.45 cmH2O and the standard deviation of the mean difference was 2.7 cmH2O. 
For the current study it was assumed that the difference in Pcrit between CHF-OSA and CHF-
only  would  be  smaller  because  pharyngeal  collapsibility  is  thought  to  increase  with  age 
(Eikermann et al., 2007). It was also assumed that there would be a similar difference in Pcrit 
between  CHF-only  and  healthy  age-matched  volunteers.  Therefore,  the  sample  size  was 
calculated with the aim of detecting a mean difference of 3 cmH2O and standard deviation of 
the  mean  difference  of  2.7  cmH2O.  At  80%  power  with  5%  confidence  interval,  14 
participants in each group (42 in total) would be required.
Data from most of the parameters measured violated one or more assumptions of normality, 
therefore all data were analysed using non-parametric methods and are presented as median 
and  interquartile  range  (IQR).  Differences  between  groups  were  analysed  using  Kruskal-
Wallis tests. When a difference was detected,  pair-wise analysis of groups was performed 
using  two-sample  Wilcoxon  tests  with  a  Bonferroni  correction  for  multiple  comparisons. 
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Overnight differences in Pcrit  within groups were analysed using paired-sample Wilcoxon 
tests. All data were analysed using R-Project statistical packages (R Foundation for Statistical 
Computing, Austria) and R Commander (version 1.8-3).
4.3. Results
4.3.1. Subjects
As in Chapter 3, 35 CHF patients agreed to participate in this study; 7 were subsequently 
excluded from the study due to previously undiagnosed sleep-disorders (CSA, 4; PLMs, 3) 
being found on the polysomnography. Fourteen CHF patients were found to have OSA and 
met  all  other  inclusion/exclusion criteria,  and  14  had  no  OSA  and  met  all  other 
inclusion/exclusion criteria. After undergoing the Pcrit study, 5 CHF patients were excluded 
from final analysis  because it  was not possible to obtain Pcrit  data in them  as they were 
unable to sleep in the lab and  they aroused during Pcrit measurements (see  Figure 4.1 for 
consort diagram).
Twenty-one healthy controls agreed to participate in this study; 6 were subsequently excluded 
from the study due to previously undiagnosed sleep-disorders (OSA/CSA, 3; PLMs, 3) being 
discovered  on  the  polysomnography.  Fifteen  healthy  controls  met  all  inclusion/exclusion 
criteria.  After  undergoing  the  Pcrit  study,  7  healthy  volunteers  were  excluded  from final 
analysis because it was not possible to obtain Pcrit data in them as they were unable to sleep 
in the lab and arousing during Pcrit measurements (see Figure 4.1 for consort diagram). 
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All three groups were matched for age, BMI and neck circumference. Healthy controls had a 
significantly  lower  Epworth  score  than  CHF-OSA and  CHF-only  patients  (p<0.05).  The 
characteristics of the 3 groups are given in Table 4.1.
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Figure 4.1: Consort diagram for recruitment of CHF patients and healthy controls.
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Table 4.1: Group characteristics. 
CHF-OSA (n=13) CHF-only (n=10) Controls (n=8)
Age (rs) 68 (63, 70) 70 (64, 77) 63 (59, 65)
BMI (kg/m2) 29 (29, 31)* 27 (26, 31) 27 (25, 29)
Neck Circumference (cm) 43 (40, 44) 41 (38, 43) 39 (39, 40)
Epworth (/24) 9 (5, 12)* 8 (5, 11)† 4 (1, 5)
NYHA (I-IV) 2 (2, 2) 2 (2, 3) N/A
LVEF (%) 42 (29, 52) 38 (26, 57) N/A
BNP (pmol/L) 39 (35, 58) 43 (27, 59) N/A
Medications:
Diuretics (%) 69 70 N/A
B-blockers (%) 62 80 N/A
Ace-inhibitors (%) 46 80 N/A
Data  expressed  as  median  (interquartile  range).  *  CHF-OSA significantly  different  to  
healthy controls (p<0.05). † CHF-only significantly different to healthy controls (p<0.05).
4.3.2. Sleep Studies
The CHF-OSA group had an AHI greater than 10 events/hr, and the CHF-only and healthy 
controls had an AHI below 10 events/hr by design. The CHF-OSA group included individuals 
whose OSA was predominantly in the moderate range of severity (10-30 events/hr) (see Table
4.2).
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Table 4.2: Respiratory and sleep parameters.
CHF-OSA (n=13) CHF-only (n=10) Controls (n=8)
Respiratory Parameters:
AHI (events/hr) 13 (12, 28) 5 (4, 6) 1 (0, 2)
Obstructive apnoeas Index (events/hr) 1 (0.5, 9) 0 (0, 1) 0 (0, 0)
Central apnoeas Index (events/hr) 1 (0, 3) 0 (0, 0) 0 (0, 0)
Mixed apnoeas Index (events/hr) 0 (0, 0) 0 (0, 0) 0 (0, 0)
Hypopnoeas Index (events/hr) 12 (9, 13) 3 (2, 5) 1 (0, 2)
ODI (4% desaturations/hr) 16 (13, 23) 6 (5, 8) 2 (1, 2)
Pcrit Parameters:
Duration between Early and Late (hrs) 3.5 (3.0, 3.75) 2.25 (1.25, 4.25) 3.5 (1.75, 4.0)
Position (%Supine vs. %Lateral) 46/54 50/50 50/50
Data expressed and median (interquartile range) unless otherwise stated.
4.3.3. Pcrit Between Groups
The median Pcrit of CHF-OSA patients (-1.2; IQR -4.4, -0.5 cmH2O) had a tendency to be 
higher than CHF-only (-5.9; IQR -6.8, -3.7 cmH2O) and healthy controls (-2.7; IQR -4.3, -1.5 
cmH2O),  however  this  trend failed  to  reach significance  (Figure  4.2).  There  was  also no 
significant difference between CHF-only and healthy controls (Figure 4.2).
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Each data point represents an individual, p-values are for group statistics. There was no  
significant difference in Pcrit between any of the groups, although CHF-OSA patients had  
a tendency to have a higher Pcrit than CHF-only and controls.
4.3.4. Overnight Changes in Pcrit
Approximately half of all participants had Pcrit measurements made while lying in a lateral 
posture due to being unable to sleep in a supine posture (CHF-OSA=46%; CHF-only=50%; 
controls=50%),  with the  remainder  of  Pcrit  measurements  being  performed in  the  supine 
posture. In all participants, Pcrit was measured in the early and late parts of night in the same 
posture. The time elapsed between early and late measurements of Pcrit were similar in all 
three groups (see Table 4.2).
Figure  4.3 Shows  the  overnight  changes  in  Pcrit  for  each  group.  There  was  individual 
variation, with some participants showing an increase in Pcrit, some a decrease, and some 
remained the same. Overall there were no significant changes in median Pcrit between the 
early and late part of the night in CHF-OSA patients (-1.2; IQR -4.4, -0.5 cmH 2O vs. -1.2; 
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Figure 4.2: Pcrit of CHF-OSA, CHF-only and healthy controls. 
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IQR -3.1, 0.3 cmH2O), CHF-only patients (-5.9; IQR -6.8, -3.7 cmH2O vs. -3.4; IQR -5.2, -3.0 
cmH2O), or healthy controls (-2.7; IQR -4.3, -1.5 cmH2O vs. -2.0; IQR -3.4, -1.3 cmH2O). 
When Pcrit  measurements  were analysed as  a  percentage  of  baseline,  there  were also no 
significant differences in any groups (Table 4.3).
Table 4.3: Percentage difference in Pcrit from early to late part of night.
CHF-OSA (n=13) CHF-only (n=10) Controls (n=8)
Early Pcrit (%baseline) 0 (0, 0) 0 (0, 0) 0 (0, 0)
Late Pcrit (%baseline) 0 (-45, 21) -27 (-40, -13) 0 (-40, 0)
P-value 0.9 0.2 0.2
Data  expressed  as  median  (interquartile  range).  There  were  no  significant  differences  
between early and late Pcrit measurements when data were expressed as % baseline (where  
early measurements were taken as baseline).
4.3.5. Predictors of Pcrit
Given that there were no significant differences between groups in Pcrit,  the groups were 
pooled for further analysis of predictors of Pcrit. Linear regression models were computed 
with Pcrit as the response variable. The univariate factors that were tested for correlation with 
Pcrit were AHI, BMI, neck circumference and the various measures of pharyngeal calibre that 
were measured in Chapter 3. There were no significant univariate relationships between Pcrit 
and BMI, neck circumference or pharyngeal dimensions (mean pharyngeal area, pharyngeal 
volume, glottis cross-sectional area, pharyngeal length), as measured in Chapter 3. The only 
univariate  correlation  found  was  between  Pcrit  and  AHI  (see  Table  4.4 for  summary  of 
univariate models).
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Table 4.4. Univariate predictors of Pcrit. 
Univariate Predictor R2 p-value
AHI 0.2 0.02
BMI 0.02 0.4
Neck Circumference 0.01 0.6
Mean Pharyngeal Area 0.01 0.7
Pharyngeal Volume 0.02 0.4
Glottis Area 0.02 0.4
Pharyngeal Length 0.1 0.07
When all groups were pooled, the only significant univariate predictor of Pcrit was AHI.  
Pharyngeal length was also close, but did not reach significance.
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Each data point represents an individual participant and lines between data points indicate the change in Pcrit between the early and late part of  
the night; p-values are group statistics. The time between “Early” and “Late” measurements was approximately 2-4 hours in each group (see Table
4.2). Overall, there were no significant overnight changes in Pcrit in any group.
Figure 4.3: Overnight changes in Pcrit. 
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4.4. Discussion
The Pcrit  of  CHF-OSA patients  had a  tendency to be higher  than CHF-only and healthy 
controls,  however this did not reach statistical  significance.  There was also no significant 
difference  in  Pcrit  between  CHF-only  and  healthy  controls.  Moreover,  there  was  no 
significant overnight change in Pcrit  in CHF-OSA patients, CHF-only or healthy controls. 
When the data from all 3 groups were pooled, the only significant univariate predictor of Pcrit 
was AHI.
4.4.1. Limitations
There were some limitations that should be considered when interpreting the results of this  
study. The small sample size may have resulted in the study being underpowered, increasing 
the chance of a type II error. Care was taken during the planning of this study to ensure that 
sufficient  numbers  of  participants  were  recruited,  and  a  statistical  power  calculation  was 
performed in collaboration with a statistician. The power calculation was conservative in its 
estimation of the difference to be detected between CHF-OSA patients and CHF-only and 
healthy age-matched controls.  This  is  because pharyngeal  collapsibility has a  tendency to 
increase due to ageing (Eikermann et al., 2007; Kirkness et al., 2008), therefore the pharynx 
of all participants was likely to be more collapsible than would be expected in a younger 
population, irrespective of CHF and OSA (for a discussion of this topic see Chapter 1, Section 
1.2.2).  Therefore  this  study was  powered  to  detect  a  smaller  difference  in  Pcrit  than  is 
typically seen between middle-aged OSA patients and healthy controls. The target sample size 
was also calculated assuming a failure rate of Pcrit studies of approximately 10-20%. This 
was based on reports in the literature, however there have been no studies that attempted to 
measure Pcrit in the early and late part of the night. This led to a higher failure rate and a  
smaller sample size than had been anticipated. 
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The second potential limitation in this study was the decision to allow participants to choose 
their own sleeping posture. Pcrit is significantly higher in the supine posture compared to the 
lateral  posture  (Penzel  et  al.,  2001),  therefore  many  studies  control  for  this  by  asking 
participants to sleep in a supine posture only. During early sleep studies for this investigation 
a number of CHF patients reported difficulty sleeping in the supine posture due to discomfort 
and breathlessness. Therefore to obtain as long a period of sleep as possible, participants were 
allowed to choose their  sleep posture.  In all  3 groups, approximately 50% of participants 
chose to sleep in the supine posture and approximately 50% in the lateral posture. Care was 
taken to ensure that all participants had their Pcrit measured in the same posture in the early 
and late parts of the night. Therefore, despite the posture of participants being a limitation in 
this study, I believe that comparisons between groups, and comparisons in Pcrit overnight 
were valid.
4.4.2. Pcrit in CHF-OSA, CHF-only and Healthy Controls
The finding that  Pcrit  was similar  between all  3 groups was surprising,  given that in the 
general population, OSA patients have a higher Pcrit than controls (Patil et al., 2007). It could 
be argued that due to the small sample size of the current study, the healthy age-matched 
controls were not representative of their population and that the true Pcrit of healthy controls 
should  be  lower  in  comparison  to  CHF-OSA patients.  However,  Kirkness  et  al.  (2008) 
reported findings from a much larger cohort of subjects with and without OSA that appear to 
corroborate the data from the present study. Kirkness et al. (2008) showed that the Pcrit of  
participants aged 50-70 years old (with and without OSA) was between -5 and 5 cmH 2O. The 
Pcrit values of healthy participants in the present study were similar but generally lower than 
those reported by Kirkness et al. (2008) and ranged from -7 to -1 cmH2O. Although data is 
limited in older populations, this demonstrates that the Pcrit values for the healthy volunteers 
of this study have external validity.
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The majority of all participants from all 3 groups (21/31) had a Pcrit greater than -5 cmH2O, 
placing them at a high risk of OSA (Kirkness et al., 2008). It is not clear from this study what 
differentiated the CHF patients with OSA from the CHF patients without OSA and healthy 
controls, given that all 3 groups were relatively well matched in demographics. Three of the 
CHF-OSA patients had Pcrit values equal to or greater than 0 cmH2O, meaning that their 
airway  was  prone  to  collapse  at  atmospheric  pressures.  Pharyngeal  collapse  at  or  above 
atmospheric  pressure  is  thought  to  be  a  consequence  of  high  extra-luminal  pressure,  as 
opposed to being a consequence of negative intra-luminal pressure. This can be demonstrated 
using a Starling resistor model of the human airway (see Chapter 1, Section 1.2.2). This may 
hint that there was some additional extra-luminal pressure being exerted on the pharynges of 
these patients. However, regression analysis revealed that there was no relationship between 
neck circumference and Pcrit in the entire sample of patients and healthy controls as a whole 
(r2=0.01).
4.4.3. Overnight Changes in Pcrit
The finding that there was no overnight change in Pcrit for any group is contrary to what 
would be predicted from the rostral fluid shift hypothesis of OSA in CHF. This is the first  
study to measure the Pcrit of CHF-OSA patients in the early and late part of the night to try to  
ascertain the effects of rostral fluid shift on pharyngeal collapsibility. I found that there was no 
evidence that rostral fluid shift affected pharyngeal collapsibility of CHF-OSA, CHF-only, or 
healthy controls. One possible reason for finding no change overnight in Pcrit could be that 
rostral fluid shift is fast acting and the Pcrit tests did not have sufficient time resolution to 
detect the changes. The measurements of Pcrit certainly were time consuming and often took 
1-2 hours at the start and end of the night respectively. Fluid shift may occur quickly, soon 
after assuming a recumbent posture and then remain stable for the rest of the night. If this is 
the pattern and time course of nocturnal rostral fluid shift then the Pcrit measurements would 
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not be expected to detect any change in the late part of the night compared to the early part of 
the night. These questions warrant further investigation, as the true impact of rostral fluid shift 
cannot be accurately determined if its time-course is not better understood.
This is not the first study to investigate overnight changes in sleep parameters in relation to 
overnight rostral fluid shift. Jafari and Mohsenin (2011) compared the AHI in the first half of 
the night to the AHI in the second half of the night in OSA patients. It was found that although 
there was evidence of rostral fluid shift during the night (neck circumference increased), there 
was no difference in AHI between the first and second half of the night. They concluded that 
rostral fluid shift may not be a significant risk factor in OSA patients.
4.4.4. Conclusions
This study reports for the first time, the Pcrit of CHF-OSA patients compared to CHF-only 
and healthy controls. Remarkably, the Pcrit was similar between all 3 groups, and all 3 groups 
had Pcrit values in a range normally associated with OSA. It is not clear why the Pcrit  was 
similar between groups, given that the groups were well matched in all physical respects. This 
study demonstrates that Pcrit is not a sensitive predictor of OSA in CHF.
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Chapter 5: The Effect of Age on Pharyngeal Calibre
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5.1. Introduction
Pharyngeal calibre and pharyngeal critical closing pressure are similar in CHF patients with 
OSA, CHF patients  without  OSA,  and age-matched healthy controls  (Chapters  3  and 4). 
Given that all 3 groups were a similar age and that their Pcrit values were in a range normally 
associated with a higher risk of OSA (see discussion in Chapter 4), I speculate that ageing per 
se may result in anatomical and physiological changes to the upper airway that predispose it  
to narrowing and/or collapse.
There is growing evidence to suggest that the prevalence of OSA increases with age. In a 
seminal paper based on the Wisconsin Sleep Cohort (Young et al., 1993) it was observed that 
the prevalence of OSA (AHI >5 events/hr, with or without daytime somnolence) increased in 
males from 17% (95% CI: 9.6-25%) in 30-39 year olds to 31% (95% CI: 21-40%) in 50-60 
year olds. In females OSA had a lower baseline prevalence at all ages but also increased with 
age, from 6.5% (95% CI: 1.4-11%) in 30-39 year olds to 16% (95% CI: 5.2-26%) in 50-60 
year olds. These findings have been replicated in other large studies of cohorts drawn from 
different populations  (Bixler et  al.,  2001, 1998; Durán et  al.,  2001). There is  also limited 
prospective data suggesting that the severity of OSA increases over time (Young et al., 2002). 
Over the age of 65 years the prevalence and severity of OSA may plateau (Ancoli-Israel et al., 
2001).
As in the general population, the mechanisms of OSA in older age are likely to be multi-
factorial and the relative contributions of certain factors within individuals are likely to vary. 
These factors include BMI (which has a tendency to increase with age; see Chapter 1, Section 
1.2.6), pharyngeal collapsibility (which may increase with age; see Chapter 4), pharyngeal 
dilator muscle tone and responses to negative pressure challenge (which may deteriorate with 
age;  Malhotra et  al.,  2006),  and pharyngeal dilator muscle composition (which have been 
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shown to transition to fast twitch, fatigable muscle fibres with age in a rat model;  Oliven et 
al., 2001; Skelly et al., 2011).
There is no clear consensus in the literature regarding the effects of ageing on pharyngeal 
calibre,  despite  a  number of studies  attempting to  address  this  question,  and despite  data 
suggesting that surrounding bone and soft tissue structures are altered with age (see Chapter 1, 
Section 1.2.3). Some studies suggest that pharyngeal calibre is reduced with age (Brown et al., 
1986; Huang et al., 1998; Kollias and Krogstad, 1999b; Martin et al., 1997; Shigeta et al., 
2008b), some suggest that it is increased with age  (Brooks and Strohl, 1992; Burger et al., 
1992;  Mayer  et  al.,  1996;  Tagaya  et  al.,  2011),  and  others  suggest  there  is  no  change 
(Malhotra et al., 2006). When the methodologies of these studies are examined, it is apparent 
that  the studies  reporting a  decrease in pharyngeal  calibre with age failed to  screen their 
cohorts adequately to eliminate people with undiagnosed OSA. This could have led to false 
findings as the prevalence of OSA would be expected to increase with age (Bixler et al., 2001, 
1998; Durán et al., 2001; Young et al., 1993), and the pharyngeal calibre of OSA patients is 
known  to  be  smaller  than  non-OSA patients  (Bradley  et  al.,  1986;  Ciscar  et  al.,  2001). 
Therefore these studies may not accurately represent the effect of ageing per se on pharyngeal 
calibre. The majority of studies that report an increase or no change in pharyngeal calibre with 
age used polysomnography to screen for undiagnosed OSA in their cohorts, therefore there is 
currently stronger evidence to suggest that the effect of age on pharyngeal calibre is for it to  
increase (for a full discussion of these studies, see Chapter 1, Section 1.2.3).
A relatively new alternative hypothesis to explain the increase in OSA with age is that the 
pharynx may be longer in the older population (see Chapter 1, Section 1.2.5 for discussion of 
the mechanisms). This hypothesis is supported by findings suggesting that pharyngeal length 
is associated with OSA severity  (Segal et al.,  2008), and that older age is associated with 
increased  facial  length  (Kollias  and  Krogstad,  1999a),  a  caudal  shift  of  the  hyoid  bone 
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position (Pae et al., 2008), and increased pharyngeal length (Malhotra et al., 2006).
The aims of this study were to determine the effects of age per se on pharyngeal calibre and 
pharyngeal length, independent of confounding factors related to OSA, such as BMI and neck 
circumference. This was done by comparing a group of healthy older males with a group of 
healthy younger males, matched for BMI and neck circumference. The null hypothesis was 
that  pharyngeal  calibre  and  length  would  be  similar  in  healthy  older  males  and  healthy 
younger males.
5.2. Methods
5.2.1. Ethical Review
This study was reviewed by the local Research Ethics Committee (London-Chelsea; formerly 
Brompton Harefield and NHLI Research Ethics Committee) and given a favourable opinion 
(REC  number:  09/H0708/24).  All  volunteers  gave  written  informed  consent  prior  to 
participating in this study.
5.2.2. Subjects
Healthy younger males and healthy older males were recruited from the general population. 
Advertising was placed in local newspapers and local sports clubs, social clubs and charitable 
groups were contacted. Inclusion criteria for the study were that participants were male, aged 
between 18 and 40 years (younger group) or over 60 years (older group), and had no history 
of  sleep,  respiratory or  cardiovascular  disorders.  Exclusion  criteria  included any previous 
diagnosis of a sleep disorder or an AHI >5 events/hr.  The older  group was recruited and 
studied first, thus providing a set of target demographics for the younger group to be matched 
to. The key demographics that groups were matched on at recruitment were BMI and neck 
circumference.
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All potential  participants were contacted by telephone prior to enrolment and asked for a 
medical history including self-reported height, weight, and subjective sleepiness according to 
the Epworth Sleepiness Score. Participants were then screened for sleep-disordered breathing 
using respiratory polygraphy performed in their home or in the sleep laboratory (see Protocol 
below for full description of techniques). Volunteers that met all inclusion/exclusion criteria 
were invited to undergo measurement of their upper airway calibre using acoustic reflection 
and magnetic resonance imaging (MRI).
5.2.3. Protocol
All volunteers that met the inclusion criteria after telephone interview underwent respiratory 
polygraphy either in their home or at the Royal Brompton Hospital research sleep laboratory, 
according  to  their  preference.  Prior  to  sleep,  participants  had  their  height,  weight,  blood 
pressure  and  lung  function  recorded.  Participants  were  then  instrumented  for  respiratory 
polygraphy  using  a  commercial  multi-channel  polygraphy  system  (SOMNOscreen, 
Somnomedics GmbH, Germany). See Chapter 2, Section  2.2.2 for a full description of the 
polygraphy equipment and methods. In brief, airflow, respiratory effort, oxygen saturation and 
heart rate were monitored. Participants were asked to keep a written record of the time they 
turned their lights out in order to go to sleep, and the time that they woke up in the morning. 
Participants were also asked to record any periods when they woke during the night. 
Participants whose AHI was <5 events/hr after respiratory polygraphy were invited to attend 
the Royal  Brompton Hospital  to  undergo acoustic  reflection and MRI scans  of  the upper 
airway. Pharyngeal dimensions were measured using the acoustic reflection technique. The 
same general protocol was followed for all acoustic reflection measurements (see Chapter 2, 
Section 2.4.1). Measurements were made in the supine posture only, after participants had lay 
quietly for 5 minutes. All participants also underwent measurement of their pharynx using 
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MRI. This was performed on the same day as acoustic reflection measurements. Due to the 
volume of data this produced and time constraints for the submission of this thesis, MRI data 
were not analysed in time to be included in this chapter.
5.2.4. Data Analysis
Respiratory  polygraphy  data  were  analysed  according  to  AASM  recommended  scoring 
criteria (Iber et al., 2007). Time in bed was defined as the period between turning lights off, 
and waking in the morning, as reported by the participants. For the purposes of respiratory 
analysis, this period was defined as “sleep”. Apnoeas and hypopnoeas were scored using the 
methods described in Chapter 2, Section 2.2.1.
Acoustic reflection traces were analysed as described in the General Methods (Chapter 2, 
Section  2.4.1).  Each  individual  acoustic  reflection  trace  (up  to  50  per  participant)  was 
analysed to find 3 measures of pharyngeal calibre: 1) mean pharyngeal area (APmean); 2) 
pharyngeal volume (VP); 3) glottis area (AG). Furthermore, pharyngeal length was obtained 
by measuring the distance between the end of the mouthpiece (positioned inside the oral 
cavity, between the incisors) and the glottis (defined as the minimal cross-sectional area on 
the acoustic trace, distal of the local maxima in the oral cavity; see Error: Reference source
not found). 
5.2.5. Statistical Analysis
This study was treated as a pilot study, to precede a larger cross-sectional study investigating 
pharyngeal  calibre  in  older  and younger  males,  females,  and OSA patients.  Therefore  no 
sample size was calculated for the two pilot groups presented in this chapter.
Data  from  most  of  the  measurements  violated  one  or  more  assumptions  of  normality, 
therefore all data were analysed using non-parametric methods and are presented as median 
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and interquartile range (IQR). Differences between groups were analysed using two-sample 
Wilcoxon tests. All data were analysed using R-Project statistical packages (R Foundation for 
Statistical Computing, Austria) and R Commander (version 1.8-3).
5.3. Results
5.3.1. Subjects
A total of 12 older males (>60 years old) underwent measurement of their upper airway by 
acoustic reflection and MRI (see consort diagram, Figure 5.1). Three older males (>60 years 
old) that had participated in previous research (see studies described in Chapter 3 and Chapter 
4) agreed to participate in this study. All had received full nocturnal polysomnography studies 
within 6 months prior to entry into this study, therefore respiratory polygraphy testing was not 
performed.  A further  11  older  males  that  met  all  inclusion  criteria  were  recruited  after 
answering public advertising and canvassing of local sports clubs, social clubs and charity 
groups.  Following  respiratory  polygraphy  tests,  two  older  males  were  found  to  have 
undiagnosed OSA (AHI ≥5 events/hr) and were excluded from further testing. 
Sixteen younger males that met all inclusion criteria were recruited after answering public 
advertising and canvassing of local sports clubs, social clubs and charity groups. Following 
respiratory polygraphy tests, two younger males were found to have undiagnosed OSA (AHI 
≥5 events/hr) and were excluded from further testing. A total of 14 younger males (18-40 
years old) underwent measurement of their upper airway by acoustic reflection and MRI (see 
consort diagram, Figure 5.1).
135
Three  older  males  from  previous  research  had  received  full  polysomnography  studies  
within  6  months  of  participating  in  the  present  study,  therefore  they  did  not  undergo  
respiratory polygraphy testing.
The baseline characteristics for the two groups are presented in Table 5.1. By design there was 
a significant difference between the groups' ages. The groups were well matched for all other 
characteristics. 
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Figure 5.1: Consort diagram showing recruitment of older and younger males. 
Males >60 years old invited for 
sleep study = 11
Males >60 years old invited from 
previous research = 3
Males >60 years old undergoing 
pharyngeal measurements = 12
Excluded  due to 
OSA = 2
Males 18-40 years old invited for 
sleep study = 16
Males 18-40 undergoing pharyngeal 
measurements = 14
Excluded  due to 
OSA = 2
Respiratory 
Polygraphy
Table 5.1: Participant characteristics. 
Younger Males (n=14) Older Males (n=12) p-values
Age (years) 28 (26, 32) 65 (63, 70) <0.001
Height (m) 1.8 (1.7, 1.8) 1.8 (1.7, 1.8) 0.3
Weight (kg) 84 (79, 87) 76 (72, 93) 0.3
BMI (kg/m2) 26 (24, 27) 26 (25, 29) 0.9
Neck Circumference (cm) 39 (38, 41) 40 (39, 41) 0.6
Epworth (/24) 6 (3, 8) 5 (3, 6) 0.2
Data are expressed as median (interquartile range). There were no significant differences  
between groups in baseline characteristics, except for age by design.
5.3.2. Respiratory Polygraphy
Both groups reported spending a similar time in bed (younger males: 383, IQR 380, 509 mins; 
older males: 391, IQR 272, 413 mins). Older males had a tendency to spend more time in the 
lateral posture and less time in the supine posture than younger males, however this did not 
reach statistical significance (supine p=0.5; lateral p=0.3). The younger and older group had 
similar  AHIs and ODIs  and neither  group had any significant  sleep  disordered  breathing 
(Table 5.2).
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Table 5.2. Sleep parameters. 
Younger Males (n=14) Older Males (n=12) p-values
Time in Bed (mins) 383 (380, 509) 391 (272, 413) 0.2
AHI (/hr) 0.8 (0.6, 1.4) 2.4 (1.4, 4.1) 0.8
Obstructive apnoea Index (/hr) 0.2 (0.1, 0.3) 0.0 (0.0, 0.3) 0.4
Central apnoea Index (/hr) 0.2 (0.0, 0.2) 0.3 (0.0, 1.0) 0.4
Mixed apnoea Index (/hr) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.5
Hypopnoea Index (/hr) 0.7 (0.3, 1.2) 0.8 (0.1, 1.8) 0.8
ODI (4% desaturations/hr) 0.8 (0.3, 1.9) 2.0 (0.7, 2.8) 1.0
Supine (%Time in bed) 42 (19, 71) 15 (12, 71) 0.5
Left (%Time in bed) 21 (3, 36) 25 (15, 54) 0.6
Right (%Time in bed) 27 (23, 35) 25 (13, 34) 0.8
Total Lateral (%Time in bed) 57 (29, 75) 85 (29, 88) 0.3
Prone (%Time in bed) 0 (0, 0) 0 (0, 0) 0.8
All  data  are  expressed  as  median  (interquartile  range).  There  were  no  significant  
differences between groups in any sleep parameter.
5.3.3. Pharyngeal Calibre and Length
Figure 5.2 shows original traces of the pharynx from a representative older and younger male. 
The trace of the pharynx of the older male has a greater cross-sectional area than the younger 
male along most of its length, suggesting a larger APmean and VP. The lowest distal point on 
the traces represent the glottis and it can be seen that the AG is greater in the older male than 
the younger male, and that the location of the glottis as a function of distance along the airway 
is similar in the older and younger males, suggesting pharyngeal length is similar.
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See Figure 2.5 for full description of acoustic trace. The older male had larger APmean,  
VP and AG than the younger male, but pharyngeal length was similar. See text for further  
description.
Overall, the pharyngeal calibre of older males was significantly greater than younger males 
according to  the APmean (older:  4.7,  IQR 3.8,  6.5 cm2;  younger:  3.4,  IQR 2.8,  4.6 cm2; 
p=0.03)  (Figure  5.3,  upper  panel).  Older  males  also  had  a  significantly greater  AG than 
younger males (older: 2.9, IQR 2.1, 4.0 cm2; younger: 1.2, IQR 1.1, 1.9 cm2; p=0.003) which 
by definition is the narrowest point on the pharyngeal acoustic reflection trace (Figure 5.3, 
lower panel). There was a tendency for VP to be greater in older males than younger males, 
however  this  just  failed to reach statistical  significance (older:  34.9,  IQR 30.9,  54.1 cm3; 
younger: 27.2, IQR 22.7, 44.2 cm3; p=0.053) (Figure 5.4, upper panel). Pharyngeal length was 
similar in older males and younger males (older: 8.4, IQR 7.4, 9.6 cm; younger: 8.1, IQR 7.6,  
8.7 cm; p=0.9) (Figure 5.4, lower panel).
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Figure 5.2: Original acoustic traces of the pharynx from an older and younger male. 
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Each  data  point  represents  one  subject.  The  mean  pharyngeal  area was  significantly  
greater in older males, suggesting that they had a larger pharyngeal calibre overall. The  
glottis area was also greater in the older males; the glottis area is the narrowest point in  
the airway that can be measured by acoustic reflection.
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Figure 5.3: Mean pharyngeal area (upper panel) and glottis area (lower panel) in younger  
and older males. 
Younger Older
G
lo
tti
s 
A
re
a 
(c
m
2 )
p = 0.003
M
ea
n 
P
ha
ry
ng
ea
l A
re
a 
(c
m
2 ) p = 0.03
There was a tendency for  pharyngeal volume to be greater in older males, however this  
failed to reach statistical significance. There was no significant difference in pharyngeal  
length.
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Figure 5.4: Pharyngeal volume (upper panel) and pharyngeal length (lower panel) in older  
and younger males. 
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5.4. Discussion
The main findings of this study were that the pharyngeal calibre of healthy older males was 
significantly greater than the pharyngeal calibre of healthy younger males when groups were 
matched  for  BMI,  neck  circumference,  subjective  daytime  sleepiness,  AHI  and  ODI. 
However,  pharyngeal  length  was  not  significantly  different  in  older  males  compared  to 
younger males.
5.4.1. Limitations
As in Chapter 3, the main limitation of this study was the use of AR to make measurements of 
pharyngeal  calibre.  The  AR device  requires  subjects  to  be  awake  during  measurements, 
meaning potentially important differences between the pharynx of older and younger males 
that occur during sleep may have been missed. Another limitation of the acoustic reflection 
technique  is  that  it  requires  subjects  to  elevate  their  soft  palate  in  order  to  occlude  the 
nasopharynx. This allows the oropharynx to be modelled as a continuous tube. The result of 
this  is  that  measurements  of  pharyngeal  calibre  exclude  the  retro-palatal  region  of  the 
pharynx,  and measurements  of  pharyngeal  length  are  made  between  the  incisors  and the 
glottis and include measurement of the oral cavity. Other studies utilising imaging techniques 
such as CT and MRI measure the pharyngeal length from the hard or soft palate to the glottis. 
Therefore  measurements  of  pharyngeal  length  reported  in  this  study  are  not  directly 
comparable  to  imaging  studies.  This  limitation  was  overcome  by  also  performing 
measurements of the pharynx using MRI. This data will be analysed at a later time.
5.4.2. Differences in Pharyngeal Calibre Between Older and Younger Males 
The finding that pharyngeal calibre is greater in older males than younger males is consistent 
with some studies (Brooks and Strohl, 1992; Burger et al., 1992; Mayer et al., 1996; Tagaya et 
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al., 2011), however it contradicts others (Brown et al., 1986; Huang et al., 1998; Kollias and 
Krogstad, 1999b; Martin et al., 1997; Shigeta et al., 2008b). The reasons for these differing 
results are not clear, however a range of techniques, populations and methodologies have been 
used and may have contributed to some of the variability in the observations. A consistent 
methodological limitation in many studies is that study populations included OSA patients by 
design, or participants were not robustly screened for the presence of OSA. Given that OSA 
prevalence (irrespective of daytime somnolence) is known to increase with age (Bixler et al., 
2001, 1998; Durán et al., 2001; Young et al., 1993), it is possible that many of these studies 
investigating the effects of age on pharyngeal calibre included participants with undiagnosed 
OSA. Table 5.3 has been constructed to further detail the methodological differences between 
studies.
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Table 5.3:Characteristics of studies reporting age-related changes in pharyngeal calibre.
Study Pharyngeal 
Measurement
Study Design/ Target 
Population
Subjects
(n)
Age
(Old vs. Young)
AHI
(/hr)
Screening 
Method
Effect of age on 
pharyngeal calibre
Brown et al. 
(1986)
Acoustic 
Reflection
Cross-sectional/ Healthy M:14
F:10
M: 32±10
F: 33±7
M: NA
F: NA
Medical history Decrease
Martin et al. 
(1997)
Acoustic 
Reflection
Cross-sectional/ Healthy M: 60
F: 54
M: 40±15
F: 45±16
M: NA
F: NA
Medical history Decrease
Huang et al. 
(1998)
Acoustic 
Reflection
Cross-sectional/ Healthy 
and OSA
M: 77
F: 78
M: 45±2
F: 33±1
M: NA
F: NA
Medical history Decrease
Kollias and 
Krogstad (1999)
Cephalometry Longitudinal/ Healthy M: 26
F: 24
Baseline : 22±2 (M); 23±2 (F)
Follow up: 43±2 (M); 43±2 (F)
M: NA
F: NA
Not stated Decrease
Shigeta et al. 
(2008)
CT Cross-sectional/ Healthy 
and OSA
M: 19
F: 19
M: 57±16
F: 51±17
M: NA
F: NA
Medical history Decrease
Brooks and 
Strohl (1992)
Acoustic 
Reflection
Cross-sectional/ Healthy M: 77
F: 98
M: 32±10
F: 33±10
M: NA
F: NA
Medical history Increase
Burger et al. 
(1992)
CT Cross-sectional/ Healthy Younger: 10
Older: 10
Younger: 28±1
Older: 66±2
Younger: 3±1
Older: 5±1
Polysomnography Increase
Mayer et al. 
(1996)
CT Cross-sectional/ Snorers 
and OSA
Younger: 45
Older: 47
Younger: 42±7
Older: 69±6
Younger: 32±31
Older: 38±24
Polysomnography Increase
Tagaya et al. 
(2011)
Visual 
morphometrics
Cross-sectional/ Healthy 
and OSA
Younger: 72
Older: 81
Younger: 31±6
Older: 67±3
Younger: 37±28
Older: 32±19
Polysomnography Increase
Malhotra et al. 
(2006)
MRI Cross-sectional/ Healthy Younger: 8
Older: 10
Younger: 35±10
Older: 65±9
Younger: 3±2
Older: 5±3
Polysomnography No change
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In studies that screened for OSA using sleep studies, findings were consistent with the present  
study. As in the present study, Burger et al. (1992) and Mayer et al. (1996) both found that  
pharyngeal  calibre was greater  in  older  age.  Malhotra  et  al.  (2006) found a tendency for 
pharyngeal  volume  to  be  greater  in  older  subjects  that  just  failed  to  reach  statistical 
significance  (p=0.08).  In  the  present  study  the  groups  were  screened  for  OSA  using 
respiratory polygraphy. Therefore it appears that when participants are adequately screened 
for  OSA,  older  participants  tend  to  have  a  greater  pharyngeal  calibre  than  younger 
participants. 
The present  study (and the  studies  cited above)  had a  cross-sectional  design and did  not 
include  long  term  follow  up  of  participants.  The  only  longitudinal  study  of  pharyngeal 
dimensions that I am aware of involved a 20 year follow up of students whose mean age was 
22.3  ±  1.8  at  baseline.  After  20  years  (at  a  mean  follow  up  age  of  42.7  ±  1.9  years)  
participants  had  a  significant  decrease  in  oropharyngeal  calibre  (Kollias  and  Krogstad, 
1999b). Data from the Wisconsin Sleep Cohort suggest that over an 8 year follow up period, 
the progression of OSA (measured as the increase in AHI over time) is significantly greater in 
people aged 45-60 years at baseline compared to people aged 30-45 years at baseline (Young 
et al.,  2002). Therefore it seems that  (Kollias and Krogstad, 1999b) may have ended their 
follow up at a crucial age for the progression of OSA, missing potentially important changes 
to the pharynx for OSA progression.
5.4.3. Differences in Pharyngeal Length Between Older and Younger Males
The finding that pharyngeal length was similar in older and younger males was contrary to 
previous studies (Malhotra et al., 2006; Shigeta et al., 2008b) and contradicts the hypothesis 
that pharyngeal length may be a mechanism for increased OSA prevalence in older age. Some 
researchers have suggested that a longer pharynx may be more collapsible than a shorter 
pharynx (Pae et al., 1997; Segal et al., 2008; see Section  1.2.5 for a full discussion). Some 
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studies have used x-ray to image the bony structures of the upper airway and have observed 
that the hyoid bone is positioned more caudally in older subjects (Pae et al., 2008). Due to the 
hyoid bone having a number of superior attachments to muscles of the tongue and pharynx it  
is  possible  that  a  more  descended  hyoid  bone  is  indicative  of  a  longer  pharynx.  Direct 
measurement of pharyngeal length using MRI and CT scans would appear to support this; 
(Shigeta et al., 2008b) and Malhotra et al. (2006) measured the length of the pharynx from the 
level of the hard palate to the level of the epiglottis and observed a significant relationship 
between increased age and pharyngeal length.
In the current study pharyngeal length was measured using acoustic reflection which has a 
number of important  differences  to  direct  imaging techniques  such as x-ray and MRI. In 
imaging studies it is common to obtain a sagittal image of the airway (or bony structures) and 
mark the bounds of the pharynx using easily identifiable anatomical landmarks such as the 
hard palate and epiglottis. Using these methods, the portion of the pharynx that is measured 
encompasses  part  of the nasopharynx,  the oropharynx and part  of  the laryngopharynx.  In 
contrast,  the acoustic reflection technique measures the length of the pharynx between the 
incisors (where the mouthpiece terminates) and glottis. This measure encompasses the oral 
cavity,  the  oropharynx and part  of  the  laryngopharynx.  The contrasting  findings  between 
previous studies  (Malhotra et al., 2006; Shigeta et al., 2008b) and the current study may be 
due to these differences in the segments of the pharynx that are measured using CT and MRI 
vs. acoustic reflection. Analysis of the MRI data collected for this study will resolve this issue 
in the future.
5.4.4. Conclusions
This study has investigated the differences in pharyngeal calibre between a group of older and 
younger males that were confirmed by sleep study to be free of OSA and that were carefully 
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matched for BMI, neck circumference, daytime sleepiness, AHI and ODI. I have shown in 
these very well matched healthy groups that older age is associated with increased pharyngeal 
calibre but no difference was found in pharyngeal length. Based on the results of this study I 
speculate that  pharyngeal calibre may be an important factor in the pathogenesis of OSA in 
older age and that a large pharyngeal calibre may be protective against OSA in older age. 
Studies in older patients will be needed to investigate this suggestion.
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Chapter 6: Changes in Pharyngeal Calibre and Neck 
Circumference Measured During Sleep Using 
Endoscopy in Patients with Heart Failure
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6.1. Introduction
Obstructive sleep apnoea is defined as cessation of airflow despite ongoing respiratory efforts, 
indicating that the pharynx has closed. Central sleep apnoea is defined as cessation of airflow 
with cessation of respiratory efforts, indicating that ventilatory drive to the respiratory pump 
muscles has decreased or is absent (see Chapter 1, Section 1.2.7). The passive airway may be 
predicted to close during central  apnoea; as neuromuscular tone to the pharyngeal  dilator 
muscles is reduced the transmural pressure would decrease. If intra-luminal pressure were to 
fall to equal or lower than extra-luminal pressure, the pharynx would collapse passively (Gold 
and Schwartz, 1996; Schwartz et al., 1998, 1988). This phenomenon has been observed in 
patients with central sleep apnoea  (Badr et al., 1995; see Chapter 1,  Figure 1.1) and airway 
narrowing has been observed during induced hypocapnic hypopnoea in healthy volunteers 
(Sankri-Tarbichi et al., 2009). Passive narrowing of the airway has also been observed during 
expiration,  the  period  of  the  respiratory  cycle  thought  to  be  associated  with  low  phasic 
respiratory and upper airway muscle tone (Morrell et al., 1998; Sankri-Tarbichi et al., 2009). 
CHF patients have a high prevalence of both CSA and OSA (Bitter et al., 2009; Ferrier et al., 
2005; Javaheri, 2006; Javaheri et al., 1998; Lanfranchi et al., 2003; MacDonald et al., 2008; 
Oldenburg et al., 2007; Schulz et al., 2007; Vazir et al., 2007).
CHF patients may be predisposed to CSA by being chronically hypocapnic with an arterial  
PCO2 close to their hypocapnic apnoeic threshold (Xie et al., 2002). Moreover, patients with 
CHF are known to have an increased hypercapnic ventilatory response which may contribute 
to breathing instability during sleep (Javaheri et al., 1998). Taken together, a predisposition to 
breathing instability may be associated with passive upper airway collapse during central 
apnoeic events in patients with CHF.
Passive pharyngeal narrowing and collapse has not been directly measured in CHF patients 
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before, however the rostral fluid shift hypothesis predicts that this phenomenon is likely to 
occur.  Displacement  of  fluid from the legs  to  the neck may increase extra-luminal  tissue 
pressure, resulting in decreased pharyngeal calibre (Shiota et al., 2007), increased pharyngeal 
resistance (Chiu et al., 2006) and increased pharyngeal collapsibility (Su et al., 2008).
The aims of this study were twofold; the first aim was to investigate whether CHF patients 
with  CSA (CHF-CSA)  experience  any passive  pharyngeal  collapse  during  central  sleep 
apnoea.  The second aim was to determine  any effects of rostral  fluid shift  on pharyngeal 
calibre across the night and during sleep in CHF-CSA patients. I tested two hypotheses: 1) 
that CSA is  associated  with  passive  pharyngeal  collapse  in  CHF-CSA patients.  2)  that 
overnight rostral fluid shift  was associated with pharyngeal narrowing across the night and 
during sleep. In order to test both of these hypotheses, the pharyngeal lumen of CHF-CSA 
patients was directly visualised using a fibre-optic bronchoscope during sleep.
6.2. Methods
6.2.1. Ethical Review
This study was carried out while on sabbatical in Detroit, USA. The study was reviewed by 
the local Research Ethics Committee (John D. Dingell Veterans Affairs Medical Center and 
the Wayne State University Institutional Review Board; IRB number 081596MP4F) and given 
a favourable opinion. All volunteers gave written informed consent prior to participating in 
this study.
6.2.2. Subjects
CHF patients with predominantly CSA (CHF-CSA) were recruited from the John D. Dingell 
Veterans Affairs Medical Center, Detroit, USA over 6 months between February and August 
2010.  I identified potential participants by  retrospective review of the hospital's electronic 
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database of clinical records and by screening of heart  failure and sleep apnoea outpatient 
clinics.
The CHF status and diagnosis and severity of CSA of potential participants was determined 
by review of their clinical notes and clinical assessment by their clinical care team. To be 
included in the study, participants were required to be 18-85 years old, have an AHI ≥10 
events per hour with >50% of events classified as central,  have a left ventricular ejection 
fraction <40% and be in  a  clinically stable  condition,  having had no heart  failure-related 
hospital admission in the 3 months prior to recruitment. Potential participants were excluded 
from the study if they had previously undergone upper airway surgery, had uncontrolled or 
treatment-resistant  hypertension  or  were  known  to  have  recent  or  current  problems  with 
opioid abuse. Patients that met the inclusion/exclusion criteria were approached by a member 
of their clinical care team and invited to participate in this study. Following informed consent, 
patients were asked to attend the research sleep laboratory at the John D. Dingell Veterans 
Affairs  Medical  Center  for  one  night.  Patients  were  asked  to  restrict  their  sleep  to 
approximately 4 hours on the night before the study and to abstain from caffeine or alcohol on 
the day of the study.
6.2.3. Materials and Data Acquisition
Prior to sleep, anthropometric measurements were performed including height, weight, neck 
circumference  and  routine  lung  function.  Patients  were  then  set  up  for  the  sleep  study.  
Sleep/wake state was measured using standard polysomnography techniques. A commercial 
polysomnography system (Comet-PLUS, Grass Technologies, USA) was used to record brain 
waves  (EEG),  eye  movements  (EOG),  chin  muscle  activity  (EMG),  heart  rate  (ECG), 
breathing  movements  (using  respiratory inductance  plethysmography)  and arterial  oxygen 
saturation (using a pulse oximeter attached to the ear).
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Patients were attached to a bi-level positive air pressure (BiPAP) ventilator via a nasal mask 
prior to sleep.  Attached to the mask was a pneumotachometer (range 0-160 L/min, Series 
3700, Hans Rudolph Inc, USA) coupled with a pressure transducer (Series 1110 PA-1, Hans 
Rudolph Inc, USA) for recording of airflow. End-tidal carbon dioxide was sampled at the 
nose  and  measured  using  an  infra-red  carbon  dioxide  analyser  (Model  CD-3A,  AEI 
Technologies, USA). Pressure at the mask was measured using a pressure transducer (Series 
1110 PA-1, Hans Rudolph Inc, USA). Oesophageal pressure was measured using a solid-tip 
pressure manometer  (Mikro-Tip pressure catheter,  Millar  Instruments,  USA) passed trans-
nasally and positioned just below the palatal rim. A paediatric fibre-optic bronchoscope was 
positioned at  the approximate level of the palatal  rim, allowing visualisation of the retro-
palatal and retro-glossal pharyngeal lumen. The tip of the oesophageal pressure manometer 
was used to assist with locating the bronchoscope at  the correct level of the airway. This 
procedure was carried out by a trained physician (Dr Sankri-Tarbichi; see Sankri-Tarbichi et 
al.,  2009).  All  signals  were  amplified  via  an  analogue  to  digital  converter  (Powerlab, 
ADInstruments, USA) and data was recorded via data acquisition software (LabChart Pro, 
ADInstruments, USA) that was synchronised with the video images of the airway from the 
bronchoscope and the polysomnography data.
6.2.4. Protocol
After  monitoring  equipment  had been  attached,  patients  were  allowed to  fall  asleep  in  a 
supine  posture.  The  BiPAP ventilator  was  set  to  deliver  the  lowest  continuous  pressure 
possible (baseline pressure of 2 cmH2O). The bronchoscope was adjusted when necessary 
throughout  the  night  in  order  to  maintain  a  clear  image  of  the  pharyngeal  lumen. 
Measurements  of  pharyngeal  cross-sectional  area  were made during  stage  I-III  non-REM 
(NREM) sleep and during central apnoeic events. Apnoeic events were identified according to 
the criteria of the AASM; central apnoeas were identified by cessation of airflow associated 
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with cessation of respiratory efforts and oesophageal pressure swings.
Patients were allowed to breathe spontaneously for at least 30 minutes of NREM sleep at the 
start of the night and at the end of the night. If central apnoeas occurred spontaneously within 
these times then no further intervention was performed. If central apnoea did not occur after 
30 minutes then patients were mechanically hyperventilated using the BiPAP ventilator in 
order to reduce PETCO2 and induce central apnoea. Mechanical ventilation was applied for 3 
minute periods and then abruptly returned to baseline pressure (2 cmH2O). Hyperventilation 
was  induced  by increasing  inspiratory  pressure  by 1-2  cmH2O, while  keeping  expiratory 
pressure constant at 2 cmH2O. Inspiratory pressure was increased by greater increments above 
baseline  in  subsequent  periods  of  mechanical  ventilation  until  termination  of  ventilation 
resulted in central apnoea. 
6.2.5. Data Analysis
Polysomnography data were used for real-time sleep staging and classification of apnoeas as 
central,  obstructive  or  mixed.  Apnoeic  events  were  later  checked  offline  for  accuracy of 
classification and to confirm the sleep stage.  Scoring of sleep stages and classification of 
apnoeas  was  performed  according  to  standard  AASM definitions  (Iber  et  al.,  2007).  See 
Chapter 3, Section 3.2.4 for definitions of apnoeas and hypopnoeas.
Image Analysis
Images of the pharyngeal lumen were sampled from periods of interest throughout the night 
(see Central  Apnoea Analysis  and Dynamic Pharyngeal Compliance Analysis  below). The 
cross-sectional  area  of  the  pharynx  was  measured  by manually  outlining  the  pharyngeal 
lumen in  each video frame using  image analysis  software (ImageJ,  National  Institutes  of 
Health, USA). The measurements of pharyngeal cross-sectional area were calibrated in each 
frame using the tip of the oesophageal pressure manometer as a reference point with a known 
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cross-sectional area. Image frames where the tip of the pressure manometer could not be seen 
were excluded from analysis. 
Central Apnoea Analysis
The start of a central apnoea was defined as the point of peak expiratory flow immediately 
preceding cessation of airflow. The end of central apnoeas was defined as the point at which a  
positive  inspiratory  airflow  was  detectable,  which  preceded  resumption  of  ventilatory 
deflections in  airflow. Images of the pharyngeal lumen recorded by video were inspected 
frame by frame between the start and end of central apnoeas to determine whether the airway 
occluded. If airway occlusion did occur, the time to occlusion was measured.
Dynamic Pharyngeal Compliance Analysis
In order to quantify the extent to which the pharyngeal calibre varies over the respiratory 
cycle, and to determine whether this variation changes overnight, a novel measure of within-
breath dynamic pharyngeal compliance was conceived.
Pharyngeal cross-sectional area, airflow and mask pressure were measured simultaneously at 
5 points in the respiratory cycle: 1) beginning inspiration (BI), defined as the point at which 
airflow  crossed  from positive  to  negative;  2)  peak  inspiration  (PI),  defined  as  the  peak 
inspiratory  airflow;  3)  beginning  expiration  (BE),  defined  as  the  point  at  which  airflow 
crossed from negative to positive; 4) peak expiration (PE), defined as the peak expiratory 
airflow; 5) end expiration (EE), defined as the point at which airflow crossed from positive to  
negative  to  begin  a  new respiratory cycle.  Breaths  were  sampled  from periods  of  stable 
breathing,  during  stage  I-III  NREM sleep.  The within-breath  dynamic  compliance  of  the 
pharynx was then calculated during the inspiratory and expiratory phases of respiration.
Inspiratory dynamic compliance was calculated as the change in pharyngeal cross-sectional 
area between BI and EI. Expiratory dynamic compliance was calculated as the change in 
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pharyngeal cross-sectional area between BE and EE. Changes in pharyngeal cross-sectional 
area were divided by the change in mask pressure (Pmask) between BI and EI or BE and EE 
respectively in order to control for the confounding effect of ventilator pressure on pharyngeal 
cross-sectional area. The formula for inspiratory dynamic compliance (I-DC) and expiratory 
dynamic compliance (E-DC) are given in equations 1 and 2 below:
I-DC = 
Equation 1: Inspiratory dynamic pharyngeal compliance.
E-DC = 
Equation 2: Expiratory dynamic pharyngeal compliance.
6.3. Results
6.3.1. Subjects
From a population of approximately 1700 patients who had undergone polysomnography at 
the John D. Dingell Medical Center in the 5 years preceding this study (February 2005 to 
August 2010), 38 potential participants were identified on the basis of having both CHF and 
some form of  sleep apnoea  (AHI >10 events/hr;  see  Figure  6.1).  After  further  review of 
clinical notes and sleep studies, 34 patients were excluded from participation in the study (10 
had predominant OSA, 17 opioid abuse, 5 could not be contacted, 2 declined). Four patients  
were recruited for this study, however it was not possible to complete data collection and 
analysis in the fourth patient within the time limits of the collaboration, therefore the data 
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EI cross-sectional area – BI cross-sectional area
EI Pmask – BI Pmask
EE cross-sectional area – BE cross-sectional area
EE Pmask – BE Pmask
from  3  patients  are  presented  in  this  chapter  (see  consort  diagram,  Figure  6.1).  The 
characteristics of the 3 patients are given in Table 6.1.
See text for further description.
156
Figure 6.1: Consort diagram for the recruitment of CHF patients with predominant CSA.
Clinical records screened for eligible 
patients
= ~1700
Patients with confirmed heart failure 
and AHI >10 events/hr= 38
Recruited = 4
Studied = 3
Excluded = 34
OSA = 10
Opioid abuse = 17
Could not contact = 5
Declined = 2
Table 6.1. Patient characteristics and sleep parameters for 3 patients studied.
Patient A Patient B Patient C
Age (years) 37 44 41
Gender F F F
BMI (kg/m2) 26.4 47.8 39.9
ESS 15 14 16
FVC (% predicted) 79 73 71
FEV1 (% predicted) 74 88 71
FEV1/FVC 86 120 79
Resting CO2 (mmHg) 36.5 39.2 40.5
Resting SpO2 (%) 96 95 98
Systolic BP (mmHg) 125 120 164
Diastolic BP (mmHg) 84 75 100
Resting HR (beats/min) 70 60 68
Left Ventricular Ejection Fraction (%) 20 45 35
AHI (events/hr) 16 46.4 31.8
Central Apnoea Index (events/hr) 1.3 9 11.5
Obstructive Apnoea Index (events/hr) 0 5.3 0.3
Hypopnoea index (events/hr) 14.7 32.1 20
Arousal Index (arousals/hr) 8.4 29.7 25.3
Oxygen Desaturation Index (≥4% desats/hr) 5.5 52.9 36.8
6.3.2. Spontaneous and Induced Central Apnoeas
All three patients experienced spontaneous central apnoeas during their sleep study, and all 
three patients were also mechanically ventilated for periods of the night in order to induce 
further  hyperventilation  and  central  apnoeas.  Not  all  periods  of  mechanical  ventilation 
resulted in central apnoeas, and not all central apnoeas were analysed due to movement of the 
bronchoscope  rendering  the  images  of  the  pharynx  unusable.  Table  6.2 summarises  the 
number of spontaneous central apnoeas and induced central apnoeas for each patient.
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Table 6.2. Number of spontaneous central apnoeas and induced central apnoeas yielding  
usable images for analysis in 3 patients. 
Patient A Patient B Patient C
Spontaneous Central Apnoeas:
Total Spontaneous Central Apnoeas (n) 2 3 14
Spontaneous apnoeas yielding usable images (n) 0 3 4
Induced Central Apnoeas:
Mechanical Ventilation Periods (n) 3 1 1
Mechanical ventilation resulting in central apnoea (n) 3 0 1
Induced apnoeas yielding usable images (n) 3 0 1
Total Central Apnoeas Analysed 3 3 5
Patient A
Patient A yielded 3 central apnoeas that were suitable for analysis, all of which were induced 
using mechanical ventilation. All three apnoeas resulted in narrowing of the pharynx and the 
pharynx completely occluded during two of the apnoeas.  Table 6.3 summarises the results 
from the three apnoeas.
Table 6.3. Results of apnoea analysis for Patient A.
Induced 1 Induced 2 Induced 3
Sleep stage during apnoea 2 1 2
Mask pressure during apnoea (cmH2O) 1.5 1.5 1.5
Apnoea duration (s) 13.7 16.1 9.8
Pharyngeal occlusion (Y/N) Y N Y
Pre-apnoea EE lumen area (mm2) 2.6 3.1 2.7
Min. lumen area (mm2) 0 1.4 0
Min. lumen area (% pre-apnoea EE lumen area) 0% 45% 0%
Time to min. lumen area (s) 3.3 1.9 4.5
Time to min. lumen area (% apnoea duration) 24% 12% 46%
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Patient B
Patient  B  yielded  3  central  apnoeas  that  were  suitable  for  analysis,  all  of  which  were 
spontaneous central apnoeas. All three apnoeas resulted in narrowing of the pharynx and the 
pharynx completely occluded during one of the apnoeas. Table 6.4 summarises the results of 
the three apnoeas.
Table 6.4. Results of apnoea analysis for Patient B.
Spon. 1 Spon. 2 Spon. 3
Sleep stage during apnoea 2 2 3
Mask pressure during apnoea (cmH2O) 1.4 1.4 1.5
Apnoea duration (s) 10.6 10.1 9.9
Pharyngeal occlusion (Y/N) N Y N
Pre-apnoea EE lumen area (mm2) 6.4 NA* 9.6
Min. lumen area (mm2) 2.6 0.0 6.1
Min. lumen area (% pre-apnoea EE lumen area) 41% 0% 64%
Time to min. lumen area (s) 7.2 1.8 9.9
Time to min. lumen area (s, % apnoea duration) 68% 18% 100%
*Scope moved, image unusable.
Patient C
Patient  C  yielded  5  central  apnoeas  that  were  suitable  for  analysis,  4  of  which  were 
spontaneous central apnoeas and 1 of which was induced by mechanical ventilation. Three of 
the spontaneous apnoeas resulted in narrowing of the pharynx, however in  the fourth the 
pharyngeal  cross-sectional  area  increased.  The  apnoea  induced  by mechanical  ventilation 
resulted  in  complete  occlusion  of  the  pharynx.  Table  6.5 summarises  the  results  of  the 
apnoeas.
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Table 6.5. Results of apnoea analysis for Patient C
Spon. 1 Spon. 2 Spon. 3 Spon. 4 Ind. 1
Sleep stage during apnoea 1 1 1 1 2
Mask pressure during apnoea (cmH2O) 1.6 1.5 1.7 1.7 1.6
Apnoea duration (s) 11.2 9.6 12.9 11.6 13.9
Pharyngeal occlusion (Y/N) N N N N Y
Pre-apnoea EE lumen area (mm2) 30.8 10.2 12.7 18.0 3.1
Min. lumen area (mm2) 15.1 3.9 10.5 21.4 0
Min. lumen area (% pre-apnoea EE lumen area) 49% 38% 83% 119% 0
Time to min. lumen area (s) 4.2 9.6 12.9 11.6 9.6 
Time to min. lumen area (% apnoea duration) 38% 100% 100% 100% 69%
6.3.3. Pharyngeal Cross-Sectional Area Across the Night During Sleep
A breakdown of pharyngeal cross-sectional area over the respiratory cycle at the start, middle 
and end of the night is presented for each patient in  Figure 6.2. Patient A showed the most 
dramatic change in pharyngeal cross-sectional area of the 3 patients. The bronchoscope was 
maintained in a relatively stable position for 3 periods throughout the night, allowing images 
of the pharyngeal lumen to be measured from near the start of the night (00:59 hrs), middle of 
the night (01:39 hrs) and end of the night (04:37 hrs). The pharyngeal lumen was most patent 
at  the  start  of  the  night,  then  narrowed  in  the  middle  of  the  night  across  all  phases  of 
respiration, and narrowed further by the end of the night in all phases of respiration. Patient A 
experienced an increase in neck circumference between the evening and morning, from 34.5 
cm to 35.5 cm, respectively.
Patient B also yielded usable bronchoscope images near the start of the night (01:33 hrs), 
middle of the night (02:20 hrs) and end of the night (03:26 hrs). Pharyngeal cross-sectional  
area increased slightly during all phases of respiration from the start of the night to the middle 
of the night. It then decreased in all phases of respiration at the end of the night. Overall, there 
was not a large decrease in pharyngeal cross-sectional area between the start and end of the 
160
night, however pharyngeal cross-sectional area was decreased at end inspiration/beginning 
expiration at the end of the night compared to the start of the night. Patient B experienced a 
decrease in neck circumference between the evening and morning, from 46 cm to 44.5 cm, 
respectively.
Patient  C  had  the  smallest  pharyngeal  lumen  of  the  3  patients  and  yielded  usable 
bronchoscope images from near the start of the night (01:57 hrs) and end of the night (03:30 
hrs).  Pharyngeal  cross-sectional  area  decreased  across  all  phases  of  the  respiratory cycle 
between the start and end of the night (Figure 6.2). Patient C experienced a slight increase in 
neck circumference between the evening and morning, from 37.5 cm to 38.0 cm, respectively.
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Each line represents the mean of 5 breaths sampled during stable breathing during the start, middle and end of night; error bars represent SD.  
Patient C had no data available from the middle of the night. BI, Beginning Inspiration; PI, Peak Inspiration; EI/BE, End Inspiration/Beginning  
Expiration; PE, Peak Expiration; EE, End Expiration.
Figure Key: Solid line: start of night; dotted line: middle of night; dashed line: end of night.
Figure 6.2: Changes in pharyngeal cross-sectional area related to respiratory phase. 
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6.3.4. Dynamic Pharyngeal Compliance Across the Night During Sleep
Following the analysis of pharyngeal cross-sectional area across the night during sleep, it was 
apparent  that  the  pharyngeal  lumen  varied  throughout  the  respiratory  cycle,  and  that 
pharyngeal  lumen  had  a  tendency  to  decrease  between  the  start  and  end  of  the  night. 
Furthermore,  it  appeared  that  the  normal  variation  in  the  cross-sectional  area  of  the 
pharyngeal lumen within the respiratory cycle was attenuated at the end of the night compared 
to the start of the night. This phenomenon appeared to occur in all 3 patients but was most 
apparent in Patient A, where there is a clear “flattening” of the pharyngeal cross-sectional area 
graph at  the end of the night compared to the start  and middle of the night (Figure 6.2). 
Therefore we attempted to quantify this observation by calculating the inspiratory dynamic 
pharyngeal compliance (I-DC) and the expiratory dynamic pharyngeal compliance (E-DC). 
Figure 6.3 shows changes in dynamic pharyngeal compliance across the night for Patient A, B 
and C.
Patient A had a progressive decrease in I-DC between the start of the night (10.8 IQR 4.7, 
10.9 mm2/cmH2O), middle of the night (5.1 IQR 4.4, 6.3 mm2/cmH2O), and end of the night 
(0.4 IQR -0.3, 0.9 mm2/cmH2O). The E-DC was similar at the start of the night (6.2 IQR 4.5, 
7.6  mm2/cmH2O)  and  the  middle  of  the  night  (5.6  IQR 5.6,  6.4  mm2/cmH2O),  but  was 
decreased at the end of night (0.5 IQR 0.4, 0.8 mm2/cmH2O).
Patient B had a progressive decrease in I-DC between the start of the night (4.2 IQR 3.3, 4.9 
mm2/cmH2O), middle of the night (2.6 IQR 2.0, 3.4 mm2/cmH2O), and end of the night (1.5 
IQR 0.8, 1.6 mm2/cmH2O). The E-DC also progressively decreased from the start of the night 
(4.8 IQR 4.3, 5.7 mm2/cmH2O), middle of the night (2.9 IQR 1.9, 4.6 mm2/cmH2O), and end 
of night (1.8 IQR 0.8, 2.3 mm2/cmH2O).
Patient C did not have usable data during the middle of the night therefore only data from the 
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start and end of the night are reported. In contrast to the other 2 patients, I-DC and E-DC were 
both low at the start of the night. There was also very little change between the start and end 
of the night in I-DC (-0.5 IQR -0.7, -0.1 mm2/cmH2O vs. -0.02 IQR -0.2, 0.2 mm2/cmH2O) or 
E-DC (0.4 IQR -0.1, 0.5 mm2/cmH2O vs. 0.3 IQR -0.3, 0.6 mm2/cmH2O).
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Patient C had no data available during the middle of the night. Box and whisker plots represent the median and interquartile range of 5 breaths  
sampled during stable breathing at the start, middle and end of night.
Figure 6.3: Inspiratory and expiratory dynamic pharyngeal compliance. 
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6.4. Discussion
The  main  findings  of  this  study were  that  progressive  pharyngeal  narrowing  or  collapse 
occurred for all CHF-CSA patients and in all but one apnoea. Neck circumference increased 
and pharyngeal cross-sectional area decreased overnight in 2 out of 3 CHF-CSA patients, and 
a new method for quantifying the within-breath dynamic compliance of the pharynx showed 
that dynamic pharyngeal compliance was decreased between the start and end of the night in 2 
out of 3 CHF-CSA patients.
6.4.1. Limitations
The main limitation of this study was the small number of participants. The population from 
which the study sample was drawn had a high prevalence of obesity and opioid abuse which 
made it difficult to recruit CHF patients with predominant primary CSA. However, the small 
numbers  also  allowed a  more  explorative  approach to  data  analysis,  which  led  to  a  new 
method to be conceived for quantifying the dynamic compliance of the pharynx within the 
respiratory cycle, which may be of use in future studies with further validation.
6.4.2. Pharyngeal Narrowing and Collapse During Central Sleep Apnoea
The pharynx passively narrowed during  all  central  apnoeas  in  all  3  heart  failure  patients 
(except one apnoea where the pharyngeal cross-sectional area appeared to increase) and the 
pharynx completely occluded during central apnoea at least once in all 3 patients and in 5 out 
of a total of 11 apnoeas observed in all patients.
Passive pharyngeal collapse during central apnoea was first observed by Badr et al. (1995). 
These researchers (some of whom were part of the team that I collaborated with on this study) 
demonstrated  that  in  patients  with  predominantly  central-  or  mixed-  sleep  apnoea,  the 
majority of central apnoeas resulted in progressive passive narrowing and occlusion of the 
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pharynx. This finding led them to suggest that the mechanisms of central  and obstructive 
sleep apnoea are linked. They postulated that one of the causes for pharyngeal collapse during 
central  apnoea  could  be  increased  extra-luminal  pressure  and  that  passive  expiratory 
narrowing of the pharynx could also be a mechanism for obstructive sleep apnoea. This view 
was supported by Morrell et al. (1998) when they found that the pharyngeal lumen became 
progressively narrower at end-expiration in the 4 breaths preceding an obstructive apnoea in 
patients with OSA. This occurred at  positive intra-luminal pressure, suggesting that extra-
luminal positive pressure was greater than intra-luminal pressure and was sufficient to cause 
expiratory pharyngeal narrowing. The findings from the present study support the findings of 
Badr et al. (1995) and are the first data to measure progressive pharyngeal narrowing during 
central  apnoea  in  CHF  patients.  Similarly  to  Morrell  et  al.  (1998),  passive  pharyngeal 
narrowing occurred at positive pressure, suggesting that positive extra-luminal pressure may 
have caused passive pharyngeal narrowing and/or collapse in the CHF patients of this study.
6.4.3. Pharyngeal Cross-Sectional Area Across the Night During Sleep
Pharyngeal cross-sectional area decreased between the start and end of the night in 2 out of 3 
patients and this was reflected in an overnight increase in neck circumference in the same 2 
CHF-CSA patients. This is the first study that I am aware of that has attempted to quantify the 
overnight  change  in  pharyngeal  calibre  during  sleep  in  any  population.  In  chapter  3, 
pharyngeal calibre was measured during wake in CHF patients and no difference was found 
between the evening and morning. The data from the current study suggest that overnight 
narrowing may occur in some heart failure patients during sleep. Taken together, these data 
are consistent with research suggesting that neuromuscular tone may compensate for a narrow 
pharynx during wake, but during sleep this compensation is reduced or absent  (Fogel et al., 
2005).
167
6.4.4. Dynamic Pharyngeal Compliance Across the Night During Sleep
Another interesting finding from this study with respect to overnight changes in pharyngeal 
calibre was that the dynamic behaviour of the pharynx within a respiratory cycle appeared to 
be altered overnight. All 3 patients had a tendency for the normal variation in pharyngeal 
calibre over the respiratory cycle to be attenuated at the end of the night. To explore this, a 
new measure was conceived to quantify the magnitude of the change in pharyngeal calibre 
during inspiration and expiration which we have called within-breath dynamic pharyngeal 
compliance. Two out of three patients in this study had a tendency for both I-DC and E-DC to 
decrease progressively from the start of the night to the end of the night. In the case of Patient  
B, dynamic pharyngeal compliance decreased between the start of the night and the middle of 
the  night,  despite  the  absolute  pharyngeal  calibre  increasing.  This  suggests  that  a  fixed 
measurement  alone  of  pharyngeal  calibre  may not  be  sufficient  to  describe  the  dynamic 
behaviour of the pharyngeal lumen during sleep.
A similar pattern of decreased dynamic pharyngeal compliance can be observed in the data of 
Sankri-Tarbichi  et  al.  (2009).  They  induced  hypocapnic  hypopnoea  using  mechanical 
ventilation in healthy volunteers and found that expiratory pharyngeal calibre was decreased 
during  hypopnoea.  Dynamic  pharyngeal  compliance  was  not  quantified  in  their  paper, 
however, a similar pattern of “flattening” of the pharyngeal lumen trace can be observed in 
their hypopnoeas compared to eupnoeic breaths. In the present study the same pattern was 
observed to occur between the start and end of the night during eupnoea. Given that neck 
circumference increased overnight in 2 out of 3 patients, and given that dynamic pharyngeal 
compliance was measured during eupnoea at the start and end of the night, the present study 
suggests that dynamic pharyngeal compliance may have been affected by passive mechanical 
forces acting on the pharyngeal lumen. This observation is consistent with the physiological 
model  proposed  by  Shepard  et  al.  (1996) whereby  extra-luminal  fluid  may  attenuate 
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inspiratory pharyngeal dilation (see Chapter 1, Figure 1.3).
6.4.5. Implications for the Pathogenesis of Sleep Apnoea in Heart Failure
This study has confirmed that passive pharyngeal narrowing occurs in CHF-CSA patients. 
Given that passive pharyngeal narrowing has been observed in CSA and OSA patients without 
heart failure, it is reasonable to suggest that passive pharyngeal narrowing may also contribute 
to  the  pathogenesis  of  SDB in CHF, particularly given the tendency for  CHF patients  to 
present  with a mixture of  central  and obstructive respiratory events  during a single night 
(Tkacova et al., 2001) and across several nights (Vazir et al., 2007). The data from this study 
showing an overnight increase in neck circumference associated with an overnight decrease in 
pharyngeal  calibre during  sleep suggests  that  rostral  fluid  shift  could  be a  mechanism of 
increased extra-luminal pressure leading to pharyngeal narrowing and collapse during sleep. 
However, these data are not supported by the studies in Chapter 3. One possible reason for 
this could be that measurements of the pharynx were made during wake in Chapter 3, whereas 
they were made during sleep in this study. Taken together, the data from Chapter 3 and this 
study  suggest  that  the  pharynx  may  undergo  overnight  narrowing  during  sleep  in  CHF 
patients, but that this is compensated for during wake, perhaps by increased neuromuscular 
tone (Fogel et al., 2005, 2003).
The progressive overnight decrease in dynamic pharyngeal compliance in 2 out of 3 patients 
may have important repercussions for the pathogenesis of OSA in CHF. This supports the 
theory that rostral fluid shift may attenuate normal pharyngeal dilation during inspiration. A 
decreased pharyngeal cross-sectional area could increase the risk of pharyngeal occlusion due 
to negative intra-luminal pressure and/or positive extra-luminal pressure.
In summary, it has been shown that the pharyngeal lumen of CHF-CSA patients is subject to 
passive narrowing and closure during central apnoea. Furthermore, it has been shown that an 
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increase  in  neck circumference  is  associated  with  overnight  pharyngeal  narrowing during 
sleep; these may also be associated with decreased inspiratory expiratory dynamic pharyngeal 
compliance.  Therefore this  study supports  the theory that  rostral  fluid shift  may result  in 
increased  extra-luminal  pressure  being exerted  on  the  pharynx during  sleep,  sufficient  to 
increase the propensity for airway narrowing.
170
Chapter 7: General Discussion
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7.1. Summary of Aims
OSA is prevalent in CHF but the reasons for this are are not clear. CHF patients with OSA are  
typically older,  do not  present  with daytime somnolence,  and have a  BMI similar  to  the  
general population. This contrasts with OSA patients without CHF who  present in clinic as 
being typically  middle-aged,  with  daytime  somnolence  and  are  overweight  or  obese.  A 
recently proposed mechanism to explain the high prevalence of OSA in CHF is retention of 
fluid during the day, and rostral fluid shift during the night, increasing extra-luminal pressure 
on the pharynx. The aim of this thesis was to investigate whether this mechanism contributed 
to the development of OSA in CHF. The studies in  this  thesis  have also investigated the 
properties of the pharynx of CHF patients by measuring pharyngeal anatomical dimensions 
via indirect and direct techniques, and pharyngeal collapsibility during sleep.
7.2. Summary and Discussion of Main Findings
To  investigate  the  role  of  pharyngeal  calibre  in  the  pathophysiology  of  OSA in  CHF, 
measurements were made non-invasively using acoustic reflection in 14 CHF-OSA patients, 
14  CHF-only  patients  and  15  healthy  age-matched  controls.  Neck  circumference  and 
pharyngeal calibre were also measured in the seated and supine posture, in the evening and 
morning, in order to determine any differential effects of posture change and overnight rostral 
fluid shift on pharyngeal calibre. The results of this study showed that the pharyngeal calibre 
of CHF-OSA patients was similar  to  CHF-only patients and healthy controls.  It  was also 
shown that neck circumference increased and pharyngeal calibre decreased in all groups when 
assuming a supine posture. Finally it was shown that pharyngeal calibre decreased overnight 
in the healthy controls but not in the CHF-OSA or CHF-only patients. Based on these findings 
I have argued that rostral fluid shift may be a normal physiological phenomenon, but that it is 
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not a major mechanism for OSA in CHF.  Measurements of pharyngeal calibre were made 
during  wake  in  this experiment.  Therefore  this  argument  assumes  that  the  overnight 
differences  observed  in  the  healthy controls would  be  similar  if  made during  sleep.  It  is 
known that there is a decrease in pharyngeal dilator muscle tone in sleep compared to wake 
(Lo et al., 2007; Mezzanotte et al., 1992). It could be argued that a  fluid shift-related effect 
great enough to be  detectable during wake, while pharyngeal dilator muscle tone is higher, 
would also be likely to be detectable during sleep, when pharyngeal muscle tone is lower. 
This would need to be confirmed by further controlled experiments.
To further investigate the possible mechanisms by which rostral fluid shift may contribute to 
OSA in CHF, 13 CHF-OSA, 10 CHF-only and 8 healthy controls underwent measurement of 
their  pharyngeal  collapsibility  using  the  Pcrit  technique.  Pharyngeal  collapsibility  was 
measured  in  the  early  and  late  part  of  the  night  in  order  to  determine  whether  it  was 
influenced  by  fluid  shift.  As  with  pharyngeal  calibre,  it  was  found  that  the  pharyngeal 
collapsibility of CHF-OSA patients was similar to CHF-only patients and healthy controls. 
Furthermore, there was no significant change in pharyngeal collapsibility overnight in any 
group. These findings combined with the previous findings regarding pharyngeal calibre led 
me to speculate that  fluid shift does not have a substantial impact on pharyngeal calibre or 
collapsibility in the a CHF population.
In order to  investigate any impact of age on the pharyngeal calibre, 12 healthy older males 
(age >60 years) and 14 healthy younger males (age 18-40 years) underwent measurements of 
pharyngeal calibre using AR. The groups were closely matched for BMI, neck circumference, 
AHI and ODI. It was found that the pharyngeal calibre of the older males was significantly 
greater  than  that  of  younger  males.  This  finding is  supported  by  other  studies  utilising 
different  methods  of  pharyngeal  measurement, that have  also  found  that  older  subjects 
without SDB  have  a  larger  pharyngeal  calibre  than  younger  subjects  without SDB  (see 
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Chapter 5,  Table 5.3).  This finding could be explained by two possible phenomena. First, it 
could be possible that the younger group represented a “normal” range of pharyngeal calibres. 
Thus the older group may have reflected a survivor effect whereby older people who survive 
to >60 years old without developing OSA may possess protective phenotypes such as a large 
pharynx. Alternatively, the older group may have been composed of people with a “normal” 
range of pharyngeal calibres. Thus the younger group may have contained participants with a 
smaller airway. This would reflect a phenotype that placed them at greater risk of developing 
OSA. This notion is illustrated graphically in Figure 7.1.
In Figure 7.1 the typical onset of SDB, and particularly OSA, in middle-age is represented by 
the left-most hatched area and is characterised as an age-related disorder. This is because SDB 
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Figure 7.1: Theoretical diagram illustrating the incidence of SDB as a function of age.
is associated with middle-age,  but middle-age is not likely to be causative  of SDB in itself 
(Bliwise, 2009). SDB that develops in middle-age may be associated with increased mortality 
therefore such a cohort  may be predicted to decline in numbers as age advances and the 
number of survivors decrease. However, as age increases, the risk of developing SDB  also 
increases, secondary to increased body mass, increased pharyngeal collapsibility, decreased 
sleeping pharyngeal  muscle  tone and decreased pharyngeal  muscle  fatigue resistance  (see 
General Introduction for a discussion of all these factors). Therefore such cases of SDB could 
be argued to be age-dependent as the SDB is a consequence of the age-related changes to 
physiological systems (Bliwise, 2009). Such cases of SDB would have a later onset and are 
represented by the right-most hatched area in Figure 7.1.
The younger group of participants in Chapter 5  were free of any SDB at the time of being 
studied and so would not be placed in a group of age-related SDB patients (Figure 7.1, left-
most  hatched  area).  However,  I  would  speculate  that  some  may  go  on  to  develop  age-
dependent SDB in older age due to physiological changes associated with age, coupled with a 
pre-existing  smaller  airway (Figure  7.1,  right-most  hatched  area).  The  older  group  of 
participants in Chapter 5 were free of any SDB at the time of being studied and so cannot be 
placed anywhere in the model illustrated in Figure 7.1. I would speculate that this is because 
they  either  possessed  “normal”  pharyngeal  dimensions  that  did  not  place  them  at  any 
particular risk of developing OSA in later life; or some may have been particularly resistant to 
age-dependent  SDB  due  to  possessing a  larger pharyngeal  calibre.  In  order  to  test  these 
speculations, a larger study would be required in order to determine the range of pharyngeal 
calibre's across health and disease in younger and older populations.
Finally, in Chapter 6 the effects of rostral fluid shift on pharyngeal calibre during sleep were 
assessed  by  directly  visualising  the  airway  of  3  CHF-CSA patients  using  a  fibre-optic 
bronchoscope. It was found that pharyngeal calibre was reduced during sleep. Additionally, a 
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novel  method  for  quantifying  the  within-breath  dynamic  compliance  of  the  pharynx  was 
developed  and  was  used  to  demonstrate  that  the  within-breath  dynamic  pharyngeal 
compliance is also decreased overnight during sleep in CHF-CSA patients.
7.3. Future Directions
There were a number of novel findings in this thesis that warrant further investigation. The 
data in Chapter 5 could be used as a basis for a larger study including groups of older and 
younger females, and older and younger OSA patients. This study would address the effect of 
ageing per se on pharyngeal calibre in patients with OSA, and also the effect of gender, as the 
majority of patients studied in this thesis were male.
One of the difficulties in comparing the findings of the studies investigating rostral fluid shift 
to research in this field, is that previous studies have been uncontrolled observational studies. 
These studies have firmly established a correlation between rostral fluid shift and various risk 
factors and markers of OSA. However,  in this  thesis  two studies were presented where a 
control group of healthy age-matched volunteers displayed similar or greater evidence of fluid 
shift than CHF patients. I speculated that optimal treatment on diuretics attenuated fluid shift 
in CHF patients, and so fluid shift may not be a significant mechanism of OSA in such a 
group of CHF patients. Further investigation of the effect of diuretics and other fluid control 
therapies would be very useful  in  evaluating the clinical  merits  of  targeting fluid control 
therapies at CHF patients with OSA.
Finally,  a novel  method for measuring within-breath dynamic pharyngeal compliance was 
conceived in collaboration with our colleagues in Detroit. The preliminary findings presented 
in  Chapter  6  suggest  that  it  may have  utility  in  investigating  the  effect  of  extra-luminal 
pressure on the pharynx, independent of changes in pharyngeal calibre. Before this measure is 
used further, it should be validated against conventional measures of pharyngeal compliance.
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7.4. Conclusion
Overall, the findings from the studies presented in this thesis suggest that the mechanism of 
OSA in CHF is not a compromised pharyngeal calibre or increased pharyngeal collapsibility; 
although  the  possibility  cannot  be  ruled  out  because  changes  in  pharyngeal  calibre  were 
measured during wakefulness, not sleep. As age increases, the risk of developing OSA may 
also increase; therefore OSA in CHF may reflect the fact that CHF patients are older, and an 
age-related increase in OSA coincides with an age-related onset of CHF. 
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